{"AllianceGenome": "6893", "HGNC": "6893", "MIM": "157140", "_id": "4137", "_version": 2, "accession": {"genomic": ["AC004139.2", "AC010792.4", "AC217771.1", "AC217779.1", "AC243621.2", "AC243658.3", "AH005895.2", "BX544879.6", "CH471233.1", "CP068261.2", "CR936218.6", "HI635311.1", "JA078072.1", "JF412354.1", "KC980907.1", "NC_000017.11", "NC_060941.1", "NG_007398.2", "NT_167251.2", "NT_187663.1"], "protein": ["AAA57264.1", "AAA60615.1", "AAH00558.1", "AAH98281.1", "AAH99721.1", "AAI01937.1", "AAI14505.1", "AAI14949.1", "AAP35418.1", "AAS17881.1", "AAU45390.1", "ACJ54951.1", "AGT42007.1", "BAB71065.1", "BAG53132.1", "BAG61575.1", "BAG61605.1", "CAA32636.1", "CAG26750.1", "CBX55119.1", "CCA63951.1", "EAW93565.1", "EAW93566.1", "EAW93567.1", "EAW93568.1", "EAW93569.1", "EAW93570.1", "EAW93571.1", "EAW93572.1", "EAW93573.1", "EAW93574.1", "NP_001116538.2", "NP_001116539.1", "NP_001190180.1", "NP_001190181.1", "NP_001364194.1", "NP_001364195.1", "NP_001364196.1", "NP_001364197.1", "NP_005901.2", "NP_058518.1", "NP_058519.3", "NP_058525.1", "P10636.5", "XP_005257419.1", "XP_005257422.1", "XP_005257423.1", "XP_005257424.1", "XP_005257425.1", "XP_005257426.1", "XP_005257427.1", "XP_005257428.1", "XP_047292030.1", "XP_047292031.1", "XP_047292032.1", "XP_047292033.1", "XP_047292034.1", "XP_047292035.1", "XP_047292036.1", "XP_047292037.1", "XP_054172106.1", "XP_054172107.1", "XP_054172108.1", "XP_054172109.1", "XP_054172110.1", "XP_054172111.1", "XP_054172112.1", "XP_054172113.1", "XP_054172114.1", "XP_054172115.1", "XP_054172116.1", "XP_054172117.1", "XP_054172118.1", "XP_054172119.1", "XP_054172120.1", "XP_054172121.1", "XP_054184539.1", "XP_054184540.1", "XP_054184541.1", "XP_054184542.1", "XP_054184543.1", "XP_054184544.1", "XP_054184545.1", "XP_054184546.1", "XP_054184547.1", "XP_054186080.1", "XP_054186081.1", "XP_054186082.1", "XP_054186083.1", "XP_054186084.1", "XP_054186085.1", "XP_054186086.1", "XP_054186087.1", "XP_054186088.1", "XP_054186089.1", "XP_054186090.1", "XP_054186091.1", "XP_054186092.1", "XP_054186093.1"], "rna": ["AB073354.1", "AF456477.1", "AK055986.1", "AK095802.1", "AK226139.1", "AK299658.1", "AK299704.1", "AW161357.1", "AW295014.1", "AY526356.1", "AY730549.1", "BC000558.2", "BC032572.1", "BC040444.1", "BC061892.1", "BC071830.1", "BC094805.1", "BC098281.1", "BC099721.1", "BC101936.1", "BC114504.1", "BC114948.1", "BI552187.1", "BN000503.1", "BT006772.1", "DN996935.1", "DR002467.1", "FJ429137.1", "J03778.1", "M25298.1", "NM_001123066.4", "NM_001123067.4", "NM_001203251.2", "NM_001203252.2", "NM_001377265.1", "NM_001377266.1", "NM_001377267.1", "NM_001377268.1", "NM_005910.6", "NM_016834.5", "NM_016835.5", "NM_016841.5", "NR_165166.1", "X14474.1", "XM_005257362.5", "XM_005257365.5", "XM_005257366.4", "XM_005257367.5", "XM_005257368.5", "XM_005257369.5", "XM_005257370.5", "XM_005257371.5", "XM_047436074.1", "XM_047436075.1", "XM_047436076.1", "XM_047436077.1", "XM_047436078.1", "XM_047436079.1", "XM_047436080.1", "XM_047436081.1", "XM_054316131.1", "XM_054316132.1", "XM_054316133.1", "XM_054316134.1", "XM_054316135.1", "XM_054316136.1", "XM_054316137.1", "XM_054316138.1", "XM_054316139.1", "XM_054316140.1", "XM_054316141.1", "XM_054316142.1", "XM_054316143.1", "XM_054316144.1", "XM_054316145.1", "XM_054316146.1", "XM_054328564.1", "XM_054328565.1", "XM_054328566.1", "XM_054328567.1", "XM_054328568.1", "XM_054328569.1", "XM_054328570.1", "XM_054328571.1", "XM_054328572.1", "XM_054330105.1", "XM_054330106.1", "XM_054330107.1", "XM_054330108.1", "XM_054330109.1", "XM_054330110.1", "XM_054330111.1", "XM_054330112.1", "XM_054330113.1", "XM_054330114.1", "XM_054330115.1", "XM_054330116.1", "XM_054330117.1", "XM_054330118.1"], "translation": [{"protein": "XP_047292037.1", "rna": "XM_047436081.1"}, {"protein": "XP_054186081.1", "rna": "XM_054330106.1"}, {"protein": "XP_005257426.1", "rna": "XM_005257369.5"}, {"protein": "XP_047292032.1", "rna": "XM_047436076.1"}, {"protein": "XP_054172111.1", "rna": "XM_054316136.1"}, {"protein": "AAH00558.1", "rna": "BC000558.2"}, {"protein": "XP_054172109.1", "rna": "XM_054316134.1"}, {"protein": "XP_054172118.1", "rna": "XM_054316143.1"}, {"protein": "AAI14505.1", "rna": "BC114504.1"}, {"protein": "NP_001364194.1", "rna": "NM_001377265.1"}, {"protein": "XP_054172121.1", "rna": "XM_054316146.1"}, {"protein": "NP_058519.3", "rna": "NM_016835.5"}, {"protein": "XP_054186084.1", "rna": "XM_054330109.1"}, {"protein": "XP_054186088.1", "rna": "XM_054330113.1"}, {"protein": "NP_001364195.1", "rna": "NM_001377266.1"}, {"protein": "XP_054172112.1", "rna": "XM_054316137.1"}, {"protein": "AAI01937.1", "rna": "BC101936.1"}, {"protein": "XP_054172110.1", "rna": "XM_054316135.1"}, {"protein": "XP_047292035.1", "rna": "XM_047436079.1"}, {"protein": "XP_054184542.1", "rna": "XM_054328567.1"}, {"protein": "XP_054184539.1", "rna": "XM_054328564.1"}, {"protein": "XP_005257428.1", "rna": "XM_005257371.5"}, {"protein": "XP_047292030.1", "rna": "XM_047436074.1"}, {"protein": "XP_054186089.1", "rna": "XM_054330114.1"}, {"protein": "NP_001364196.1", "rna": "NM_001377267.1"}, {"protein": "XP_054184544.1", "rna": "XM_054328569.1"}, {"protein": "ACJ54951.1", "rna": "FJ429137.1"}, {"protein": "NP_001116539.1", "rna": "NM_001123067.4"}, {"protein": "AAH99721.1", "rna": "BC099721.1"}, {"protein": "NP_001190181.1", "rna": "NM_001203252.2"}, {"protein": "AAH98281.1", "rna": "BC098281.1"}, {"protein": "BAG61605.1", "rna": "AK299704.1"}, {"protein": "XP_054172113.1", "rna": "XM_054316138.1"}, {"protein": "NP_058518.1", "rna": "NM_016834.5"}, {"protein": "XP_054186087.1", "rna": "XM_054330112.1"}, {"protein": "NP_001116538.2", "rna": "NM_001123066.4"}, {"protein": "XP_054184541.1", "rna": "XM_054328566.1"}, {"protein": "XP_005257425.1", "rna": "XM_005257368.5"}, {"protein": "XP_005257424.1", "rna": "XM_005257367.5"}, {"protein": "XP_054172114.1", "rna": "XM_054316139.1"}, {"protein": "XP_054172119.1", "rna": "XM_054316144.1"}, {"protein": "XP_054172108.1", "rna": "XM_054316133.1"}, {"protein": "XP_054184545.1", "rna": "XM_054328570.1"}, {"protein": "XP_005257423.1", "rna": "XM_005257366.4"}, {"protein": "AAP35418.1", "rna": "BT006772.1"}, {"protein": "XP_005257419.1", "rna": "XM_005257362.5"}, {"protein": "BAG61575.1", "rna": "AK299658.1"}, {"protein": "XP_054186086.1", "rna": "XM_054330111.1"}, {"protein": "XP_054184543.1", "rna": "XM_054328568.1"}, {"protein": "XP_054186083.1", "rna": "XM_054330108.1"}, {"protein": "XP_054172120.1", "rna": "XM_054316145.1"}, {"protein": "AAI14949.1", "rna": "BC114948.1"}, {"protein": "AAA57264.1", "rna": "M25298.1"}, {"protein": "CAA32636.1", "rna": "X14474.1"}, {"protein": "XP_054172106.1", "rna": "XM_054316131.1"}, {"protein": "XP_054172116.1", "rna": "XM_054316141.1"}, {"protein": "XP_047292036.1", "rna": "XM_047436080.1"}, {"protein": "AAA60615.1", "rna": "J03778.1"}, {"protein": "XP_054186093.1", "rna": "XM_054330118.1"}, {"protein": "XP_047292033.1", "rna": "XM_047436077.1"}, {"protein": "XP_054172117.1", "rna": "XM_054316142.1"}, {"protein": "XP_047292031.1", "rna": "XM_047436075.1"}, {"protein": "AAU45390.1", "rna": "AY730549.1"}, {"protein": "XP_054186090.1", "rna": "XM_054330115.1"}, {"protein": "BAG53132.1", "rna": "AK095802.1"}, {"protein": "XP_047292034.1", "rna": "XM_047436078.1"}, {"protein": "AAS17881.1", "rna": "AY526356.1"}, {"protein": "NP_005901.2", "rna": "NM_005910.6"}, {"protein": "XP_054186082.1", "rna": "XM_054330107.1"}, {"protein": "XP_005257422.1", "rna": "XM_005257365.5"}, {"protein": "XP_054186080.1", "rna": "XM_054330105.1"}, {"protein": "XP_005257427.1", "rna": "XM_005257370.5"}, {"protein": "XP_054186092.1", "rna": "XM_054330117.1"}, {"protein": "NP_058525.1", "rna": "NM_016841.5"}, {"protein": "XP_054172107.1", "rna": "XM_054316132.1"}, {"protein": "BAB71065.1", "rna": "AK055986.1"}, {"protein": "NP_001190180.1", "rna": "NM_001203251.2"}, {"protein": "XP_054172115.1", "rna": "XM_054316140.1"}, {"protein": "NP_001364197.1", "rna": "NM_001377268.1"}, {"protein": "CAG26750.1", "rna": "BN000503.1"}, {"protein": "XP_054184540.1", "rna": "XM_054328565.1"}, {"protein": "XP_054186091.1", "rna": "XM_054330116.1"}, {"protein": "XP_054184546.1", "rna": "XM_054328571.1"}, {"protein": "XP_054186085.1", "rna": "XM_054330110.1"}, {"protein": "XP_054184547.1", "rna": "XM_054328572.1"}]}, "alias": ["DDPAC", "FTDP-17", "MAPTL", "MSTD", "MTBT1", "MTBT2", "PPND", "PPP1R103", "TAU", "Tau-PHF6", "tau-40"], "ensembl": [{"gene": "ENSG00000276155", "protein": ["ENSP00000477703", "ENSP00000479142", "ENSP00000481769", "ENSP00000483784", "ENSP00000485831", "ENSP00000485913", "ENSP00000486039", "ENSP00000487403", "ENSP00000487570"], "transcript": ["ENST00000613360", "ENST00000620981", "ENST00000621329", "ENST00000622728", "ENST00000625417", "ENST00000625688", "ENST00000626571", "ENST00000626880", "ENST00000627067", "ENST00000627711", "ENST00000627800", "ENST00000628393", "ENST00000628437", "ENST00000629368"], "translation": [{"protein": "ENSP00000486039", "rna": "ENST00000626571"}, {"protein": "ENSP00000487570", "rna": "ENST00000628393"}, {"protein": "ENSP00000485913", "rna": "ENST00000627711"}, {"protein": "ENSP00000477703", "rna": "ENST00000621329"}, {"protein": "ENSP00000481769", "rna": "ENST00000620981"}, {"protein": "ENSP00000487403", "rna": "ENST00000629368"}, {"protein": "ENSP00000483784", "rna": "ENST00000613360"}, {"protein": "ENSP00000485831", "rna": "ENST00000625688"}, {"protein": "ENSP00000479142", "rna": "ENST00000622728"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000186868", "protein": ["ENSP00000262410", "ENSP00000303214", "ENSP00000334886", "ENSP00000340820", "ENSP00000389250", "ENSP00000408975", "ENSP00000410838", "ENSP00000413056", "ENSP00000443028", "ENSP00000458742", "ENSP00000460048", "ENSP00000460965", "ENSP00000505258", "ENSP00000505478", "ENSP00000515557", "ENSP00000515558", "ENSP00000515559", "ENSP00000515600"], "transcript": ["ENST00000262410", "ENST00000334239", "ENST00000344290", "ENST00000351559", "ENST00000415613", "ENST00000420682", "ENST00000431008", "ENST00000446361", "ENST00000535772", "ENST00000570299", "ENST00000571311", "ENST00000571987", "ENST00000572440", "ENST00000574436", "ENST00000576518", "ENST00000577017", "ENST00000680542", "ENST00000680674", "ENST00000703922", "ENST00000703923", "ENST00000703924", "ENST00000703974", "ENST00000703975", "ENST00000703976", "ENST00000703977", "ENST00000703978", "ENST00000703979", "ENST00000703980", "ENST00000703981", "ENST00000703982"], "translation": [{"protein": "ENSP00000505478", "rna": "ENST00000680674"}, {"protein": "ENSP00000515557", "rna": "ENST00000703922"}, {"protein": "ENSP00000515558", "rna": "ENST00000703923"}, {"protein": "ENSP00000515559", "rna": "ENST00000703924"}, {"protein": "ENSP00000443028", "rna": "ENST00000535772"}, {"protein": "ENSP00000262410", "rna": "ENST00000262410"}, {"protein": "ENSP00000303214", "rna": "ENST00000351559"}, {"protein": "ENSP00000340820", "rna": "ENST00000344290"}, {"protein": "ENSP00000413056", "rna": "ENST00000420682"}, {"protein": "ENSP00000460048", "rna": "ENST00000571311"}, {"protein": "ENSP00000505258", "rna": "ENST00000680542"}, {"protein": "ENSP00000515600", "rna": "ENST00000703978"}, {"protein": "ENSP00000334886", "rna": "ENST00000334239"}, {"protein": "ENSP00000408975", "rna": "ENST00000446361"}, {"protein": "ENSP00000410838", "rna": "ENST00000415613"}, {"protein": "ENSP00000389250", "rna": "ENST00000431008"}, {"protein": "ENSP00000458742", "rna": "ENST00000571987"}, {"protein": "ENSP00000460965", "rna": "ENST00000574436"}], "type_of_gene": "protein_coding"}, {"gene": "ENSG00000277956", "protein": ["ENSP00000478602", "ENSP00000480217", "ENSP00000482244", "ENSP00000483396", "ENSP00000484321", "ENSP00000484491", "ENSP00000487613", "ENSP00000487819", "ENSP00000487837", "ENSP00000488046", "ENSP00000488081", "ENSP00000488101", "ENSP00000488245", "ENSP00000488373"], "transcript": ["ENST00000612872", "ENST00000618029", "ENST00000618825", "ENST00000620070", "ENST00000620818", "ENST00000622106", "ENST00000631447", "ENST00000631701", "ENST00000631918", "ENST00000632122", "ENST00000632500", "ENST00000632975", "ENST00000633047", "ENST00000633054", "ENST00000633409", "ENST00000633415", "ENST00000633801", "ENST00000634049"], "translation": [{"protein": "ENSP00000487613", "rna": "ENST00000633415"}, {"protein": "ENSP00000488245", "rna": "ENST00000633047"}, {"protein": "ENSP00000482244", "rna": "ENST00000622106"}, {"protein": "ENSP00000488081", "rna": "ENST00000633054"}, {"protein": "ENSP00000487819", "rna": "ENST00000634049"}, {"protein": "ENSP00000488373", "rna": "ENST00000631447"}, {"protein": "ENSP00000488046", "rna": "ENST00000633801"}, {"protein": "ENSP00000487837", "rna": "ENST00000632500"}, {"protein": "ENSP00000488101", "rna": "ENST00000632122"}, {"protein": "ENSP00000484491", "rna": "ENST00000620070"}, {"protein": "ENSP00000484321", "rna": "ENST00000620818"}, {"protein": "ENSP00000478602", "rna": "ENST00000612872"}, {"protein": "ENSP00000483396", "rna": "ENST00000618825"}, {"protein": "ENSP00000480217", "rna": "ENST00000618029"}], "type_of_gene": "protein_coding"}], "entrezgene": "4137", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 18.8113947323, "exp_mis": 295.18520638, "exp_syn": 154.263901172, "lof_z": 2.01244430088186, "mis_z": 1.5141188773097, "mu_lof": 1.34929239254e-06, "mu_mis": 2.82047509336e-05, "mu_syn": 1.45302824651e-05, "n_lof": 10.0, "n_mis": 242.0, "n_syn": 145.0, "p_li": 4.68264962282433e-05, "p_null": 0.0370481288410833, "p_rec": 0.962905044662688, "syn_z": 0.462392917680866}, "bp": 2331, "cds_end": 44101537, "cds_start": 44039703, "n_exons": 14, "nonpsych": {"exp_lof": 16.7729240159, "exp_mis": 266.917901072, "exp_syn": 139.370512066, "lof_z": 1.86394041246503, "mis_z": 1.72632968037233, "mu_lof": 1.34929239254e-06, "mu_mis": 2.82047509336e-05, "mu_syn": 1.45302824651e-05, "n_lof": 9.0, "n_mis": 211.0, "n_syn": 133.0, "p_li": 0.000128312556391772, "p_null": 0.0507074222019607, "p_rec": 0.949164265241648, "syn_z": 0.339743828198452}, "nontcga": {"exp_lof": 17.281802969, "exp_mis": 271.545728951, "exp_syn": 141.898113135, "lof_z": 1.96522202323818, "mis_z": 1.55840747792317, "mu_lof": 1.34929239254e-06, "mu_mis": 2.82047509336e-05, "mu_syn": 1.45302824651e-05, "n_lof": 9.0, "n_mis": 220.0, "n_syn": 138.0, "p_li": 0.000143232765375463, "p_null": 0.0367190098533073, "p_rec": 0.963137757381317, "syn_z": 0.207198699204871}, "transcript": "ENST00000344290.5"}, "exons": [{"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [778232, 778325], [791725, 791991], [794412, 794466], [796802, 796929], [798313, 798511], [801323, 801379], [804487, 805240], [810008, 810074], [813979, 814066], [816505, 816592], [825869, 826019], [893533, 893837]], "strand": -1, "transcript": "NM_001123066", "txend": 893837, "txstart": 760287}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894381, 45894686], [45962320, 45962470], [45971858, 45971945], [45974384, 45974471], [45978374, 45978440], [45983177, 45983930], [45987039, 45987095], [45989877, 45990075], [45991459, 45991586], [45993923, 45993977], [45996398, 45996664], [46010309, 46010402], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001123066", "txend": 46028333, "txstart": 45894381}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596512, 596817], [664448, 664598], [673976, 674063], [676502, 676589], [680492, 680558], [685296, 686049], [689158, 689214], [691996, 692194], [693578, 693705], [696042, 696096], [698517, 698783], [712428, 712521], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001123066", "txend": 730445, "txstart": 596512}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596512, 596817], [664448, 664598], [673976, 674063], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [712428, 712521], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001123067", "txend": 730445, "txstart": 596512}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894381, 45894686], [45962320, 45962470], [45971858, 45971945], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46010309, 46010402], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001123067", "txend": 46028333, "txstart": 45894381}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [778232, 778325], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [816505, 816592], [825869, 826019], [893533, 893837]], "strand": -1, "transcript": "NM_001123067", "txend": 893837, "txstart": 760287}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [816505, 816592], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NM_001203251", "txend": 893665, "txstart": 760287}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [673976, 674063], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001203251", "txend": 730445, "txstart": 596684}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45971858, 45971945], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001203251", "txend": 46028333, "txstart": 45894553}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894381, 45894686], [45962320, 45962470], [45971858, 45971945], [45974384, 45974471], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001203252", "txend": 46028333, "txstart": 45894381}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596512, 596817], [664448, 664598], [673976, 674063], [676502, 676589], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001203252", "txend": 730445, "txstart": 596512}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [813979, 814066], [816505, 816592], [825869, 826019], [893533, 893837]], "strand": -1, "transcript": "NM_001203252", "txend": 893837, "txstart": 760287}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [778232, 778325], [791725, 791991], [796802, 796929], [798313, 798511], [801323, 801379], [804487, 805552], [810008, 810074], [816505, 816592], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NM_001377265", "txend": 893665, "txstart": 760287}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [673976, 674063], [680492, 680558], [684984, 686049], [689158, 689214], [691996, 692194], [693578, 693705], [698517, 698783], [712428, 712521], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001377265", "txend": 730445, "txstart": 596684}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45971858, 45971945], [45978374, 45978440], [45982865, 45983930], [45987039, 45987095], [45989877, 45990075], [45991459, 45991586], [45996398, 45996664], [46010309, 46010402], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001377265", "txend": 46028333, "txstart": 45894553}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [673976, 674063], [680492, 680558], [684984, 686049], [689158, 689214], [693578, 693705], [698517, 698783], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001377266", "txend": 730445, "txstart": 596684}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45971858, 45971945], [45978374, 45978440], [45982865, 45983930], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001377266", "txend": 46028333, "txstart": 45894553}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [791725, 791991], [796802, 796929], [801323, 801379], [804487, 805552], [810008, 810074], [816505, 816592], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NM_001377266", "txend": 893665, "txstart": 760287}, {"cdsend": 46025188, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45971858, 45971945], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46014242, 46014278], [46025116, 46028333]], "strand": 1, "transcript": "NM_001377267", "txend": 46028333, "txstart": 45894553}, {"cdsend": 826002, "cdsstart": 763426, "chr": "17_GL000258v2_alt", "position": [[760287, 763498], [774356, 774392], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [816505, 816592], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NM_001377267", "txend": 893665, "txstart": 760287}, {"cdsend": 727300, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [673976, 674063], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [716361, 716397], [727228, 730445]], "strand": 1, "transcript": "NM_001377267", "txend": 730445, "txstart": 596684}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45961604, 45961757], [45962320, 45962470], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_001377268", "txend": 46028333, "txstart": 45894553}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [825869, 826019], [826583, 826736], [893533, 893665]], "strand": -1, "transcript": "NM_001377268", "txend": 893665, "txstart": 760287}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [663732, 663885], [664448, 664598], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_001377268", "txend": 730445, "txstart": 596684}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894381, 45894686], [45962320, 45962470], [45971858, 45971945], [45974384, 45974471], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46010309, 46010402], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_005910", "txend": 46028333, "txstart": 45894381}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [778232, 778325], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [813979, 814066], [816505, 816592], [825869, 826019], [893533, 893837]], "strand": -1, "transcript": "NM_005910", "txend": 893837, "txstart": 760287}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596512, 596817], [664448, 664598], [673976, 674063], [676502, 676589], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [712428, 712521], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_005910", "txend": 730445, "txstart": 596512}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [778232, 778325], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NM_016834", "txend": 893665, "txstart": 760287}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [712428, 712521], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_016834", "txend": 730445, "txstart": 596684}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46010309, 46010402], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_016834", "txend": 46028333, "txstart": 45894553}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596512, 596817], [664448, 664598], [673976, 674063], [676502, 676589], [680492, 680558], [685296, 686049], [689158, 689214], [691996, 692194], [693578, 693705], [698517, 698783], [712428, 712521], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_016835", "txend": 730445, "txstart": 596512}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894381, 45894686], [45962320, 45962470], [45971858, 45971945], [45974384, 45974471], [45978374, 45978440], [45983177, 45983930], [45987039, 45987095], [45989877, 45990075], [45991459, 45991586], [45996398, 45996664], [46010309, 46010402], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_016835", "txend": 46028333, "txstart": 45894381}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [778232, 778325], [791725, 791991], [796802, 796929], [798313, 798511], [801323, 801379], [804487, 805240], [810008, 810074], [813979, 814066], [816505, 816592], [825869, 826019], [893533, 893837]], "strand": -1, "transcript": "NM_016835", "txend": 893837, "txstart": 760287}, {"cdsend": 46024171, "cdsstart": 45962337, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45978374, 45978440], [45987039, 45987095], [45991459, 45991586], [45996398, 45996664], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NM_016841", "txend": 46028333, "txstart": 45894553}, {"cdsend": 726283, "cdsstart": 664465, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [680492, 680558], [689158, 689214], [693578, 693705], [698517, 698783], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NM_016841", "txend": 730445, "txstart": 596684}, {"cdsend": 826002, "cdsstart": 764447, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [791725, 791991], [796802, 796929], [801323, 801379], [810008, 810074], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NM_016841", "txend": 893665, "txstart": 760287}, {"cdsend": 46028333, "cdsstart": 46028333, "chr": "17", "position": [[45894553, 45894686], [45962320, 45962470], [45971858, 45971945], [45978374, 45978440], [45987039, 45987095], [45991459, 45991557], [45996508, 45996664], [46014242, 46014324], [46018617, 46018730], [46023955, 46028333]], "strand": 1, "transcript": "NR_165166", "txend": 46028333, "txstart": 45894553}, {"cdsend": 893665, "cdsstart": 893665, "chr": "17_GL000258v2_alt", "position": [[760287, 764663], [769883, 769996], [774310, 774392], [791725, 791881], [796831, 796929], [801323, 801379], [810008, 810074], [816505, 816592], [825869, 826019], [893533, 893665]], "strand": -1, "transcript": "NR_165166", "txend": 893665, "txstart": 760287}, {"cdsend": 730445, "cdsstart": 730445, "chr": "17_KI270908v1_alt", "position": [[596684, 596817], [664448, 664598], [673976, 674063], [680492, 680558], [689158, 689214], [693578, 693676], [698627, 698783], [716361, 716443], [720731, 720844], [726067, 730445]], "strand": 1, "transcript": "NR_165166", "txend": 730445, "txstart": 596684}], "exons_hg19": [{"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971747, 43972052], [44039686, 44039836], [44049224, 44049311], [44051750, 44051837], [44055740, 44055806], [44060543, 44061296], [44064405, 44064461], [44067243, 44067441], [44068825, 44068952], [44071289, 44071343], [44073764, 44074030], [44087675, 44087768], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001123066", "txend": 44105699, "txstart": 43971747}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [780225, 780318], [793718, 793984], [796405, 796459], [798795, 798922], [800306, 800504], [803316, 803372], [806480, 807233], [812001, 812067], [815972, 816059], [818498, 818585], [827862, 828012], [895526, 895830]], "strand": -1, "transcript": "NM_001123066", "txend": 895830, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971747, 43972052], [44039686, 44039836], [44049224, 44049311], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44087675, 44087768], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001123067", "txend": 44105699, "txstart": 43971747}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [780225, 780318], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [818498, 818585], [827862, 828012], [895526, 895830]], "strand": -1, "transcript": "NM_001123067", "txend": 895830, "txstart": 762280}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [818498, 818585], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NM_001203251", "txend": 895658, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44049224, 44049311], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001203251", "txend": 44105699, "txstart": 43971919}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971747, 43972052], [44039686, 44039836], [44049224, 44049311], [44051750, 44051837], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001203252", "txend": 44105699, "txstart": 43971747}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [815972, 816059], [818498, 818585], [827862, 828012], [895526, 895830]], "strand": -1, "transcript": "NM_001203252", "txend": 895830, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44049224, 44049311], [44055740, 44055806], [44060231, 44061296], [44064405, 44064461], [44067243, 44067441], [44068825, 44068952], [44073764, 44074030], [44087675, 44087768], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001377265", "txend": 44105699, "txstart": 43971919}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [780225, 780318], [793718, 793984], [798795, 798922], [800306, 800504], [803316, 803372], [806480, 807545], [812001, 812067], [818498, 818585], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NM_001377265", "txend": 895658, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44049224, 44049311], [44055740, 44055806], [44060231, 44061296], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001377266", "txend": 44105699, "txstart": 43971919}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [793718, 793984], [798795, 798922], [803316, 803372], [806480, 807545], [812001, 812067], [818498, 818585], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NM_001377266", "txend": 895658, "txstart": 762280}, {"cdsend": 827995, "cdsstart": 765419, "chr": "17_ctg5_hap1", "position": [[762280, 765491], [776349, 776385], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [818498, 818585], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NM_001377267", "txend": 895658, "txstart": 762280}, {"cdsend": 44102554, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44049224, 44049311], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44091608, 44091644], [44102482, 44105699]], "strand": 1, "transcript": "NM_001377267", "txend": 44105699, "txstart": 43971919}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44038970, 44039123], [44039686, 44039836], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_001377268", "txend": 44105699, "txstart": 43971919}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [827862, 828012], [828576, 828729], [895526, 895658]], "strand": -1, "transcript": "NM_001377268", "txend": 895658, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971747, 43972052], [44039686, 44039836], [44049224, 44049311], [44051750, 44051837], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44087675, 44087768], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_005910", "txend": 44105699, "txstart": 43971747}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [780225, 780318], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [815972, 816059], [818498, 818585], [827862, 828012], [895526, 895830]], "strand": -1, "transcript": "NM_005910", "txend": 895830, "txstart": 762280}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [780225, 780318], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NM_016834", "txend": 895658, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44087675, 44087768], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_016834", "txend": 44105699, "txstart": 43971919}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971747, 43972052], [44039686, 44039836], [44049224, 44049311], [44051750, 44051837], [44055740, 44055806], [44060543, 44061296], [44064405, 44064461], [44067243, 44067441], [44068825, 44068952], [44073764, 44074030], [44087675, 44087768], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_016835", "txend": 44105699, "txstart": 43971747}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [780225, 780318], [793718, 793984], [798795, 798922], [800306, 800504], [803316, 803372], [806480, 807233], [812001, 812067], [815972, 816059], [818498, 818585], [827862, 828012], [895526, 895830]], "strand": -1, "transcript": "NM_016835", "txend": 895830, "txstart": 762280}, {"cdsend": 827995, "cdsstart": 766440, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [793718, 793984], [798795, 798922], [803316, 803372], [812001, 812067], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NM_016841", "txend": 895658, "txstart": 762280}, {"cdsend": 44101537, "cdsstart": 44039703, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44055740, 44055806], [44064405, 44064461], [44068825, 44068952], [44073764, 44074030], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NM_016841", "txend": 44105699, "txstart": 43971919}, {"cdsend": 44105699, "cdsstart": 44105699, "chr": "17", "position": [[43971919, 43972052], [44039686, 44039836], [44049224, 44049311], [44055740, 44055806], [44064405, 44064461], [44068825, 44068923], [44073874, 44074030], [44091608, 44091690], [44095983, 44096096], [44101321, 44105699]], "strand": 1, "transcript": "NR_165166", "txend": 44105699, "txstart": 43971919}, {"cdsend": 895658, "cdsstart": 895658, "chr": "17_ctg5_hap1", "position": [[762280, 766656], [771876, 771989], [776303, 776385], [793718, 793874], [798824, 798922], [803316, 803372], [812001, 812067], [818498, 818585], [827862, 828012], [895526, 895658]], "strand": -1, "transcript": "NR_165166", "txend": 895658, "txstart": 762280}], "generif": [{"pubmed": 11166961, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11255441, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11303757, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 11391737, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11698154, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11706972, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11831025, "text": "Associated with etilogical mechanism of Alzheimer's disease."}, {"pubmed": 11831556, "text": "a biomarker for Alzheimer disease"}, {"pubmed": 11837744, "text": "Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease."}, {"pubmed": 11852060, "text": "The glycosylation of tau is an early abnormality that can facilitate the subsequent abnormal hyperphosphorylation of tau in Alzheimer's disease brain."}, {"pubmed": 11861703, "text": "This suggests that usually FTDP-17 and PSP, including the rare familial form of PSP, are likely to be separate conditions and that usually PSP and typical PSP-like syndromes are not due to mutations in tau."}, {"pubmed": 11939896, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 11958849, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 11958849, "text": "The tau H1 haplotype is associated with increased risk of Parkinson disease in a Norwegian population."}, {"pubmed": 11959122, "text": "Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities."}, {"pubmed": 11959919, "text": "Tau is essential to beta -amyloid-induced neurotoxicity"}, {"pubmed": 11988340, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12000767, "text": "additional regulatory sequences rugulating tau exon 10 splicing"}, {"pubmed": 12032355, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12056929, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12070658, "text": "Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred."}, {"pubmed": 12082079, "text": "These results provide strong evidence suggesting that MAP2c and tau stabilize microtubules by binding along individual protofilaments, possibly by bridging the tubulin interfaces."}, {"pubmed": 12112079, "text": "Pick's disease is characterized by accumulation of Pick bodies in the hippocampus and cortex, and by the presence of microtubule-binding repeat tau pathology in gray and white matter, distinguishing this tauopathy from other neurodegenerative disorders."}, {"pubmed": 12144513, "text": "Results suggest that binding of tau to DNA occurs in an aggregation-dependent, and a phosphorylation-independent, manner."}, {"pubmed": 12177374, "text": "In aging and sporadic Alzheimer's disease, severe tau pathology (stage 7 to stage 10) correlates well with a huge and widespread Abeta burden."}, {"pubmed": 12198126, "text": "new insights into the conformation of tau in the soluble state and after incorporation into paired helical filaments"}, {"pubmed": 12212558, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12212558, "text": "no evidence seen for association of tau gene polymorphism with transmissible spongiform encephalopathies"}, {"pubmed": 12220379, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12231446, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12368187, "text": "biochemical analysis in argyrophilic grain disease, Alzheimer's disease, and Pick's disease"}, {"pubmed": 12368474, "text": "Expression of mutant human tau isoform in transgenic mice resulted in the development of congophilic hyperphosphorylated tau inclusions in forebrain neurons."}, {"pubmed": 12387894, "text": "phosphorylation by cdk5 and GSK-3beta"}, {"pubmed": 12464279, "text": "two phosphorylation sites (serines 262 and 356) were identified in the tubulin binding sites. When tau was phosphorylated by CaM kinase II, the binding of tau to taxol-stabilized microtubules was remarkably impaired."}, {"pubmed": 12470988, "text": "REVIEW: tau dysfunction can lead to neurodegeneration and the development of clinical symptoms"}, {"pubmed": 12476321, "text": "This is a possible candidate gene in frontal lobe dementia."}, {"pubmed": 12492138, "text": "The phenotype of pallidopontonigral degeneration (PPND) resulting from N279K mutation of tau includes dysfunction of the autonomic nervous system, correlating with the duration of illness and clinical and functional severity of parkinsonism."}, {"pubmed": 12505985, "text": "Repeat motifs of this protein bind to the insides of microtubules in the absence of taxol"}, {"pubmed": 12527113, "text": "Tau isoforms are O-GlcNAc modified (a marker of healthy brain Tau) and a balance occurs between phosphorylation, glycosylation and nuclear localization"}, {"pubmed": 12565146, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12573250, "text": "can prevent DNA from thermal denaturation, improve renaturation and protect DNA from damage induced by free radicals"}, {"pubmed": 12590615, "text": "The interaction of the amino terminus of tau with its microtubule-binding repeat regions, creating a conformation similar to that recognized by the monoclonal antibody Alz50, is very likely a propolymerization state of the tau molecule."}, {"pubmed": 12629248, "text": "Significant overrepresentation of the tau H1/H1 genotype, also found in progressive supranuclear palsy and corticobasal degeneration, was found in the primary progresssive aphasia group."}, {"pubmed": 12641733, "text": "Paired helical filament-tau inhibits proteasome activity in Alzheimer disease brain"}, {"pubmed": 12649279, "text": "results implicate the human tau gene as a target gene for the alternative splicing regulator Tra2 beta protein, suggesting that Tra2 beta may play a role in aberrant tau exon 10 alternative splicing"}, {"pubmed": 12678504, "text": "This protein binds to DNA but not single-stranded DNA."}, {"pubmed": 12710929, "text": "A positive association between the H1 haplotype and frontotemporal dementia was found, consistent with the hypothesis that the tau gene, or nearby gene on the H1 haplotype, is a risk factor for frontotemporal dementia"}, {"pubmed": 12714745, "text": "results suggest that interactions between alpha-synuclein and tau can promote their fibrillization and drive the formation of pathological inclusions in human neurodegenerative diseases"}, {"pubmed": 12756133, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12756133, "text": "Sequence variations in intronic or regulatory regions of tau may have previously unrecognized consequences leading to tau dysfunction and neurodegeneration."}, {"pubmed": 12765608, "text": "cdk5 can initiate a major impact on tau pathology progression that probably involves several kinases."}, {"pubmed": 12796837, "text": "Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family."}, {"pubmed": 12811584, "text": "In this study the presence of tau and 14-3-3 proteins in GCIs of 21 patients with MSA was investigated."}, {"pubmed": 12826737, "text": "MAPT mutations are not connected with most of the frontotemporal dementia cases in the Polish population."}, {"pubmed": 12826737, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12847166, "text": "The authors describe a case of clinically diagnosed young onset progressive supranuclear palsy (PSP) with symptom onset at 40 years of age, no family history and tau exon 10 +16 mutation (MAPT, IVS10, C-U, +16)"}, {"pubmed": 12853572, "text": "native filaments from brain and filaments assembled in vitro from expressed tau protein have a clear cross-beta structure"}, {"pubmed": 12872001, "text": "expressed normal and FTDP-17 mutant human tau (mutations P301L and V337M) in Caenorhabditis elegans to model tauopathy disorders"}, {"pubmed": 12883828, "text": "L266V is a pathogenic tau mutation that is associated with Pick-like pathology."}, {"pubmed": 12888622, "text": "tau is proteolyzed by multiple caspases at a highly conserved aspartate residue (Asp421) in its C terminus in vitro in neurons in Alzheimer's disease"}, {"pubmed": 12925374, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12932819, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12937143, "text": "Nitrative injury is directly linked to the formation of filamentous tau inclusions."}, {"pubmed": 12975285, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14503643, "text": "The presence of filamentous tau protein in the frontal cortex of these patients suggests a possible link between tau and the genetic defect present on chromosome 3 and associated with FTD-3."}, {"pubmed": 14523627, "text": "CSF-tau was a useful biological marker to discriminate Alzheimer's disease from normal aging, neurological and psychiatric disorders."}, {"pubmed": 14572459, "text": "A novel mechanism of apoptotic cell death is suggested in mutant TauP301L (but not in wild-type)-expressing cells that involves survivin-mediated activation of cell cycle checkpoint."}, {"pubmed": 14600827, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14612456, "text": "tau binds to Hsc70, and its phosphorylation is a recognition requirement for the addition of ubiquitin"}, {"pubmed": 14615799, "text": "novel, physiological role of the N-terminal domain of tau, but also underlay that its possible proteolytic truncation mediated by apoptotic proteases may generate a highly toxic fragment that could contribute to neuronal death"}, {"pubmed": 14627651, "text": "Overexpressing the longest human tau isoform in rat astrocytes resulted in increases in tubulin biosynthesis and the accumulation of acetylated, tyrosinated, alpha- and beta-tubulin"}, {"pubmed": 14660557, "text": "results indicate that in an appropriate cellular context R406W tau is hyperphosphorylated, which leads to decreased microtubule binding"}, {"pubmed": 14730711, "text": "Tau, modified after ischemia, undergoes a reversible conformational change on Triton-X exposure. Because conformation at Ser101 of bovine tau is crucial for its affinity to tau2, this Ser-like conformation mimicked by its human counterpart."}, {"pubmed": 14761950, "text": "Casein kinase 1 delta phosphorylates tau at sites that modulate tau/microtubule binding"}, {"pubmed": 14769047, "text": "Structure of tau from Alzheimer brain paired helical filaments is based on beta structure embedded in an environment of unstructured protein with no measurable indication of alpha-helical structure, thus it can be classifed as \"amyloid\" in a broad sense."}, {"pubmed": 14769048, "text": "It is proposed that the progression from amorphous aggregation of tau through intermediate formation and fibrillization may underlie the activity of other inducers such as hyperphosphorylation and may be operative in vivo."}, {"pubmed": 14963027, "text": "tau binds to heat shock protein 27, leading to decreased concentration of hyperphosphorylated tau and enhanced cell survival"}, {"pubmed": 14966169, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 14967043, "text": "NMR spectroscopy and fluorescence mapping demonstrate that the epitope centered around the phospho-Thr212-Pro213 motif of Tau is a newly recognized Pin1 prolyl cis/trans-isomerase interaction site."}, {"pubmed": 14991810, "text": "an increase in expression of the MAPT gene is a susceptibility factor in idiopathic PD."}, {"pubmed": 14991828, "text": "This study found exon 9 to 13 of the tau gene have deletation of the conserved asparagin 296."}, {"pubmed": 14993907, "text": "Overexpression of human tau in Drosophila larvae disrupts axonal transport causing vesicle aggregation and this is associated with loss of locomotor function."}, {"pubmed": 14999081, "text": "Tyrosine phosphorylated tau is distributed in Alzheimer disease brain differently from other phosphorylated tau. Evidence of differentially phosphorylated tau within degenerating neurons was found supporting a role for fyn in neurodegeneration"}, {"pubmed": 15004327, "text": "Increase of soluble Abeta42 and Abeta40 in FTDP-17, compared to normal and DLDH brains, both of which had comparable levels of Abeta species.Immunoreactivity of the intracellular Abeta42 was increased in cortical neurons of subjects with FTDP-17."}, {"pubmed": 15009664, "text": "we reconstituted naturally occurring exon 10 FTDP mutants and classified their effects on its splicing. We also carried out a survey of the influence of splicing regulators on Tau exon 10 inclusion and tentatively identified the site of action for several"}, {"pubmed": 15020716, "text": "Both 3- and 4-repeat tau isoforms suppressed microtubule dynamics, though to different extents."}, {"pubmed": 15034924, "text": "Expression of one particular tau isoform which contain exon 6, significantly inhibits neurite elongation in neuroblastoma cells ."}, {"pubmed": 15053964, "text": "Evidence is provided for the first time that olfactory dysfunction is present in a transgenic mouse model of neurodegenerative tauopathy, including the filamentous tau tangles seen in Alzheimer's disease."}, {"pubmed": 15075227, "text": "In cells transfected with human tau, mitochondrial clustering was found in cells in which tau was unphosphorylated"}, {"pubmed": 15083285, "text": "Both in multiple sclerosis and other inflammatory neurological diseases, tau protein levels in the cerebrospinal fluid (csf) are significantly higher than in csf samples from non-inflammatory neurological diseases."}, {"pubmed": 15096589, "text": "reversible binding occurs between tau and the surface of preassembled microtubules, whereas irreversible binding results when tau is coassembled with tubulin into a tau-microtubule copolymer"}, {"pubmed": 15106853, "text": "In a case-control study a novel polymorphism in the tau gene (IVS11+ 90G-->A) shows significant association between possession of the A allele of tau and male Japanese Alzheimer's disease with early-onset."}, {"pubmed": 15106853, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15115761, "text": "We show that the entire, fully extended H1 haplotype is associated with progressive supranuclear palsy, which implicates several other genes in addition to MAPT, as candidate pathogenic loci"}, {"pubmed": 15126504, "text": "Tau phosphorylation is induced in vitro by down-regulation of WW domain-containing oxidoreductase"}, {"pubmed": 15140937, "text": "Human mutant R406W tau transgenic mice developed an age-dependent accumulation of insoluble filamentous tau aggregates in neuronal perikarya of the cerebral cortex, hippocampus, cerebellum, and spinal cord"}, {"pubmed": 15178931, "text": "Frontotemporal lobar degeneration can result from mutations in tau gene on chromosome 17. Brains with tau mutations accumulate insoluble tau within neurons and glia. Two new tau mutations may cause disease in absence of tau accumulation. Review."}, {"pubmed": 15178932, "text": "Hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in the tau gene shows a wide range in age at onset, several distinct clinical presentations, and a spectrum of tau pathology. Review."}, {"pubmed": 15178951, "text": "Staining for tau was negative in 5 of the frontal-lobe degeneration cases and faintly positive in 1, but positive in all Alzheimer's disease cases."}, {"pubmed": 15198676, "text": "we generated a series of constructs with intron deletions from full length tau exons 9-11. A minimum distance requirement between exon 10 and 11 for correct splicing was noted. SRp20 facilitates exon10 exclusion and FTDP-17 mutant exon 10 skipping"}, {"pubmed": 15201350, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15228591, "text": "A novel Tau isoform localizes differently from canonical Tau in SH-SY5Y cells which stably overexpress it. In both normal and Alzheimer's hippocampus it is in dentate gyrus granular cells and CA1/CA3 pyramidal cells, not with Tau but partly with MAP2"}, {"pubmed": 15228592, "text": "We show that c-Jun N-terminal kinases JNK1 JNK2 and JNK3 phosphorylate tau at many serine/threonine-prolines; these findings extend the number of candidate protein kinases for tau hyperphosphorylation in Alzheimer's disease and neurodegenerative disorders"}, {"pubmed": 15240881, "text": "filament growth wherein the existing filament serves as a template for the incoming, unfolded tau molecule, resulting in a new structured layer with maximized hydrogen-bonded contact surface and side-chain stacking."}, {"pubmed": 15249677, "text": "Results reveal a mechanism of regulation of tau phosphorylation and suggest that abnormal hyperphosphorylation of tau could result from decreased tau O-GlcNAcylation, which may be induced by deficient brain glucose uptake/metabolism."}, {"pubmed": 15266787, "text": "Strong genetic evidence for the involvement of tau gene variability in the pathogenesis of progressive supranuclear palsy (PSP) has been demonstrated in several Caucasian populations and is discussed in this review."}, {"pubmed": 15283964, "text": "in primary cultures, Akt selectively phosphorylates tau at S214 rather than T212 so tau S214 may participate in Akt-mediated anti-apoptotic signaling."}, {"pubmed": 15293277, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15297935, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15356202, "text": "As Alzheimer tablges evolve, the extreme N terminus of tau is lost & a C-terminal caspase-truncated epitope lacking AA 422-441 appears. Caspase-6 cleaved the N terminus of tau in vitro at D13, a semicanonical, undescribed caspase cleavage site in tau."}, {"pubmed": 15365985, "text": "Review. 34 different pathogenic MAPT mutations in 101 families have been described & their differing phenotypes characterized. In vitro & transgenic studies show their effect on tau function. Tau's role in dementia is discussed."}, {"pubmed": 15372253, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15376481, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15376481, "text": "mutations in this gene are not a frequent cause of the frontotemporal dementia phenotype in Canadian patients."}, {"pubmed": 15385569, "text": "beta-amyloid and tau-bearing skeletal myotubes show calcium dyshomeostasis"}, {"pubmed": 15459824, "text": "Tau H1 contains an important susceptibility allele contributing to increased risk of neurodegeneration"}, {"pubmed": 15464261, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15475684, "text": "These results indicate that the patterns of the tau epitopes represented by this panel that reside in the pathological aggregates of PSP and CBD are similar to each other but distinct from that of AD."}, {"pubmed": 15477533, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15509534, "text": "a mutant human tau protein causes induction of inflammatory mediators and microglial activation in the mouse model"}, {"pubmed": 15525651, "text": "tau phosphorylation and PP2A activity are regulated by Galpha12"}, {"pubmed": 15532542, "text": "Neuronal tau non-specifically functions in a chaperone-like manner towards the enzymes of carbohydrate metabolism, e.g., lactate dehydrogenase."}, {"pubmed": 15542598, "text": "possible role for thrombin in proteolysis of tau under physiological and/or pathological conditions in human brains"}, {"pubmed": 15546861, "text": "tau is probably a physiological substrate of protein phosphatase 5 (PP5) and that the abnormal hyperphosphorylation of tau in Alzheimer disease might result in part from the decreased PP5 activity in the diseased brains"}, {"pubmed": 15570502, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15596612, "text": "Data are compatible with the notion that tau aggregates predispose neurons to develop secondary Lewy bodies."}, {"pubmed": 15627775, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15627775, "text": "Our results support the notion that tau gene H1 haplotype may be an important risk factor of PD."}, {"pubmed": 15638805, "text": "The conformation of the tau protein was studied because of its importance in maintaining the shape of the axon."}, {"pubmed": 15652510, "text": "the initial structural moiety and its structural feature necessary for starting the tau paired helical filament formation of tau"}, {"pubmed": 15671021, "text": "Results suggest that tau causes a conformational shift in microtubules resulting in altered dynamics."}, {"pubmed": 15721985, "text": "4-hydroxy-2-nonenal modifications of tau promote and contribute to the generation of the major conformational properties defining neurofibrillary tangles"}, {"pubmed": 15732111, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15732111, "text": "was an increased risk of PD for persons with either SNCA 261/261 or MAPT H1/H1 genotypes as compared with persons with neither. The combined effect of the two genotypes was the same as for either of the genotypes alone (separate and equal)."}, {"pubmed": 15733856, "text": "a mechanism through which site-specific posttranslational modifications can modulate filament accumulation at low free intracellular tau concentrations"}, {"pubmed": 15746184, "text": "results demonstrate that glyceraldehyde-3-phosphate dehydrogenase, a glycolytic and microtubule binding protein, co-localized to neurofibrillary tangles and immunoprecipitated with paired helical filament-tau"}, {"pubmed": 15750210, "text": "tau FTDP-mutation N279K is implicated in dementias."}, {"pubmed": 15765246, "text": "novel missense mutation in exon 12 of the tau gene, G335V, in a German family with frontotemporal dementia of early age at onset, in the third decade of life"}, {"pubmed": 15792962, "text": "underlying variations in MAPT could contribute to disease pathogenesis by subtle effects on gene expression and/or splicing"}, {"pubmed": 15795929, "text": "These results obtained in vitro and in vivo demonstrate that endogenous tau is not normally degraded by the proteasome."}, {"pubmed": 15823045, "text": "the aggregation of recombinant full-length four-repeat tau (htau40) was examined in vitro under near-physiological conditions using transmission electron microscopy and spectroscopy methods"}, {"pubmed": 15823754, "text": "In Alzheimer's disease, phosphorylated tau protein, the major component of neurofibrillary tangles, is considered a central mediator of disease pathogenesis."}, {"pubmed": 15848182, "text": "abnormal nitration of tau contributes to the impaired biological activity of tau in binding to the microtubules, implying a novel mechanism responsible for the neurodegeneration seen in AD brain"}, {"pubmed": 15855160, "text": "analysis of tau binding sites important for beta-structure and for binding to microtubules and polyanions"}, {"pubmed": 15855649, "text": "In both primary hippocampal neurons and mice, the tau-induced Golgi apparatus (GA) fragmentation was not caused by apoptosis. Tau implicated in GA fragmentation. This occurs before formation of neurofibrillary tangles."}, {"pubmed": 15869817, "text": "analysis of phosphopeptides related to the human tau protein"}, {"pubmed": 15878580, "text": "tau genotype does not influence the disease course, however, may predispose to a specific clinical sign in the early stage of FTDP-17 frontotemporal dementia Parkinsonism"}, {"pubmed": 15940384, "text": "Familial frontotemporal dementia associated with the novel MAPT mutation T427M."}, {"pubmed": 15950767, "text": "This study indicates that post-translational events are likely to be the main factors controlling tau isoform composition in sporadic tauopathies and highlights the benefit of quantitative RT-PCR in the assessment of splicing abnormalities in tauopathies."}, {"pubmed": 15963640, "text": "These data indicate that 14-3-3zeta may not be directly interacting with GSK3beta and tau in the brain, but may indirectly facilitate the interactions by binding to other proteins."}, {"pubmed": 15963990, "text": "The seventh residue of the second and third repeat fragments (R2 and R3 peptides) of the microtubule-binding domain (MBD)is very important for tau filamentous assembly."}, {"pubmed": 15973541, "text": "These data suggest that several species of tau are variably phosphorylated at a given time in a given region (and probably in a given cell), and that tau aggregates are composed of several phosphorylated truncated or cleaved tau molecules."}, {"pubmed": 15975068, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15994305, "text": "Mutations do not affect the phosphorylatability of FTDP-17 tau by Cdk5 complexed with p35, p25, or p39"}, {"pubmed": 15997419, "text": "The levels of t-tau and p-tau were higher in MS patients than in controls; however, increased levels were not related to the clinical activity of the disease."}, {"pubmed": 16000144, "text": "CaM kinase II is involved in the accumulation of tau in neuronal soma in Alzheimer's disease brain."}, {"pubmed": 16005901, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16005901, "text": "The studied tau genotype may contribute to the multifactorial genetic background of ALS."}, {"pubmed": 16014719, "text": "Tyr-18 was the major site for Fyn phosphorylation, but Tyr-394 was the main residue for Abl. Phosphorylation of tau on Tyr-394 is a physiological event that is potentially part of a signal relay"}, {"pubmed": 16020737, "text": "after the suppression of transgenic tau in mice with progressive age-related neurofibrillary tangles, memory function recovered"}, {"pubmed": 16023860, "text": "Our results demonstrate that tau over-expression in vivo cause a synaptic dysfunction, which may be caused by a reduced complement of functional mitochondria."}, {"pubmed": 16042549, "text": "H2 haplotype is derived from Homo neanderthalensis and entered H. sapiens populations during the co-existence of these species in Europe from approx. 45000 to 18000 years ago. (review)"}, {"pubmed": 16114883, "text": "This novel yeast model recapitulates hyperphosphorylation, conformation, and aggregation of protein tau and provides insight in molecular changes crucial in tauopathies."}, {"pubmed": 16115884, "text": "the Fyn-tau interaction has a role in neurodegeneration"}, {"pubmed": 16125396, "text": "These findings challenge the idea that tau pathology in Alzheimer's disease is merely a downstream effect of amyloid production/deposition and suggest that reciprocal interactions between beta-amyloid and tau alterations may take place in vivo."}, {"pubmed": 16129700, "text": "Abeta but not tau is deregent-insoluble early in the pathogenesis of Alzheimer's disease"}, {"pubmed": 16157753, "text": "A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy."}, {"pubmed": 16165272, "text": "Our study indicates that the apoE epsilon4 carrier status should be considered when CSF P-tau(231P) is evaluated as biomarker candidate of AD in MCI subjects."}, {"pubmed": 16176937, "text": "The axonal transport of tau occurs via a mechanism utilising fast transport motors, including the kinesin family of proteins, and that alpha-synuclein transport in neurons may involve both kinesin and dynein motor proteins."}, {"pubmed": 16182262, "text": "These results suggest that R406W tau Tg mice exhibit changes in depression-related behavior involving serotonergic neurons and provide an animal model for investigating AD with depression."}, {"pubmed": 16195395, "text": "High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy."}, {"pubmed": 16221853, "text": "Accumulation of tau in transgenic mice expressing human tau exclusively in oligodendrocytes causes neurodegeneration by disrupting axonal transport"}, {"pubmed": 16225961, "text": "Cu2+ plays an important role in the aggregation of R2 peptide (derived from the second repeat region of tau protein) and tau protein and that copper binding to R2 peptide may be another possible involvement in AD."}, {"pubmed": 16226718, "text": "Abeta(42)-mediated decrease in tau solubility depends on the interplay of distinct phospho-epitopes of tau and not only on phosphorylation of the S422 epitope"}, {"pubmed": 16226838, "text": "Human protein tau inhibits DNA replication."}, {"pubmed": 16240366, "text": "the phenotype observed in affected individuals from P301S MAPT mutation families is heterogeneous and is broader than the phenotypes seen to date in affected family members carrying other MAPT mutations"}, {"pubmed": 16246844, "text": "analysis of tau repeat domain in a model of tauopathy"}, {"pubmed": 16251138, "text": "A Degeneration, Frontotemporal Lobar patient at-risk status for the +16 exon 10 splice mutation in the tau gene (microtubule associated protein tau, MAPT), which had given rise to progressive behavioural disturbances in two of his siblings."}, {"pubmed": 16315267, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 16362633, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16362832, "text": "Familial autosomal dominant cortico-basal degeneration with the P301S mutation in the tau gene."}, {"pubmed": 16371011, "text": "Misregulation of alternative splicing of tau exon 10 seems to contribute to sporadic AD."}, {"pubmed": 16386371, "text": "In this work, we have found that in the presence of acetylsalicylic acid, at a concentration like that used for anti-inflammatory treatments, tau phosphorylation at serine 422 decreases."}, {"pubmed": 16410051, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 16415175, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16420965, "text": "Our results demonstrate that the flow cytometry-based method is a convenient tool to analyze the effect of GSK-3beta inhibitors on Tau phosphorylation."}, {"pubmed": 16443603, "text": "Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation in Alzheimer's disease"}, {"pubmed": 16446437, "text": "Blocking the sites where amyloid-beta protein initially binds to tau might arrest the simultaneous formation of plaques and tangles in Alzheimer's disease"}, {"pubmed": 16456666, "text": "Abeta and hyperphosphorylated tau formation in somatostatin cells are basically independent events Decreased somatostatin only partly goes together with cytoskeletal changes in somatostatin cells in nucleus tuberalis lateralis of Alzheimer's disease."}, {"pubmed": 16464864, "text": "SUMO1 is involved in a modification of tau and alpha-synuclein that may also have implications for their pathogenic roles in neurodegenerative diseases"}, {"pubmed": 16464956, "text": "data show that chaperone induction results in the selective clearance of specific phospho-tau and conformationally altered tau species mediated by the proteasome"}, {"pubmed": 16475161, "text": "PP2A-mediated dephosphorylation of HSP27 and tau correlated with PP2A-induced preservation of endothelial cell cytoskeleton"}, {"pubmed": 16475817, "text": "C-terminal end of tau folds over into vicinity of microtubule-binding repeat domain, N-terminus remains outside FRET distance of repeat domain, yet both ends of molecule approach one another."}, {"pubmed": 16477009, "text": "These findings unravel a cellular mechanism linking tau toxicity to NMDAR activation and might be relevant to Alzheimer's disease and tauopathies where NMDAR-mediated toxicity is postulated to play a pivotal role."}, {"pubmed": 16478530, "text": "Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease"}, {"pubmed": 16478768, "text": "The role of JNK activation in the hyperphosphorylation of abnormal tau protein during mitosis is reported."}, {"pubmed": 16487687, "text": "In DMI Tau exon 6 is mis-regulated only in the brain tissue."}, {"pubmed": 16503405, "text": "Sequencing the MAPT gene in affected individuals revealed a change in intron 9. This finding supports earlier studies on the effect of a splice-accepting element in inclusion of exon 10 in the MAPT transcript."}, {"pubmed": 16552760, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16566606, "text": "Nitration of Tyr18, Tyr29, Tyr197, & Tyr394, events known to stabilize pathological Alz-50 conformation inhibits ability of monomeric tau to promote tubulin assembly. Alz-50 conformation may be mechanism through which tau nitration modulates MT stability."}, {"pubmed": 16606369, "text": "S422E tau is more resistant to proteolysis by caspase 3 than non-pseudophosphorylated tau. Tau phosphorylation at S422 may be a protective mechanism that inhibits cleavage in vivo."}, {"pubmed": 16609851, "text": "The composite Guam parkinsonism-dementia complex neuropathology profile of tau, alpha-synuclein and 8, 12-iso-iPF(2alpha)-VI isoprostane reported here more closely resembles that seen in other tauopathies including frontotemporal dementias (FTDs)."}, {"pubmed": 16634634, "text": "Phosphorylation of serine and threonine residues in proline-rich sequences of tau protein induces a conformational change to a type II polyproline helix."}, {"pubmed": 16651626, "text": "Suppressing the transgene (tau)prevented further neuronal loss without removing or preventing additional accumulation of neurofibrillary pathology."}, {"pubmed": 16678934, "text": "Cerebrospinal fluid levels of tau are significantly increased in patients with multiple system atrophy predominated by parkinsonism."}, {"pubmed": 16687396, "text": "site-specific phosphorylation and caspase cleavage of tau differentially affect the ability of tau to bind and stabilize microtubules and facilitate tau self-association"}, {"pubmed": 16690493, "text": "A distinct isoform of abnormally phosphorylated tau (69 kDa, Tau 69) predominantly aggregates in laser-microdissected Pick bodies in sporadic Pick's disease."}, {"pubmed": 16717456, "text": "Microdeletions of this protein within the 17q21.31 segment should be considered as a possible cause of phenotypes resembling Angelman synrome."}, {"pubmed": 16734669, "text": "APP is transported on vesicles distinct from the secretase components and amyloid-beta is not generated in transit when transport is blocked by tau"}, {"pubmed": 16735465, "text": "These findings suggest that the nonfibrillized P-tau is most likely the responsible entity for the disruption of microtubules in neurons in Alzheimer's disease (AD)."}, {"pubmed": 16738255, "text": "Targeted expression of tau in hippocampal slices provides a novel model to analyze tau modification and spatiotemporal dynamics of tau-dependent neurodegeneration."}, {"pubmed": 16753151, "text": "biochemical analysis of neurofibrillary changes revealed that massive sarcosyl insoluble tau complexes consisted of human Alzheimer's tau"}, {"pubmed": 16777844, "text": "A putative intronic splicing enhancer located in intron 10 of the tau gene is required for the splicing stimulatory activity of RBM4"}, {"pubmed": 16781671, "text": "hyperphosphorylated-tau specific local phosphorylation patterns at Thr212/Ser214 and Thr231/Ser235 using monoclonal antibodies (mAb) generated against correspondingly modified peptides"}, {"pubmed": 16788822, "text": "Studies demonstrate that the full morphological phenotype of IBM including beta-amyloid and tau protein deposits may also develop in children, and that congenital muscle defects may lead to abnormal protein aggregation in IBM-like inclusions."}, {"pubmed": 16793187, "text": "Hyperphosphorylation of tau may be an underlying point of pathological convergence for several neuropsychiatric disorders, and prevention of tau hyperphosphorylation may be an important therapeutic target. (REVIEW)"}, {"pubmed": 16807328, "text": "Overexpression of mutant (P301L) human tau in CHIP-/- mice is insufficient to promote either argyrophilic or \"pre-tangle\" structures, despite marked phospho-tau accumulation throughout the brain."}, {"pubmed": 16818492, "text": "granular Tau aggregates have pathological roles in neuronal processes in tauopathies"}, {"pubmed": 16839689, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16875690, "text": "used tissue specific expression of wild type and mutant human tau transgenes to demonstrate differential phosphorylation and stability in a cell type-specific manner, which includes different neuronal types"}, {"pubmed": 16876320, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16876320, "text": "the age at onset showed significant correlation with the genotypes of Del-568TIns in PD samples when analyzed by Kendall rank correlation test. These results suggested that MAPT gene variants may modify the pathogenesis process of PD."}, {"pubmed": 16877359, "text": "This mouse model therefore displays the main features of tau pathology and several of the pathophysiological disturbances observed during neurofibrillary degeneration."}, {"pubmed": 16879631, "text": "Transgenic mice expressing the FTDP-17-associated mutation P301L of tau display intact spatial working memory but impairment in spatial reference memory at 6 and 11 months of age as well as a modest disinhibition of exploratory behavior at 6 mos of age."}, {"pubmed": 16891100, "text": "Residues 305 to 335 are essential for in vitro tau fibrillization."}, {"pubmed": 16902761, "text": "The progressive axonal pathology is most consistent with a dying-back process caused by abnormal accumulation of tau in upstream neurons, while vacuolar myelinopathy may be a secondary manifestation of neuroinflammation."}, {"pubmed": 16906163, "text": "A gene deletion of MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability."}, {"pubmed": 16906164, "text": "Deletion of MAPT is associated with a common inversion polymorphism."}, {"pubmed": 16908029, "text": "Results provide the first structural insights into a folded state of tau, and support a role for lipid membranes in mediating tau function and tau pathology."}, {"pubmed": 16909000, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16909000, "text": "We found no evidence that could support a major pathogenic role of STH and TAU haplotype in AD, FTD or PD."}, {"pubmed": 16914144, "text": "Data show that the addition of tau to cultured neuroblastoma cells provoked an increase in the levels of intracellular calcium, which is followed by cell death."}, {"pubmed": 16930434, "text": "Results reveal that expression of a truncated variant form of tau protein leads to the accumulation of reactive oxygen species and sensitizes rat cortical neurons to cell death induced by oxidative stress."}, {"pubmed": 16939415, "text": "tau turnover is dependent on degradation by the proteasome (inhibited by MG132) in HT22 neuronal cells."}, {"pubmed": 16943417, "text": "SRp54 interacts with a purine-rich element tau in exon 10 and antagonizes Tra2beta, an SR-domain-containing protein that enhances exon 10 inclusion."}, {"pubmed": 16958643, "text": "In this review microtubule-associated tau is one protein that has important functions in healthy neurons, but forms insoluble deposits in diseases now known collectively as tauopathies."}, {"pubmed": 16987883, "text": "recent work towards the unravelling of the functional basis of MAPT gene association with neurodegenrative disorders--review"}, {"pubmed": 17008320, "text": "analysis of the role of microtubule binding repeats in tau aggregation and toxicity"}, {"pubmed": 17021754, "text": "Ubiquitin-positive and tau-negative inclusions in clinical phenotypes were noted in cases of frontotemporal dementia (FTD), progressive non-fluent aphasia, type 2 histology with semantic dementia, and type 3 histology with FTD, and motor neurone disease."}, {"pubmed": 17023423, "text": "identify a region (positions 272-289) in the tau protein that, in the fibrillar state, either forms part of a core of parallel, in-register, beta-strands, or remains unfolded"}, {"pubmed": 17028556, "text": "Glycogen synthase kinase 3 betais the missing link between the amyloid and tau-pathology in Alzheimer disease."}, {"pubmed": 17029411, "text": "Three-dimensional heteronuclear NMR experiments demonstrate that the interaction with heparin induces beta-strand structure in several regions of Tau that might act as nucleation sites for its aggregation."}, {"pubmed": 17042504, "text": "N-terminal tau fragments inhibit human Tau polymerization by interacting with a specific C-terminal sequence, thereby stabilizing a soluble conformation of tau."}, {"pubmed": 17045592, "text": "phosphorylation of tau at Thr231 and Ser262 by cdk5 plus GSK-3, which inhibits its normal biological activity, is regulated both by its amino terminal inserts and its physical state"}, {"pubmed": 17056594, "text": "soluble Abeta and tau, but not soluble Abeta alone, have roles in cognitive decline in transgenic mice with plaques and tangle"}, {"pubmed": 17072625, "text": "This study report the clinical, neuroimaging, cerebral spinal fluid biomarker, genetic, biochemical and postmortem neuropathological analyses of a case of familial FTD with a Leu266Val MAPT mutation."}, {"pubmed": 17078951, "text": "GSK-3beta-catalyzed tau phosphorylation sites promoted by prephosphorylation by PKA"}, {"pubmed": 17084815, "text": "The common occurrence of intracellular accumulations of TDP-43 supports the hypothesis that these disorders represent a clinicopathological entity of a single disease, and suggests that they can be newly classified as a proteinopathy of TDP-43."}, {"pubmed": 17085483, "text": "Data may explain the increased susceptibility of H1 carriers to neurodegeneration and suggest a potential mechanism between MAPT genetic variability and the pathogenesis of neurodegenerative disease."}, {"pubmed": 17101697, "text": "These results suggest that a seminal cell biological event in Alzheimer's Disease pathogenesis is acute, tau-dependent loss of microtubule integrity caused by exposure of neurons to readily diffusible Abeta."}, {"pubmed": 17135279, "text": "Our result indicates that DYRK1A could be a key molecule bridging between beta-amyloid production and tau phosphorylation in AD."}, {"pubmed": 17169350, "text": "Beam walking tests revealed that tau transgenic rats developed progressive sensorimotor disturbances related to age; impaired reflex responses were another feature of behavioural phenotype in this novel transgenic rat."}, {"pubmed": 17172055, "text": "evidence of molecular interactions between prion protein (PrP) and tau protein highlights a potential role of tau in the biological function of PrP and the pathogenesis of TSEs"}, {"pubmed": 17174556, "text": "haplotype increases both the expression of total MAPT transcript as well as specifically increasing the proportion of 4 microtubule binding repeat containing transcripts in Alzheimer disease"}, {"pubmed": 17176091, "text": "While Lys-280 and Lys-281 play inhibitory roles in tau aggregation, Lys-311 is required for tau to assemble into fibrils."}, {"pubmed": 17179995, "text": "Data suggest that a probable cause variant may lie at or within close proximity to the rs242557 single nucleotide polymorphism as association with CSF tau levels seems to be primarily driven by rs242557 in a gene dosage-dependent manner."}, {"pubmed": 17185385, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17185385, "text": "Two independent cis-acting sites presumably influence risk for Guam neuro-degenerative disorders by regulating MAPT expression."}, {"pubmed": 17186252, "text": "The novel Tau mutation G335S in patient with Frontotemporal Lobar Degeneration ."}, {"pubmed": 17192672, "text": "Biochemical features of Alzheimer disease is modification by phosphorylation of the microtubule-associated protein TAU."}, {"pubmed": 17192721, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17192721, "text": "The data presented here suggest that subhaplotypes of haplotype H1 may confer susceptibility to Parkinson's disease (PD), and that either allelic heterogeneity or different haplotype composition explain the divergent haplotype results."}, {"pubmed": 17204369, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17266761, "text": "Our data suggest that the tagged SNPs forming the H1c haplotype at the MAPT locus do not have a causal role in the pathogenesis of late onset Alzheimer's disease"}, {"pubmed": 17274033, "text": "Mutations in exons 1 and 10 of TAU were associated with progressive supranuclear palsy.("}, {"pubmed": 17274033, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17304350, "text": "Inhibition of Hsp90 led to decreases in p-tau levels independent of heat shock factor 1 (HSF1) activation."}, {"pubmed": 17307736, "text": "analysis of the tau-microtubule interaction"}, {"pubmed": 17309878, "text": "findings suggest that disruption of the microtubule network in presynaptic nerve terminals could constitute early events in the pathological process leading to synaptic dysfunction in tau V337M pathology"}, {"pubmed": 17311412, "text": "The N-terminal region projects from the microtubule surface, and the lack of chemical shift variations when compared with free Tau proves that this region can regulate microtubular separation without adopting a stable conformation."}, {"pubmed": 17318302, "text": "Comparison of the tau genotype/haplotype carrying the proline(301)serine mutation and the initial clinical sign shows association between H1/H1 allelic genotype and parkinsonism and between H1/H2 genotype and personality change."}, {"pubmed": 17341679, "text": "The tau-4R isoform essentially contributes to hippocampal development by controlling proliferation and differentiation of neuronal precursors."}, {"pubmed": 17357082, "text": "Genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17362999, "text": "In this model we suggest a possible role for tau phosphorylation, but not for tau aggregation, in the cognitive impairment found in the transgenic mouse."}, {"pubmed": 17373874, "text": "REVIEW: Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease and their molecular rationales"}, {"pubmed": 17376439, "text": "These results suggest that phosphorylation of tau plays a dual role in modulating the activity of proteasome."}, {"pubmed": 17385861, "text": "Transition between vastly different healthy and pathological forms of tau was studied."}, {"pubmed": 17386961, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17386961, "text": "These findings do not support an association of MAPT with FTD but do not rule out its association with other tauopathies."}, {"pubmed": 17389797, "text": "There were dramatic changes in t-tau protein levels throughout the clinical course of Creutzfeldt-Jakob disease patients"}, {"pubmed": 17409229, "text": "Levels of early-stage aggregated tau species (140 and 170 kDa), before the formation of neurofibrillary tangles, is associated with the development of functional deficits during the pathogenic progression of tauopathy in a transgenic mouse model."}, {"pubmed": 17493040, "text": "Review focuses on tau dysfunction for neurodegeneration and discusses mutations in the Tau gene in cases with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)."}, {"pubmed": 17499212, "text": "The epitope of anti-tau mAb Tau5 was mapped to the human tau sequence 218-225, which is not phosphorylated in vivo."}, {"pubmed": 17512092, "text": "Increasing P-tau levels during cognitive decline and conversion to dementia suggest that P-tau may be useful as a longitudinal marker of the neurodegenerative process."}, {"pubmed": 17514749, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17514749, "text": "Strong evidence that the H1 clade, which contains MAPT and several other genes, is a risk factor for Parkinson's disease."}, {"pubmed": 17517691, "text": "the FTDP-17 tauV337M mutation has a role in impairment in impulse control that is exacerbated by age"}, {"pubmed": 17555970, "text": "Fine mapping of the MAPT region has identified sub-clades of the MAPT H1 haplotype which are specifically associated with neurodegenerative disease"}, {"pubmed": 17561815, "text": "Intermolecular disulfide crosslinking along with PHF6 hexapeptide facilitates tau oligomerization; this event is accompanied by cysteine-independent intermolecular bridging of microtubule-binding domain, leading to assembly of higher-order oligomers."}, {"pubmed": 17562708, "text": "phosphorylation sites in tau from Alzheimer brain show that casein kinase 1delta may have a role, together with glycogen synthase kinase-3beta, in the pathogenesis of Alzheimer disea"}, {"pubmed": 17565981, "text": "GSK3beta facilitates the association of T4 and T4C3, and the presence of caspase-cleaved tau is necessary for the evolution of tau oligomers into Sarkosyl-insoluble inclusions even though it is not extensively phosphorylated"}, {"pubmed": 17602795, "text": "In both cell culture and post-mortem brain tissue, we show that the protective MAPT H2 haplotype significantly expresses two-fold more 2N (exons 2+3+) MAPT transcripts than the disease-associated H1 haplotype."}, {"pubmed": 17608454, "text": "Our results are not consistent with a nucleation-elongation reaction but are consistent with an allosteric regulation model; the presence of small molecules induce a conformational change that decreases the thermodynamic barrier for polymerization."}, {"pubmed": 17637803, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17637803, "text": "Role of MAPT H1 haplotypes in the etiology of Parkinson's disease may be ethnically dependent."}, {"pubmed": 17661153, "text": "The H1/H1 genotype carriers showed a significant increase in 4R/3R mRNA ratio, suggesting that this genotype could modulate the tau mRNA splicing."}, {"pubmed": 17662000, "text": "novel MAPT mutation (P301T) is associated with familial frontotemporal dementia."}, {"pubmed": 17683088, "text": "Tau and alpha-synuclein are involved in shared or converging pathways in pathogenesis of Parkinson's disease(PD). Tau inversion influences development of cognitive impairment and dementia in patients with idiopathic PD."}, {"pubmed": 17685560, "text": "Synthesis of phenylthiazolyl-hydrazide derivative (PTH)showed that it was active in inhibiting tau aggregation and in disassembling preformed aggregates. Analysis of the binding epitope shows strong interactions between the tau and the ligand."}, {"pubmed": 17707586, "text": "Our study does not support the theory that chromosomal rearrangements in the Tau region of chromosome 17 are a cause of FTLD."}, {"pubmed": 17721707, "text": "We demonstrated increased but largely variable 4R tau/3R tau mRNA ratios in FTLD and PSP cases, suggesting heterogeneous pathophysiological processes within these disorders."}, {"pubmed": 17723255, "text": "This study presents a case of Alzheimer's disease with a deletion of the lysine residue at codon 280 (DeltaK280) in exon 10-encoded microtubule-binding repeat domain of the tau gene (MAPT)."}, {"pubmed": 17727636, "text": "Our results demonstrate that dysregulation of combinatorial splicing might serve as a signature for aging-related diseases, and the polony assay could be widely adapted for the study of other tauopathies"}, {"pubmed": 17822846, "text": "The levels of apoE in cerebrospinal fluid were also correlated to the levels of Tau and the possibility is discussed that the level of apoE in cerebrospinal fluid may be used as a marker of neurodegeneration."}, {"pubmed": 17826340, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 17889968, "text": "P-tau(231) is the strongest predictor of the decline from MCI to AD. IP levels uniquely show longitudinal progression effects. These results suggest the use of CSF biomarkers in secondary prevention trials."}, {"pubmed": 17898350, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17898350, "text": "while the extended MAPT H1 and H2 haplotypes do not appear to confer risk for frontotemporal dementia development, the H2 haplotype appears to modify age at onset and functionally shows a more severe decline of glucose utilization in frontal brain areas"}, {"pubmed": 17908237, "text": "This indicates that if the majority of tau is phosphorylated at S396/S404, in combination with increased GSK3beta activity, tau aggregation is favored."}, {"pubmed": 17914261, "text": "Despite the increased CSF concentrations of amyloid-beta, there were no signs of an Alzheimer disease-indicating tau pattern in CSF of Down syndrome patients, strengthening the theory of Abeta pathology preceding tau pathology in Alzheimer's."}, {"pubmed": 17920160, "text": "The evidence that P-tau231 and IP are the earliest markers for the neuronal damage related to AD awaits longitudinal study."}, {"pubmed": 17925548, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17932487, "text": "the N-terminal projection domain of tau binds to the C-terminus of the p150 subunit of the dynactin complex"}, {"pubmed": 17951083, "text": "Data show that high t-Tau levels in CSF are found in pediatric patients with a brain tumor, patients with hydrocephalus and patients with a serious CNS infection."}, {"pubmed": 17954934, "text": "BAG-1 associates with Tau protein in an Hsc70-dependent manner."}, {"pubmed": 17976912, "text": "Thus, it is proposed that the negative charge present in taurine may be involved in the binding to tau protein, facilitating its assembly."}, {"pubmed": 17986027, "text": "An impaired control of glycogen synthase kinase-3beta activity by insulin receptor-mediated signalling plays a role in the pathogenesis of AD, facilitating tau protein phosphorylation and neurofibrillary tangle formation."}, {"pubmed": 18007595, "text": "Data demonstrate that aged (>20 months old) mice expressing wild-type human tau display impaired place learning and memory, even though they do not form neurofibrillary tangles or display neuronal loss."}, {"pubmed": 18022644, "text": "No patients had mutations of MAPT sporadic and familial PSP."}, {"pubmed": 18022644, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18038270, "text": "The molecular interactions between PrP and tau protein highlight a potential role of tau in the biological function of PrP and the pathogenesis of transmissible spongiform encephalopathies."}, {"pubmed": 18052981, "text": "Tau phosphorylation at proline-rich region by dual-specificity tyrosine-phosphorylated and -regulated kinase 1A and at C-terminal tail region by glycogen synthase kinase-3beta affected its microtubule assembly activity and self-aggregation differently."}, {"pubmed": 18065436, "text": "multidisciplinary study of multiple system tauopathy with presenile dementia kindred; mutation +3 in intron 10 of Tau can give rise to a picture of FTD or atypical PSP; haplotype of wild-type allele may act as a modifier of disease presentation"}, {"pubmed": 18070606, "text": "Syk is also a tau kinase, phosphorylating tau in vitro and in CHO cells when both proteins are expressed exogenously."}, {"pubmed": 18072964, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18072964, "text": "Our study shows no evidence for an association between MAPT gene variations and sCJD, and some weak evidence for an association to vCJD"}, {"pubmed": 18093153, "text": "report describes a tau S305S family where mutation carriers have frontotemporal dementia and parkinsonism; findings support previous studies demonstrating that the S305S mutation influences splicing of tau exon 10 & results in an overproduction of 4R tau"}, {"pubmed": 18162161, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18162161, "text": "Our study supports the hypothesis that genetic variability in the MAPT gene confers susceptibility to PD."}, {"pubmed": 18163405, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18166610, "text": "MAPT and PGRN are responsible for the largest number of familial cases. Each of these genes differs by disease mechanism. Moreover mutations in both genes are associated with significant interfamilial and intrafamilial phenotypic variation."}, {"pubmed": 18177439, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18182010, "text": "Data show that tau overexpression leads to impaired retrograde and anterograde organelle transport, while the microtubule skeleton appears intact."}, {"pubmed": 18184373, "text": "There is an increased neurogenesis during tau hyperphosphorylation and cell cycle events during abnormal tau phosphorylation and tau aggregation preceding neuronal death and neurodegeneration."}, {"pubmed": 18185033, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18185033, "text": "To investigate associations of APOE, APOE promoter (G-219T), and tau protein exon 6 polymorphisms (47 and 53) and a history of self-reported concussion in college athletes"}, {"pubmed": 18210157, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 18216194, "text": "Aggregated tau in neurons can be associated with caspase activation, but caspase activation is not sufficient to cause acute neuronal death in this transgenic mouse model."}, {"pubmed": 18234697, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18272392, "text": "The observed effect of tau protein on neurons (in neuroblastomas and primary cultures of hippocampal and cortical neurons) is through M1 and M3 muscarinic receptors."}, {"pubmed": 18276036, "text": "Our data suggest that there is an interaction between age and the expression of MAPT in the brain."}, {"pubmed": 18284428, "text": "Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation."}, {"pubmed": 18307033, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18307268, "text": "Patients with mutations may be affected by frontotemporal dmentia and parkinsonism linked to chromosome 17."}, {"pubmed": 18312411, "text": "This systematic study of the linkage-dependent contribution of each repeat peptide to the paired helical filament formation of tau microtubule-binding domain (MBD) is useful for understanding the essence of short and long filament formation of tau MBD."}, {"pubmed": 18315566, "text": "First direct protein sequence analysis of tau post-translational modification shows how aggregatory characteristics of progressive supranuclear palsy-tau differ from Alzheimer brain."}, {"pubmed": 18318434, "text": "Our results identify a molecular mechanism by which proinflammatory stimuli affect tau pathology via the GSK-3beta signaling pathway in skeletal muscle."}, {"pubmed": 18319590, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18319590, "text": "combined gene effects between 14-3-3 zeta (intron 4, rs 983583) polymorphism and tau (intron 9, rs 2471738) polymorphism might be responsible for susceptibility to Alzheimer disease"}, {"pubmed": 18322394, "text": "FTDP-17T is associated with symmetric frontotemporal atrophy and FTDP-17U with an asymmetric degenerative process in parkinsonism and frontotemporal dementia."}, {"pubmed": 18338250, "text": "Data provide the first evidence that 17beta-estradiol can inhibit PKA overactivation and PKA-induced tau hyperphosphorylation, implying a preventive role of 17beta-estradiol in AD-like tau pathology."}, {"pubmed": 18351740, "text": "Results describe the detailed characterization of tau in human cerebrospinal fluid."}, {"pubmed": 18359772, "text": "analysis of tau filament formation and the role of dimerization"}, {"pubmed": 18380664, "text": "Expression of microtubule-associated protein tau, a major component of tangles, with an adeno-associated virus vector induces neuropathological sequelae in rats that are similar to those seen in human tauopathies."}, {"pubmed": 18382889, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18382889, "text": "Senile systemic amyloidosis was associated with age, myocardial infarctions, the G/G (Val/Val) genotype of the exon 24 polymorphism in the alpha2-macroglobulin (alpha2M), and the H2 haplotype of the tau gene"}, {"pubmed": 18395614, "text": "These results indicate the existence of a correlation between impairment of cerebral metabolism, estimated through FDG-PET, and CSF Tau protein levels."}, {"pubmed": 18403055, "text": "We found that the older control group had lower Abeta1-42 and higher (p)tau compared to the younger control group. This suggests that older individuals may have Alzheimer's disease pathology, even in the absence of objective cognitive impairment."}, {"pubmed": 18413467, "text": "Mutations in the gene encoding the microtubule-associated protein tau (MAPT; OMIM +157140) on chromosome 17 have been found in many kindreds with familial FTDP."}, {"pubmed": 18430997, "text": "study found that the level of the catalytic subunit of PP2A(PP2Ac) was dramatically decreased in adult Down syndrome brain, and this decrease correlated negatively with tau leveland phosphorylation at several abnormal hyperphosphorylation sites"}, {"pubmed": 18431250, "text": "These results indicate that tau is not randomly proteolyzed at different domains, and that proteolysis occurs sequentially from the C-terminus to inner regions of tau in AD progression."}, {"pubmed": 18431254, "text": "Taken together, the in vitro models and findings in AD suggest that in the presence of ubiquinone, Hirano bodies may result from the interaction of actin and other proteins, including tau."}, {"pubmed": 18445112, "text": "study describes the transient elevation of total tau levels in CSF of patients with Wernicke's encephalopathy, as well as the absence of elevated total tau in alcohol withdrawal delirium"}, {"pubmed": 18458217, "text": "The ratio of CSF tau/A beta(42) is a sensitive and specific biomarker at discriminating frontotemporal lobar degeneration from Alzheimer disease in patients with known pathology."}, {"pubmed": 18460467, "text": "relative resistance to phosphatases might be a common feature of Cdk5 substrates and could contribute to the hyperphosphorylation of CRMP2 and Tau observed in Alzheimer disease"}, {"pubmed": 18462837, "text": "results suggest that in cognitively healthy elderly subjects, biochemical changes in CSF tau and Abeta42 have an effect on cerebral function; CSF biomarkers and EEG theta activity might indicate early abnormal degenerative changes in the brain"}, {"pubmed": 18467692, "text": "Abeta and tau pathology are consistent with a model in which both synaptic loss and dysfunction are linked to a synaptic amyloid cascade within the synaptic compartment."}, {"pubmed": 18490011, "text": "Both animal and cell models, which were regulated under the natural tau promoter (of rat origin), provide authentic and reliable models for tauopathy, and offer valuable tools for understanding the molecular events underlying tauopathies including AD."}, {"pubmed": 18495299, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18495933, "text": "The data are incompatible with tau acting as a monomer; rather, they indicate that two tau molecules associate in an antiparallel configuration held together by an electrostatic \"zipper\" of complementary salt bridges."}, {"pubmed": 18500754, "text": "Two hsc70 binding sites on tau are identified, as well as hydrophobic amino acids crucial for hsc70 binding."}, {"pubmed": 18509094, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18509094, "text": "This study supports a role for MAPT in the pathogenesis of familial and idiopathic Parkinson disease (PD)."}, {"pubmed": 18511295, "text": "A caspase-cleaved NH2-terminal tau fragment of 20-22 kDa, consistent with the size of the N-terminal 26-230 amino-acid neurotoxic fragment of tau, is generated in vitro in differentiated human SH-SY5Y cells."}, {"pubmed": 18541914, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18541914, "text": "This endophenotype-based approach provides evidence for a gene (MAPT SNPs)-physiological environment (Abeta deposition) interaction that places changes in cerebrospinal fluid tau after Abeta deposition."}, {"pubmed": 18558718, "text": "VQIINK (280) and VQIVYK (311) are the major, if not sole, critical regions that directly mediate intermolecular contact between tau molecules during the early phases of Tau aggregation."}, {"pubmed": 18561034, "text": "parkin may counteract the alteration of tau metabolism in certain neurodegenerative diseases with tau cytopathy and parkinsonism"}, {"pubmed": 18562203, "text": "Collectively, these findings suggest that Tau nitration at Tyr 18 may be linked to astrocyte activation, an early event associated with amyloid plaque formation."}, {"pubmed": 18583940, "text": "Findings argue for a role of tau in chromosome stability by means of its interaction with both microtubules and chromatin."}, {"pubmed": 18586097, "text": "Increased demethylation of PP2A mediated by Abeta overproduction or estrogen deficiency may contribute to the reduced PP2A activity observed in the AD brain, resulting in the compromised dephosphorylation of abnormally hyperphosphorylated tau."}, {"pubmed": 18587238, "text": "although PSEN1 mutations are the most frequent cause, the MAPT R406W mutation is an important cause of early-onset familial dementia clinically diagnosed as Alzheimer's disease in Japanese"}, {"pubmed": 18588978, "text": "We conclude that the phosphorylation of tau by GSK-3beta either prior to or following polymerization promotes polymer/polymer interactions that result in stable clusters of tau filaments."}, {"pubmed": 18596978, "text": "using electrophoretic mobility shifting assay (EMSA) in the presence of DNA with different chain-lengths, we observed that tau protein favored binding to a 13 bp or a longer polynucleotide."}, {"pubmed": 18631770, "text": "MAPT is a susceptibility gene for progressive supranuclear palsy."}, {"pubmed": 18636984, "text": "These findings establish HDAC6 as a tau-interacting protein and as a potential modulator of tau phosphorylation and accumulation."}, {"pubmed": 18640988, "text": "mature, parkin null, over-expressing human mutated tau (PK(-/-)/Tau(VLW)) mice have altered behaviour and dopamine neurotransmission, tau pathology in brain and amyloid deposition in brain and peripheral organs"}, {"pubmed": 18641620, "text": "review of modifications, phosphorylation and a specific form of glycosylation, O-linked -N-acetylglucosaminylation by O-GlcNAc, relevant to pathological tau phosphorylation"}, {"pubmed": 18658135, "text": "Imbalance of 3R- and 4R-tau in DS brain by Dyrk1A-induced dysregulation of alternative splicing factor-mediated alternative splicing of tau exon 10 represents a novel mechanism of neurofibrillary degeneration"}, {"pubmed": 18661559, "text": "These results suggest for the first time that variation of alpha-synuclein modulates neurofibrillary tau pathology and support the recent observations of an interaction of alpha-synuclein and tau in neurodegeneration."}, {"pubmed": 18662339, "text": "Results suggest that differential regulation of phosphorylation is important for neurofibrillary tangle formation in neurodegenerative diseases with tau pathology."}, {"pubmed": 18668363, "text": "ER gene transcription carries weak predictive significance for benefit from endocrine therapy or for outcome in early breast cancer. The predictive significance is possibly exerted via MAP-Tau gene expression."}, {"pubmed": 18671940, "text": "This work is focused on the fourth microtubule-binding repeat (R4) of tau, which has an O-GlcNAcylation site-Ser356."}, {"pubmed": 18679696, "text": "simultaneous presence of human mutated Tau(VLW) and plaque-amyloid (and/or APP(SW)) potentiates and anticipates tau phosphorylation at the 12E8 epitope, intensifying pyramidal neuron immunostaining and tau filament formation in this alzheimer's model"}, {"pubmed": 18702695, "text": "Expression levels of misfolded truncated tau determine life span in transgenic rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load."}, {"pubmed": 18725924, "text": "Residue K280 can adopt a loop/turn conformation in WT MTBR2 and that deletion of this residue, which can adopt nonextended states, leads to an increase in locally extended conformations near the C-terminus of PHF6*, aggregation-initiating sequence."}, {"pubmed": 18765933, "text": "Haplotype frequencies vary between those developing Alzheimer's disease in Down syndrome before 45 and those developing dementia after this age"}, {"pubmed": 18768919, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 18771816, "text": "Pathological accumulation of amyloid-beta protein and hyperphosphorylation of tau develop concomitantly within synaptic terminals of Swedish mutant transgenic mice."}, {"pubmed": 18785640, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18785640, "text": "The major H1 subhaplotype in Guadeloupe, determined by analysis of linkage desequibrium, differed from the major Caucasian subhaplotype, but corresponded to minor alleles previously described."}, {"pubmed": 18803399, "text": "According to circular dichroism and NMR spectroscopy, Tau remains largely disordered upon binding to Cu(II), although a limited amount of aggregation is induced"}, {"pubmed": 18803648, "text": "Whilst dementia severity is closely related to impaired cerebral glucose metabolism, CSF t-tau is less closely related and appears to be less well suited for assessment of disease progression."}, {"pubmed": 18803694, "text": "MAPT missense mutations can directly promote tau filament formation at different stages of the aggregation pathway."}, {"pubmed": 18805362, "text": "Data show that total serum bilirubin and mean serum Tau levels of infants who manifest auditory neuropathy, neurologic abnormalities, or EEG abnormalities are significantly higher than in infants without these abnormalities."}, {"pubmed": 18806919, "text": "Data show that in AD patients, cortisol serum levels are significantly inversely correlated with T-tau, P-tau 181 and P-tau 231 protein levels and T-tau/Abeta 1-42 ratios in CSF."}, {"pubmed": 18830724, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18841019, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18843496, "text": "Data show that the pathological deposits with antibodies against tau has involved in the neuropathogenesis of the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam."}, {"pubmed": 18848323, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18854867, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18854867, "text": "The data suggest that H1 haplotype is associated with a particular cerebral morphology that may increase the susceptibility of the healthy carriers to develop neurodegenerative diseases such as sporadic tauopathies."}, {"pubmed": 18925637, "text": "We found differences between mouse and human tau in the regulation of exon 10 inclusion. Despite these differences, the isoform splicing pattern seen in normal human brain is replicated in our mouse models."}, {"pubmed": 18930114, "text": "No differences in genotypic distributions between the dementia in Parkinson's disease,Parkinson's disease and control."}, {"pubmed": 18930114, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18930955, "text": "Phosphorylation and microtubule binding plays a crucial role in the regulation of tau toxicity when misexpressed."}, {"pubmed": 18940799, "text": "FTDP-17 mutations in Tau alter the regulation of microtubule dynamics and demonstrate an \"alternative core\" model for normal and pathological Tau action"}, {"pubmed": 18946722, "text": "Report co-localization of hyperphosphorylated tau and caspases 3/6 in the brainstem of Alzheimer's disease patients."}, {"pubmed": 18948254, "text": "Tau mutations likely play a role in neurodegenerative diseases (Review)"}, {"pubmed": 18971445, "text": "Truncated tau production, which selectively affects brainstem neuron susceptibility, can be considered a specific marker for PSP. Tau form ratio was the lowest in progressive supranuclear palsy with no overlap with any other neurodegenerative illness."}, {"pubmed": 18985386, "text": "Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18991351, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18992292, "text": "Each FTDP-17 tau mutation not only site-specifically inhibits tau dephosphorylation on some sites but also promotes dephosphorylation by phosphatases on other sites."}, {"pubmed": 18992725, "text": "H/I resulted in a significant increase in tau fragments generated by caspase activation and a marked decrease in tau phosphorylation at residue T231 in cortex of wild-type but not transgenic mice."}, {"pubmed": 19001166, "text": "Considering pathologic abnormalities of these tauopathies and involvement of tau mutations seen in familial forms, MAPT gene represents most likely cause driving association."}, {"pubmed": 19001166, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19010781, "text": "Conformational diversity of wild-type Tau fibrils specified by templated conformation change."}, {"pubmed": 19011737, "text": "P-tau discriminated between vascular dementia patients and controls, but not between Alzheimer disease patients and the other groups. Higher P-tau values did predict a more rapid evolution of cognitive decline."}, {"pubmed": 19022385, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19022385, "text": "rs1880753 marker located 160 kb and 50 kb upstream of MAPT and CRHR1 genes respectively showed consistent association with disease risk and an earlier age at onset, suggesting that it could act as cis modifying factor of MAPT gene expression"}, {"pubmed": 19039589, "text": "Patients with tau-positive expression may derive less benefit than tau-negative from paclitaxel therapy in metastatic breast cancer."}, {"pubmed": 19057915, "text": "the combination of PARK2 gene deletion with hTauVLW over-expression in mice produces abnormal hyperphosphorylated tau aggregates, similar to those observed in the brain of patients diagnosed with certain tauopathies"}, {"pubmed": 19070646, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19070646, "text": "Our data suggest that the 347C polymorphism in the promoter of MAPT gene, which is associated with an up-regulation of the gene expression, is a susceptibility factor in sporadic AD."}, {"pubmed": 19074461, "text": "MAPT deletion exacerbates the Niemann-Pick type C phenotype."}, {"pubmed": 19090983, "text": "Data show that abnormal splicing with inclusion of exon 10 into tau mRNA has been observed in progressive supranuclear palsy and Alzheimer's disease patients."}, {"pubmed": 19091059, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19091059, "text": "We conclude that although pathogenic MAPT mutations are rare in Northern Finland, the MAPT H2 allele may be associated with increased risks of FTLD and eoAD in the Finnish population."}, {"pubmed": 19112391, "text": "Measurement of tau protein or phosphorylated-tau protein in cerebrospinal fluid seems to be of no importance in the differential diagnosis of early stage multiple sclerosis."}, {"pubmed": 19126401, "text": "The role of PP2A in the phosphorylation of P301L mutant human tau and in neurofibrillary tangle pathology in vivo was determined."}, {"pubmed": 19153649, "text": "While tau protein seems to be quite a reliable marker of AD, the role of beta-amyloid(1-42) and cystatin C in AD diagnosis remains at least questionable."}, {"pubmed": 19155101, "text": "This study compares equal tau gene transfer in 3- and 20-month-old rats, in order to test the hypothesis that late middle-aged rats are more susceptible to neurodegeneration."}, {"pubmed": 19158426, "text": "results show each of the 4 exonic tau mutations tested accelerate degeneration in giant neurons of the lamprey compared to WT isoforms; patterns of tau distribution, phosphorylation & cytopathology vary among WT & mutant isoforms in a single neuron"}, {"pubmed": 19165922, "text": "We found that inversion of the MAPT region is similarly polymorphic in other great ape species, and we present evidence that the inversions occurred independently in chimpanzees and humans"}, {"pubmed": 19190923, "text": "our study shows that tau truncation appears after tau hyperphosphorylation in the brain of two transgenic mouse models, and that accumulation of truncated tau is closely associated with neurons undergoing degeneration or containing neurofibrillary tangles"}, {"pubmed": 19221889, "text": "Amyloid-beta and Tau affected aging-prone astrocyte cell death, metabolism and cytoskeleton."}, {"pubmed": 19224617, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19224617, "text": "This study found that modest Modest associations (uncorrected P < 0.05) were observed for common variants around MAPT in Australia patient with Parkinson's disease."}, {"pubmed": 19226187, "text": "study shows 441-residue tau is dynamic in solution with distinct domain character & network of transient long-range contacts important for pathogenic aggregation;single-residue view by NMR analysis reveals insights of interaction of tau with microtubules"}, {"pubmed": 19232747, "text": "Neurodegenerative lesions caused by human truncated tau promote inflammatory response manifested by upregulation of immune-molecules (CD11a,b, CD18, CD4, CD45 and CD68) and morphological activation of microglial cells in a rat model of tauopathy."}, {"pubmed": 19236926, "text": "Ventricular expansion maps correlate with pathological and cognitive measures in AD, and may be useful in future imaging-based clinical trials."}, {"pubmed": 19240967, "text": "These data raise the possibility that increased tau phosphorylation may influence long-term clinical responsiveness to cholinesterase inhibitors."}, {"pubmed": 19255408, "text": "In subjects who have mutations of MAPT, patterns of atrophy seen on head magnetic resonance imaging (MRI) show greater gray matter loss, compared to head MRI of subjects with mutations in progranulin (PGRN)."}, {"pubmed": 19264130, "text": "The current studies show for the first time activity for NAP in a \"pure\" tauopathy model, positioning it as a promising drug candidate in multiple neurodegenerative tauopathies."}, {"pubmed": 19273536, "text": "Sut-2 as a gene required for human tau neurotoxicity in C. elegans."}, {"pubmed": 19304664, "text": "FTDP-17 missense mutations, by promoting phosphorylation at Ser(202), inhibit the microtubule assembly-promoting activity of tau in vitro."}, {"pubmed": 19307538, "text": "subgroup of patients with extremely high CSF levels of tau and tau phosphorylated at threonine 181 shows a distinct cognitive profile with severe impairment of memory, mental speed, and executive functions, which cannot be explained by disease severity."}, {"pubmed": 19308965, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19308965, "text": "found no evidence for allelic or haplotypic association, with SNPs in the MAPT gene and late-onset Alzheimer's disease. SNP rs242557 is nominally significant in the APOE4 positive individuals."}, {"pubmed": 19324008, "text": "The significant aggregation of 4R-tau by 14-3-3zeta suggests that 14-3-3 may act as an inducer in the generation of 4R-tau-predominant neurofibrillary tangles in tauopathies."}, {"pubmed": 19356824, "text": "The hyperphosphorylated transgenic tau accumulates in the nerve fibre layer and, from 2 months of age, aggregates into filamentous inclusions in retinal ganglion cells of human P301S tau transgenic mice."}, {"pubmed": 19365643, "text": "Results describe a cohort of frontotemporal lobar degeneration families with a homogeneous genetic background within and around the MAPT locus."}, {"pubmed": 19371722, "text": "These results implicate 14-3-3zeta/tau heterodimers as key regulators of SSH1 activity in keratinocytes and suggest they play a role in cytoskeleton remodeling during cell migration."}, {"pubmed": 19401603, "text": "Dephosphorylation of wild-type Tau was reduced in brain extracts of Pin1-knockout mice, and this reduction was not observed with P301L and R406W."}, {"pubmed": 19429119, "text": "Our data suggest that Leptin regulates tau phosphorylation through a pathway involving both AMPK and GSK-3beta."}, {"pubmed": 19433664, "text": "In individuals with very mild Alzheimer dementia, lower CSF Abeta 42 levels, high tau or ptau181 levels, or high tau:Abeta 42 ratios quantitatively predict more rapid progression of cognitive deficits and dementia."}, {"pubmed": 19450558, "text": "The repeat-number-dependent aggregation model of tau microtubule-binding domain, together with the function of each repeat, reported in this paper should help to devise a method of preventing tau paired helical filaments formation."}, {"pubmed": 19450659, "text": "This study identified risk haplotype [GAC+G] for parkinson disease(PD). In addition, haplotype AAC+A was strongly associated with early onset PD (age at onset < or =40 years) and AAC+G haplotype showed a weak association with late onset PD."}, {"pubmed": 19478088, "text": "Cyanine dye 3,3'-diethyl-9-methyl-thiacarbocyanine iodide (C11) was utilized to modulate Tau polymerization in two model systems, an organotypic slice culture model and a split green fluorescent protein complementation assay in Tau-expressing cells."}, {"pubmed": 19491104, "text": "The pathological Tau/JIP1 interaction requires phosphorylation of Tau, and Tau competes with the physiological binding of JIP1 to kinesin light chain."}, {"pubmed": 19498037, "text": "Elevated or reduced exon 10 inclusion caused by FTDP-17 mutations can be reversed by trans-splicing."}, {"pubmed": 19517062, "text": "Data show that D-ribose reacts with Tau protein rapidly, producing ThT-positive aggregations which had high cytotoxicity."}, {"pubmed": 19523877, "text": "The CSF Tau AD profile was more common in patients with SCI (31 of 60 [52%]), naMCI (25 of 37 [68%]), and aMCI (56 of 71 [79%]) than in healthy controls (28 of 89 [31%])."}, {"pubmed": 19524111, "text": "The optimal CSF P-tau(181P) cut-off level for discriminating AD from non-AD dementias was 50.4pg/mL. Optimal CSF P-tau(181P) cut-off levels differed between non-AD diagnostic dementia categories."}, {"pubmed": 19525898, "text": "results suggest that more contacts between rough endoplasmic reticulum (RER) membranes and mitochondria resulting from the accumulation of tau at the surface of RER membranes might contribute to tau-induced neurodegeneration"}, {"pubmed": 19527721, "text": "Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains"}, {"pubmed": 19540327, "text": "The tau isoform shift shows an apparent disconnect to neurogenesis, migration and volume growth, but coincides with the formation of synapses and the appearance of stable microtubules."}, {"pubmed": 19542604, "text": "Mounting evidence summarized in this review suggests that tau tyrosine phosphorylation is an early event in the pathophysiology of Alzheimer's disease."}, {"pubmed": 19542619, "text": "Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy."}, {"pubmed": 19549281, "text": "Herein, we demonstrate that oleocanthal abrogates fibrillization of tau by locking tau into the naturally unfolded state."}, {"pubmed": 19558713, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19558713, "text": "The data of this study supported the overall genetic role of MAPT and the H1 haplotype for PD susceptibility in Greek patients."}, {"pubmed": 19559700, "text": "co-localization of somatostatin expression with Abeta (65.43%) with Abeta and tau (19.75%) and with tau (2.47%) in Alzheimer's disease"}, {"pubmed": 19560101, "text": "Positivity for at least one marker increased the probability 38 times of belonging to the AD group (P < 0.0001)"}, {"pubmed": 19573950, "text": "This case-control association study in a Greek cohort of 196 parkinson disease cases and 163 healthy controls. In our study, the MAPT H1 haplotype was found to be significantly associated with Parkinson disease."}, {"pubmed": 19591849, "text": "These data unravel novel mechanisms of tau hyperphosphorylation during G-protein-coupled receptor activation and are the first to show that stimulation of D1 receptors could have a profound influence on the neuronal cytoskeletal constituent tau."}, {"pubmed": 19625749, "text": "The mechanism by which the tau unfolded molecule evolves to the well ordered helical tau filaments is a very slow process, when followed in the absence of aggregation inducers."}, {"pubmed": 19647741, "text": "Data suggest that the state of tau3 phosphorylation by protein kinase A affects the mode of 14-3-3zeta binding and by this means might modify tau filament formation."}, {"pubmed": 19654187, "text": "Studies show that components of a selective form of autophagy, chaperone-mediated autophagy, are involved in the delivery of cytosolic Tau to lysosomes for this limited cleavage."}, {"pubmed": 19665462, "text": "expression of mutated tau results in significant structural and functional changes in neurons, but that these changes occur independent of mature neurofibrillary tangle formation"}, {"pubmed": 19667268, "text": "In univariate analyses, Tau- and ER-positive status were both associated with better DFS and OS whereas greater tumor size, high grade, lymph node- and HER2-positive status were each associated with worse DFS and OS."}, {"pubmed": 19681044, "text": "Tau in prostate cancer cells does not resemble that from normal adult brain and support the hypothesis that tau is a multifunctional protein."}, {"pubmed": 19684401, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19686388, "text": "tau-induced changes in axonal transport may be an underlying theme in neurodegenerative diseases associated with isoform specific changes in tau's interaction with microtubules"}, {"pubmed": 19691919, "text": "Both total-tau and phospho-tau levels showed significant correlation with age, which was more pronounced in older population."}, {"pubmed": 19693433, "text": "differences in solubility and phosphorylation may contribute, at least in part, to the formation of distinct tau deposits, but may also have implications for the clinical differences between Alzheimer's disease and Pick's disease"}, {"pubmed": 19695742, "text": "The prevalence of tau-positive grains has been underestimated in the very old population; as neurofibrillary tangles, they appear to be a constant accompaniment of age not associated with dementia."}, {"pubmed": 19700222, "text": "Activation of transgenic c-Abl by amyloid beta precursor proteinbeta promotes tau phosphorylation through Tyr15 phosphorylation-mediated Cdk5 activation."}, {"pubmed": 19730170, "text": "both PGRN and MAPT genes seem not to be the major genetic cause of frontotemporal lobar degeneration in Northern Italy"}, {"pubmed": 19730171, "text": "All of our Frontotemporal Lobar Degeneration patients were found to be negative for MAPT mutations"}, {"pubmed": 19736351, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19749420, "text": "data might indicate that the higher CSF t-tau level is associated with more neurofibrillary tangles pathology and more severe impairment of short-term memory in Alzheimer's disease patients"}, {"pubmed": 19766248, "text": "frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) resulting from the microtubule associated protein tau (MAPT) gene IVS10+16C>T splice site mutation"}, {"pubmed": 19768372, "text": "a novel Val75Ala MAPT mutation in patient with frontotemporal dementia"}, {"pubmed": 19770469, "text": "Baseline CSF levels of tau phosphorylated at threonine 181 are independently associated with subsequent disease progression, as reflected by hippocampal atrophy rate."}, {"pubmed": 19775775, "text": "These results suggest H63D HFE increases tau phosphorylation via GSK-3beta activity and iron-mediated oxidative stress."}, {"pubmed": 19782075, "text": "It is therefore possible to speculate that the mechanism by which Abeta(42) interacts with tau in the pathogenesis of Alzheimer's disease is by down-regulating endogenous wnt signalling"}, {"pubmed": 19786698, "text": "There seem to be differences in patterns of temporal lobe atrophy across the MAPT mutations; there seems to be a possible association between mutation function and pattern of temporal lobe atrophy"}, {"pubmed": 19794916, "text": "amyloid precursor protein, but not tau, has a role in neuronal accumulation of amyloid peptides"}, {"pubmed": 19812213, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19826005, "text": "Data demonstrate that low micromolar zinc accelerates the fibrillization of human Tau protein via bridging Cys-291 and Cys-322 in physiological reducing conditions."}, {"pubmed": 19858456, "text": "At the time of Alzheimer disease diagnosis, a combination of high CSF tau without proportionally elevated p-tau-181 is associated with a faster rate of cognitive decline."}, {"pubmed": 19879020, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19879020, "text": "This study supported that genetic variability within H1 MAPT haplotype confers susceptibility to parkinson disease. H1 risk sub-haplotypes associated with parkinson disease and progressive supranuclear palsy are different."}, {"pubmed": 19889475, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19895707, "text": "suggests that the proline-rich domain and the microtubule-binding domain of tau are both involved in binding to and bundling F-actin."}, {"pubmed": 19897570, "text": "the importance of the Tyr residue located at position 310, not at other positions, was clearly shown"}, {"pubmed": 19912324, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19912324, "text": "Our findings show that the H1 haplotype is a significant risk factor for Parkinson Disease"}, {"pubmed": 19914360, "text": "Study examined splicing factors located on chromosome 21 for their effect on tau exon 10 and discovered that one of them, hnRNPE3 (PCBP3), modestly activates splicing of exon 10 by interacting with its proximal downstream intron around position +19."}, {"pubmed": 19915575, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19919107, "text": "Tau 6P and 6D isoforms are endogenous inhibitors of tau filament formation."}, {"pubmed": 19923278, "text": "Amyloid-beta alone does not cause neurodegeneration but induces toxicity through phosphorylation of wild-type tau in an NMDA receptor-dependent pathway."}, {"pubmed": 19926863, "text": "These data provide mechanistic insight into how disruptions in lipid metabolism can determine neuronal response to accumulating oligomeric amyloid-beta(42)."}, {"pubmed": 19936237, "text": "Diabetes mellitus can accelerate onset and increase severity of disease and exacerbate tau deposition"}, {"pubmed": 19938685, "text": "Recent studies have identified 44 different mutations in more than 100 families with FTDP-17 (MAPT), and 66 different mutations in more than 100 families with FTDP-17 (PGRN)."}, {"pubmed": 19940479, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19940479, "text": "alterations in gene copy number of PGRN and MAPT are not a cause of disease in a collection of frontotemporal lobar degeneration patients"}, {"pubmed": 19943189, "text": "Results describe the temporal profile for amyloid precursor protein, amyloid-beta and tau expression in primary cortical cultures from 3x transgenic-Alzheimer disease mice."}, {"pubmed": 19959468, "text": "Results suggest that the formation of the 1:1 complex of Tau monomer and heparin plays an important role in the inducer-mediated Tau filament formation, providing clues to understanding the pathogenesis of neurodegenerative diseases."}, {"pubmed": 19961883, "text": "Newborns have extremely high levels of phosphorylated tau in their CSF, and that these levels decrease during the first years of life. Tau phosphorylation in Alzheimer's disease may be a physiological response to Alzheimer-associated synaptotoxicity."}, {"pubmed": 20004218, "text": "The present results support the validity of the P301S tau mice as a model of human tauopathy."}, {"pubmed": 20005921, "text": "we found no evidence that CALHM1 P86L is associated with altered CSF levels of the investigated Alzheimer's disease biomarkers A beta 42, tau and phospho-tau"}, {"pubmed": 20020531, "text": "Sixteen different non-synonymous changes, eleven of which are novel variants, were identified in GRN AND MAPT."}, {"pubmed": 20045477, "text": "the effects of GRN and MAPT mutations are expressed in partly overlapping but distinct anatomical networks that link specific molecular dysfunction with clinical phenotype."}, {"pubmed": 20061629, "text": "Neither intraneuronal phospho-tau nor amyloid beta protein has obligatory effects on reducing the expression of genes important for memory and cognition in hippocampus of Alzheimer brains."}, {"pubmed": 20070850, "text": "Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20070850, "text": "This study confirms that SNCA and the MAPT region are major genes whose common variants are influencing risk of Parkinson disease."}, {"pubmed": 20085902, "text": "Tau expression but not excision repair cross-complementing 1 in advanced breast cancer predicts poor response to combination chemotherapy of paclitaxel and cisplatin"}, {"pubmed": 20097445, "text": "Tau-40/P301L transgenic rats express human tau mRNA and protein in the limbic cortex and associated white matter, hippocampus and spinal cord."}, {"pubmed": 20133017, "text": "In normal individuals, elevated p-tau(231), a marker of neurofibrillatory pathology, is related to both a decrease in declarative memory and progressive atrophy of the medial temporal lobe, suggesting its diagnostic potential in preclinical stage."}, {"pubmed": 20133804, "text": "Data show that FKBP52, which is abundant in brain, binds directly and specifically to Tau, especially in its hyperphosphorylated form.vv"}, {"pubmed": 20143409, "text": "the results from these three model systems suggest that a direct mechanistic link does not exist between tau aggregation and the unfolded protein response"}, {"pubmed": 20157246, "text": "MAPT gene is associated with mild congnitive impairement."}, {"pubmed": 20157246, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20159774, "text": "The DNA damage-activated kinases Chk1 and Chk2 may be involved in tau phosphorylation and toxicity in the pathogenesis of Alzheimer's disease."}, {"pubmed": 20171924, "text": "No known pathogenic mutation of either MAPT or PGRN was identified in Korean patients with progressive supranuclear palsy, frontotemporal dementia and corticobasal syndrome"}, {"pubmed": 20171924, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20193038, "text": "Accumulation of cytosolic hyperphosphorylated forms of human Tau proteins correlates with human Tau-mediated neurodegeneration in flies, supporting the key role of soluble cytosolic hyperphosphorylated Tau proteins as toxic species in vivo."}, {"pubmed": 20219685, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20236174, "text": "Caudate atrophy seen in magnetic resonance imaging is a feature that can distinguish frontotemporal lobar degeneration-fused in sarcoma protein (FTLD-FUS) from FTLD-TAR DNA-binding protein-43 (TDP) protein, and FTLD-TAU protein."}, {"pubmed": 20357768, "text": "proposition of a new model in which caspase activation cleaves tau to initiate tangle formation, then truncated tau recruits normal tau to misfold and form tangles"}, {"pubmed": 20359515, "text": "The effects of transgenic Tau on triose phosphate isomerase are investigated based on the hypothesis that its deficiency is related to neurodegeneration."}, {"pubmed": 20375017, "text": "Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding"}, {"pubmed": 20377816, "text": "Phosphorylation levels of tau at Thr(231), Ser(396), and Ser(409) were increased in cells transfected with V337M, R406W, and R406W mutant tau genes, respectively."}, {"pubmed": 20379729, "text": "results show the presence of abnormally phosphorylated tau in CSF of a model tauopathy, the correlation of CSF p-tau181 levels with sarkosyl-insoluble p-tau181 in the brain and the correlation of CSF p-tau181 level with neurobehavioural impairment"}, {"pubmed": 20415586, "text": "In this review, the intraneuronal accumulation of filamentous, hyperphosphorylated microtubule associated protein tau is the most thoroughly investigated molecular signature of frontotemporal lobar degeneration."}, {"pubmed": 20437541, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20460118, "text": "Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and fronto-temporal dementia with parkinsonism linked to chromosome 17 and in Thy-Tau22 transgenic mice"}, {"pubmed": 20466736, "text": "Tau phosphorylation at Ser262 is crucial for Abeta42-induced tau toxicity in vivo."}, {"pubmed": 20471030, "text": "This protein has been found differentially expressed in thalami from patients with schizophrenia."}, {"pubmed": 20473135, "text": "Independently of age, disease duration, education level, and clinical severity indices, AD patients with an atypical onset have significantly higher levels of total tau in the CSF (P=0.023)."}, {"pubmed": 20473510, "text": "This review highlights the features that connect prion diseases with other cerebral amyloidoses and how these relate to neurodegeneration, with focus on tau phosphorylation."}, {"pubmed": 20478262, "text": "By means of ATP-depletion, ubiquitinylation-deficient E36ts20 cells, a 19S proteasomal regulator subunit MSS1-siRNA approach, and in vitro ubiquitinylation studies, we demonstrated that ubiquitinylation is not required for normal tau degradation."}, {"pubmed": 20498436, "text": "The findings ofthis study suggested that the H1/H2 polymorphism in MAPT is not associated with human amyotrophic lateral sclerosis, and that lowering tau levels in the mutant SOD1 mouse does not affect the motor neuron degeneration in these animals."}, {"pubmed": 20513372, "text": "The cholinergic neurons of these nuclei, despite widespread expression of the P301L tau transgenic pR5 model of tauopathy, neither expressed human tau nor displayed immunoreactivity with antibodies AT8 and AT180 which recognize hyperphosphorylated tau."}, {"pubmed": 20520830, "text": "These findings indicate that disruption of the normal equimolar 3R to 4R ratio may be sufficient to drive tau aggregation and that restoration of the tau isoform balance may have important therapeutic implications in tauopathies."}, {"pubmed": 20538372, "text": "The significance of the time course of MAPT biomarker abnormalities in Alzheimer disease correlates with hippocampal volume and radial distance compared with apolipoprotein E4 carriers and noncarriers."}, {"pubmed": 20538373, "text": "Cerebrospinal fluid tau and hippocampal volume changes later than that of Abeta, showing similar monotonous trends, reflecting disease progression from mild cognitive impairment to Alzheimer's."}, {"pubmed": 20544828, "text": "Overexpression of tau in the subcortical region of 7-8-month-old transgenic mice results in a region-specific relative decrease in tau hyperphosphorylation (compared with total tau) in the subcortical area of the brain."}, {"pubmed": 20549384, "text": "Data suggest that detection of Tau protein in the serum of patients with ischemic stroke, but not its concentration, may be a bad prognostic factor for clinical outcome in early and late phase of IS."}, {"pubmed": 20553310, "text": "This review highlights a large body of evidence suggesting that tau hyperphosphorylation results from perturbation of cellular signaling, mainly through imbalance in the activities of different protein kinases and phosphatases."}, {"pubmed": 20561037, "text": "We present the first Central-Eastern European family (Gdansk Family) with FTDP-17 because of a P301L mutation in microtubule-associated protein tau."}, {"pubmed": 20571215, "text": "mitochondrial NH2-derived tau peptide distribution may exacerbate the synapse degeneration occurring in tauopathies, including Alzheimer's disease"}, {"pubmed": 20574532, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20579400, "text": "Expression of MAPT protein isoforms of less than 70 kDa is correlated with a low sensitivity to taxanes in breast cancer."}, {"pubmed": 20599474, "text": "In Alzheimer's disease patients from North India, levels of cerebrospinal fluid tau and ubiquitin are increased compared to those of controls."}, {"pubmed": 20599975, "text": "Unlike Alzheimer's disease where tauopathy is more globally observed in diverse brain regions, expression of tauopathy in brains of Parkinson disease (PD) with and without dementia is probably limited to nigrostriatal dopaminergic neurons."}, {"pubmed": 20606400, "text": "Inversion heterozygosity was also observed in a mother homozygous for the MAPT H2 haplotype, who transmitted the chromosome with the deletion to a proband with 17q21.31 microdeletion syndrome."}, {"pubmed": 20615469, "text": "Amyloid-beta peptide alteration of tau exon-10 splicing is related to its activation of GSK-3beta which in turn phosphorylates SC35."}, {"pubmed": 20620663, "text": "Ventricular enlargement as a biomarker of Alzheimer's disease highly correlates with cerebrospinal fluid (CSF) measures of amyloid beta(1-42) peptide, but not with CSF Tau protein."}, {"pubmed": 20650958, "text": "Retroposition of Rps23 mRNA occurred multiple times in different species but only generated another functionally expressed Rps23rg1-homologous gene, Rps23rg2, in mice."}, {"pubmed": 20658984, "text": "Tau cleavage in a cell model of taupathy."}, {"pubmed": 20658986, "text": "From tau phosphorylation to tau aggregation."}, {"pubmed": 20658988, "text": "Toxicity of extracellular phosphorylated tau for surrounding neurons."}, {"pubmed": 20658994, "text": "NMR spectroscopy as a proteomics tool to characterize the phosphorylation patterns of tau, after in vitro phosphorylation by recombinant kinases."}, {"pubmed": 20658995, "text": "Functional implications of the association of tau with the plasma membrane."}, {"pubmed": 20658996, "text": "Evidence for the involvement of proteases in the generation of tau pathology in neurodegenerative disease."}, {"pubmed": 20660113, "text": "results support the hypothesis that changes in the miRNA network may contribute to a neurodegenerative phenotype by affecting tau phosphorylation"}, {"pubmed": 20663882, "text": "Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration."}, {"pubmed": 20665688, "text": "Data provide information for the mechanism of tau aggregation, and the possible role of mercury(II) in the pathogenesis of AD."}, {"pubmed": 20678071, "text": "Review summarizes evidence showing that tau truncation alone is sufficient to induce the complete cascade of neurofibrillary pathology, including hyperphosphorylation and accumulation of misfolded insoluble forms of tau."}, {"pubmed": 20678073, "text": "The fact that tau has unknown cellular functions is further evidenced by its involvement in cell cycle activated neurodegeneration."}, {"pubmed": 20678074, "text": "[review] The abnormally hyperphosphorylated tau of Alzheimer's disease (AD) is distinguishable from both normal and transiently hyperphosphorylated taus and is inhibitory when in the cytosolic/oligomeric state of AD and related tauopathies."}, {"pubmed": 20679343, "text": "Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E."}, {"pubmed": 20683187, "text": "Subsequent testing revealed the R406W tau mutation in both individuals leading to a diagnosis of frontotemporal dementia [F]FDDNP retention broadly correlated with CSF levels of t-tau and p-tau."}, {"pubmed": 20708332, "text": "the early age at onset a frontotemporal dementia reflects a marked pathogenic effect of the mutation involving a disturbance of microtubule binding, tau phosphorylation or a major acceleration of tau aggregation."}, {"pubmed": 20711061, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20711177, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20720012, "text": "p5 is a 24-residue peptide, derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation"}, {"pubmed": 20800603, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20805224, "text": "Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases"}, {"pubmed": 20805522, "text": "A magnetic resonance spectroscopy case-control study shows metabolite abnormalities characterized by elevated myoinositol (mI)/creatine and decreased N-acetylaspartate/mI present several years before the onset of symptoms in MAPT mutation carriers."}, {"pubmed": 20837015, "text": "the C-Hcdots, three dots, centeredpi interaction between Ile308 and Tyr310 is the elemental structural scaffold essential for forming a dry \"steric zipper\" structure in tau amyloid fibrils"}, {"pubmed": 20837363, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20837363, "text": "This study demonistrated that ApoE4 might be involved in Alzheimer's disease pathology the MAPT H1 allele neither associates nor interacts through an epistasis with ApoE4 in the development of the disease."}, {"pubmed": 20838030, "text": "Although rare, MAPT mutations should be considered when there is an autosomal dominant family history of a progressive supranuclear palsy syndrome, particularly of young onset and with prominent behavioural features."}, {"pubmed": 20838929, "text": "Data show that exposure of postmitotic neurons to caffeine leads to changes in tau phosphorylation concomitantly with downregulation of Akt signaling."}, {"pubmed": 20847421, "text": "The CSF tau ratio, combined with midbrain-to-pons atrophy, have been evaluated as a sensitive biomarker for early identification of progressive supranuclear palsy."}, {"pubmed": 20862329, "text": "Genetic variants associated with cerebrospinal fluid ptau(181) levels may have a greater impact on rate of progression of Alzheimer's disease."}, {"pubmed": 20876472, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20881758, "text": "Chinese patients with probable CJD have similar increased levels of tau in the CSF as in Caucasian patients. Measurement of CSF tau will be another potential technique for antemortem CJD diagnosis."}, {"pubmed": 20921222, "text": "increasing concentrations of insoluble tau aggregates leads to the formation of fibrillar tau, which causes NFTs to form."}, {"pubmed": 20921227, "text": "Three- and four-repeat Tau coassemble into heterogeneous filaments."}, {"pubmed": 20926667, "text": "Human presenilin 1 and tau play convergent roles in axonal transport and neuronal survival and function, implicating their misregulation as contributors to Alzheimer disease pathogenesis."}, {"pubmed": 20927324, "text": "Unfolded protein response can ameliorate the toxicity of tau in vivo."}, {"pubmed": 20927385, "text": "Inhibition of eIF4A reduced the synthesis of APP and tau."}, {"pubmed": 20930301, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20930301, "text": "Our results suggest that both MAPT H1/H1 genotype and APOE epsilon4 allele lead to a more rapid progression to dementia among mild cognitive impairment subjects, probably mediating an increased rate of amyloid-beta and tau brain deposition."}, {"pubmed": 20951764, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20951764, "text": "The genetic association of rs242557 tau gene variant in Parkinson disease patients with dementia is only observed in individuals with low cerebrospinal fluid amyloid-beta protein levels."}, {"pubmed": 20974297, "text": "incorporation of negative charge into the T212 site can directly promote tau filament formation at multiple steps in the aggregation pathway"}, {"pubmed": 21044948, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21044986, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21044986, "text": "There is a genetic association between tau polymorphism and vascular dementia in the Chinese population."}, {"pubmed": 21054681, "text": "Single locus analysis showed that G/G SNCA and H1/H1 MAPT risk genotypes were over-represented in patients with Parkinson disease compared with controls"}, {"pubmed": 21058943, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21061060, "text": "These results suggest that tau phosphorylation and GSK-3beta activation may not be essential for adult subventricular zone neurogenesis."}, {"pubmed": 21062361, "text": "These results indicate that tau-positive granules in glia are common findings in multiple system atrophy and that tau aggregation might be another pathway to neurodegeneration"}, {"pubmed": 21062741, "text": "The C terminus of tubulin, a versatile partner for cationic molecules: binding of Tau, polyamines, and calcium."}, {"pubmed": 21062914, "text": "Although Tau overexpression has been reported to be a predictive marker of taxane resistance, it is not likely to be a direct mechanism of taxane resistance in breast cancer."}, {"pubmed": 21063069, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21063069, "text": "These results provide further support for the role of MAPT in development of Parkinson disease."}, {"pubmed": 21073671, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21073671, "text": "Prescence of of APOEepsilon4 allele and MAPT H2 haplotype in frontotemporal lobar degeneration had a significant influence on the expression of synaptophysin and SNAP-25"}, {"pubmed": 21081103, "text": "The 14-3-3 zeta mutation mimicking phosphorylation of Ser184 does not markedly affect interaction with tau protein and improves the interaction of 14-3-3 zeta with HspB6."}, {"pubmed": 21085657, "text": "Results indicate that human embryonic stem cell-derived neurons express all 6 tau isoforms and are a good model in which to study tau physiology and pathology."}, {"pubmed": 21098287, "text": "Data show that the antidiabetic drug metformin induces PP2A activity and reduces tau phosphorylation at PP2A-dependent epitopes in vitro and in vivo."}, {"pubmed": 21098973, "text": "In frontotemporal lobar degeneration, cerebrospinal fluid tau levels are associated with increased neurodegeneration and poor outcome."}, {"pubmed": 21123557, "text": "Glial-specific expression of human tau in a genetically tractable Drosophila model of tauopathy decreases lifespan and results in age-dependent glial fibrillary tangle formation."}, {"pubmed": 21127069, "text": "alpha-synuclein is an in vivo regulator of Tau protein phosphorylation at Ser(262)"}, {"pubmed": 21131359, "text": "a novel role for nuclear Tau as a key player in early stress response."}, {"pubmed": 21135556, "text": "cerebrospinal fluid tau and p-tau levels were elevated in primary progressive aphasia as compared to frontotemporal dementia"}, {"pubmed": 21157033, "text": "In brain from Alzheimer's patients, protein phosphatase 2B (PP2B) activity correlated positively, rather than negatively, to the levels of tau phosphorylation at several sites that can be dephosphorylated by PP2B in vitro."}, {"pubmed": 21157379, "text": "Overexpressed DYRK1A in Down syndrome (DS) may contribute to alternative splicing of exon 10, increased expression of 3-repeat tau, and early onset of neurofibrillary degeneration in DS."}, {"pubmed": 21159074, "text": "In the Caucasian patient-control series examined, risk for Parkinson disease was influenced by variation in alpha-synuclein and tau proteins but not glycogen synthase kinase GSK3beta."}, {"pubmed": 21176711, "text": "Unclassifiable tauopathy is associated with an A152T variation in MAPT exon 7."}, {"pubmed": 21181298, "text": "Data show that the novel gamma-secretase modulator CHF5074 can fully reverse beta-amyloid-associated tau pathology, thus representing a promising therapeutic agent for AD."}, {"pubmed": 21210655, "text": "Peroxynitrite-induced nitrative and oxidative modifications alter tau filament formation."}, {"pubmed": 21212533, "text": "This study found that GSK-3beta2 has lower phosphorylation activity to tau at than GSK-3beta1 in cells, whereas the two variants exhibit equivalent levels of phosphorylation activities to amyloid precursor protein."}, {"pubmed": 21243369, "text": "Protein interacting with NIMA (PIN1) changes are a constant feature of Alzheimer's disease pathology and could serve as a biomarker of the onset or spread of Alzheimer's disease neuropathology independent of tau or amyloid beta(Abeta) proteins."}, {"pubmed": 21276080, "text": "Tau accumulation is present in seizure-associated glioneuronal lesions associated with abnormal reconstitution of the cortex."}, {"pubmed": 21281813, "text": "Deletion of murine tau accelerated tau aggregation during aging of mutant tau transgenic model."}, {"pubmed": 21288907, "text": "there are markedly different regulatory effects on microtubule assembly and dynamic instability of tau in its phosphorylation"}, {"pubmed": 21320871, "text": "Elevation of NPEPPS activity blocks accumulation of hyperphosphorylated TAU protein and slows down the progression of Alzheimer's disease."}, {"pubmed": 21321341, "text": "The MAPT H1 haplotype is not a risk factor for essential tremor and multiple system atrophy."}, {"pubmed": 21325519, "text": "Tau(RD) mice are strongly impaired in memory and show pronounced loss of long-term potentiation (LTP), suggesting that Tau aggregation specifically perturbs these brain functions."}, {"pubmed": 21327254, "text": "Data identify Tau as potential substrates for the O-beta-N-acetylglucosaminyltransferase (OGT)."}, {"pubmed": 21333649, "text": "Data show that SC35 stabilized tau mRNA by binding to the SC35-like element of exon 10."}, {"pubmed": 21339331, "text": "A R406W mutation in TAU leads to impaired membrane binding."}, {"pubmed": 21340680, "text": "Data show that knockdown of histone deacetylase 6, a protein known to interact with tau, reveals a requirement for HDAC6 activity in tau aggresome formation."}, {"pubmed": 21342021, "text": "REVIEW: compared to controls, tau concentrations are moderately elevated in dementia with Lewy Bodies, frontotemporal lobar degeneration, and vascular dementia, while p-tau concentrations are only slightly elevated in DLB and not elevated in FTLD and VaD"}, {"pubmed": 21342022, "text": "REVIEW on the core AD biomarkers, Abeta and phosphor-tau (p-tau), on different methods and modalities of assessing them [eg, cerebrospinal fluid analysis and PET imaging], and on their diagnostic and predictive value in preclinical and clinical stages of AD"}, {"pubmed": 21343338, "text": "Using an RNA affinity pulldown-coupled mass spectrometry approach the study identified DDX5/RNA helicase p68 as an activator of TAU exon 10 splicing."}, {"pubmed": 21343707, "text": "we report the finding of the V363I mutation of the microtubule-associated protein tau gene in a sporadic early onset frontotemporal dementia patient and in several members of her family"}, {"pubmed": 21344240, "text": "Mutation screening of MAPT identifies novel sequence variants using a bioinformatic approach; further studies are necessary to determine their possible functional consequences in South African patients with Parkinson's disease."}, {"pubmed": 21348938, "text": "Studies indicate there is a growing awareness that tau is a central player in AD pathogenesis."}, {"pubmed": 21367856, "text": "down-regulation of PKA dysregulates the alternative splicing of tau exon 10 and contributes to neurofibrillary degeneration in Alzheimer disease by causing an imbalance in 3R-tau and 4R-tau expression"}, {"pubmed": 21367866, "text": "the Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics"}, {"pubmed": 21368381, "text": "Tau protein is present in platelets; the platelet levels of this oligomeric protein could serve as a novel and reliable biological marker for Alzheimer's disease."}, {"pubmed": 21388338, "text": "REVIEW: high CSF t-tau and p-tau concentrations reflect axonal and neuronal damage and injury, which correlates with a neurofibrillary tangle stage and load, also reflecting the intensity of the disease process"}, {"pubmed": 21391235, "text": "This study confirms the association between Parkin diseae and both SNCA SNPs and the H1 MAPT haplotype."}, {"pubmed": 21397051, "text": "Genetic variation in MAPT is unlikely to make a major contribution to the risk of blindness among Leber's hereditary optic neuropathy mutation carriers."}, {"pubmed": 21403021, "text": "Our data confirm that MAPT H1 is associated with Parkinson disease and has a strong influence on the risk of dementia in Parkinson disease patients"}, {"pubmed": 21425343, "text": "Single-nucleotide polymorphisms in MAPT (rs1800547; P = 3.1 x 10(-4) ) is significantly associated with Parkinson's disease"}, {"pubmed": 21435449, "text": "CDK5 activation contributes to the neurodegenerative process in HIV encephalitis via abnormal tau phosphorylation"}, {"pubmed": 21439371, "text": "observed an increased expression of CUGBP1 and ETR3-like factor 2 (CELF2) only in the brain of myotonic dystrophy type 1 patients with a mis-splicing of tau exon 10"}, {"pubmed": 21442128, "text": "Results show high levels of the 17-kDa tau fragment and enhanced calpain activity in the temporal cortex of AD patients and in brain samples obtained from patients with other tauopathies."}, {"pubmed": 21450369, "text": "Blockage of RAGE attenuates AGE-induced glycogen synthase kinase (GSK)-3 activation, tau hyperphosphorylation, and memory deficit with restoration of synaptic functions."}, {"pubmed": 21450370, "text": "Asp421-cleaved tau and Abeta cooperate to impair mitochondria, which likely contributes to neuronal dysfunction in Alzheimer disease."}, {"pubmed": 21482827, "text": "Abeta-mediated neuronal cell death involves the loss of full-length Tau and/or the generation of toxic fragments but does not involve or require hyperphosphorylation of full-length Tau."}, {"pubmed": 21489655, "text": "CSF tau markers reflect the neuronal loss associated with the physiopathological process of Alzheimer's disease."}, {"pubmed": 21489990, "text": "Egr-1 is an in vivo regulator of tau phosphorylation and suggest that in AD brain increased levels of Egr-1 aberrantly activate an Egr-1/Cdk5/PP1 pathway, leading to accumulation of hyperphosphorylated tau, thus destabilizing the microtubule cytoskeleton."}, {"pubmed": 21492964, "text": "Tau knock-in mice have age-dependent changes in axonal transport of mitochondria and increased locomotor activity in old age, resembling early consequences of tau dysfunction that eventually precipitates pathogenesis in humans."}, {"pubmed": 21498513, "text": "the conformation and aggregation of Tau are regulated through a complex balance of different intra- and intermolecular interactions."}, {"pubmed": 21504113, "text": "The concentration of tau in the cerebrospinal fluid markedly increased six months postoperatively following heart surgery; gradual cognitive decline is also present."}, {"pubmed": 21504133, "text": "Patients with mild cognitive impairment and low Abeta42 peptide fragment, with high tau levels in the cerebrospinal fluid, have a substantially increased risk of developing Alzheimer's disease, even after adjustment."}, {"pubmed": 21510936, "text": "that phosphatidic acid, via the mTOR kinase, can trigger tau phosphorylation on a site known to reduce paired helical filament (PHF) formation."}, {"pubmed": 21530001, "text": "Colocalization of human P-tau and AChE supports the conclusion that P-tau can act to increase AChE."}, {"pubmed": 21550980, "text": "the existence of alternative Tau aggregates that precede formation of fibrillar Tau pathologies and raises the possibility that these hierarchical oligomeric forms of Tau may contribute to neurodegeneration."}, {"pubmed": 21555518, "text": "MAPT is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells."}, {"pubmed": 21555603, "text": "The ratios of total tau to amyloidbeta1-42 and p-tau181 to Abeta1-42 outperforms any single analyte, including Abeta1-42, in discriminating individuals with vs without cortical amyloid in a large cohort of research participants."}, {"pubmed": 21558644, "text": "MAPT mutation(g.123798G>A), leading to an amino acidic change(p.Gly304Ser) in the second MT binding domain, ina female patient diagnosed clinically with progressive nonfluent aphasia."}, {"pubmed": 21568901, "text": "has been demonstrated that MAPT mutations are causative of monogenic autosomal dominant progressive supranuclear palsy (PSP); in sporadic PSP, confirmed role of MAPT in increasing risk; H1 MAPT haplotype has been consistently associated with PSP[review]"}, {"pubmed": 21575385, "text": "The expression of tau-related protein is demonstrated in the spinal cord of Alzheimer's disease patients, suggesting that axonal transport defect may play a role in the pathogenesis of Alzheimer's disease."}, {"pubmed": 21577325, "text": "Failure of proteasomal and non-proteasomal proteolytic clearance mechanisms leads to tau accumulation and progressive neurofibrillary degeneration in Alzheimer's disease."}, {"pubmed": 21604267, "text": "[review] Aberrations in tau splicing regulation cause several neurodegenerative diseases, which lead directly to dementia."}, {"pubmed": 21613474, "text": "This study of an exceptional cellular model of tau pathology also examines alpha-synuclein-induced tau inclusion formation and provides novel insights into hyperphosphorylation observed in disease."}, {"pubmed": 21638028, "text": "MKK4 was identified as playing a key role in Tau-S422 phosphorylation in human neuroblastoma cells"}, {"pubmed": 21666499, "text": "This study demonstrated that overexpression of P301L tau causes marked impairments in Arc upregulation in response to environmental enrichment in both tangle-bearing and morphologically normal neurons."}, {"pubmed": 21670401, "text": "This work demonstrates the previously unrealized visualization of neuropathological aggregates of beta-amyloid protein and tau levels in the living brains of a nondemented Down syndrome group."}, {"pubmed": 21677375, "text": "Unexpected discovery that in AD, there is conspicuous abnormal phosphorylation of the tau protein in a selective subset of dendritic spines."}, {"pubmed": 21685912, "text": "Variation in MAPT gene is associated with tauopathy progressive supranuclear palsy."}, {"pubmed": 21692989, "text": "Pro216 in tau PXXP motif plays role in interaction of tau with Fyn-SH3; phosphorylation of tau at Tyr18 is important for mediating Fyn-SH2-tau interactions; tyrosine phosphorylation influences tau localization in cortical neurons which is Fyn-dependent"}, {"pubmed": 21694458, "text": "These assays are suitable for analysis of CSF t-tau and p-tau181 in a single laboratory supporting multi-center Alzheimer's disease clinical trials"}, {"pubmed": 21698260, "text": "assessment of sensorimotor gating could be used to detect the earliest manifestations of tauopathies exemplified by prodromal AD, in which abnormal tau protein may play critical roles in the onset of neuronal dysfunctions"}, {"pubmed": 21705366, "text": "Hypophosphorylated Tau showed stronger neuronal toxicity compared to normal or pseudophosphorylated Tau."}, {"pubmed": 21714002, "text": "Psychotic symptoms were not associated with the presence of any examined polymorphisms in the MAPT."}, {"pubmed": 21753165, "text": "Subjects with FTD with GRN mutations have a faster rate of whole brain atrophy than subjects with FTD with MAPT mutations, with similar rates of hippocampal atrophy."}, {"pubmed": 21753175, "text": "Familial FTLD-TDP shows relatively more posterior hypoperfusion, possibly related to significant memory impairment. Patients with MAPT were characterized by impaired perfusion of the temporal regions and naming deficits."}, {"pubmed": 21755018, "text": "Upregulation of total tau expression (SFRS7-independent) and tau exon 10 splicing (SFRS7-dependent), as shown in this study to be both affected by STOX1A, is known to have implications in neurodegeneration."}, {"pubmed": 21763357, "text": "The binding of Tau stabilizes tubulin in a conformation less susceptible to oligomerization by PrP."}, {"pubmed": 21763469, "text": "Although raphe tauopathy concerns mainly non-serotoninergic (5-HT) neurons, the 5-HT metabolism of terminal Tau.P301L transgenic mice is altered."}, {"pubmed": 21807765, "text": "Changes in the miR-132/PTBP2 pathway could contribute to the abnormal splicing of tau exon 10 in the brain."}, {"pubmed": 21811019, "text": "Common genetic variation in the tau kinases pathway does underlie individual differences not only in susceptibility to Alzheimer's disease but also in disease phenotype (age at disease onset)."}, {"pubmed": 21816655, "text": "This study provides no statistically significant evidence of gene-gene interaction effects for SNCA, MAPT and LRRK2 genes for Parkinson's disease"}, {"pubmed": 21822709, "text": "Results indicate a tight relationship between the amyloidogenic character of Tau and brain malfunction, and suggest that the cognitive impairment is caused by toxic human Tau(RD) species rather than by mouse Tau aggregates."}, {"pubmed": 21825215, "text": "Within each Alzheimer clinical group the cerebrospinal fluid (CSF) Abeta42 marker level is abnormal more often than is the CSF total tau level or the adjusted hippocampal volume."}, {"pubmed": 21839061, "text": "Neuroinflammation participates essentially in tau-mediated neurodegeneration."}, {"pubmed": 21841250, "text": "Salivary tau species could be ideal biomarkers for Alzheimer's disease diagnosis; the phosphorylated tau/tau ratio significantly increases in Alzheimer patients."}, {"pubmed": 21841253, "text": "Overexpression of the longest human tau isoform in cultured primary cortical neurons has a strong impact on prion trafficking, inducing a marked down-regulation of the cell-surface bound PrPC."}, {"pubmed": 21846727, "text": "E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment"}, {"pubmed": 21849646, "text": "Functional connectivity in the default mode network is altered in MAPT subjects before the occurrence of both atrophy and clinical symptoms in behavioral variant frontotemporal dementia."}, {"pubmed": 21854751, "text": "Soluble tau plays an important role in mitochondrial abnormalities, which likely contribute to neuronal dysfunction in Alzheimer's disease."}, {"pubmed": 21860086, "text": "End-stage Abeta and tau pathologies in triple transgenic Alzheimer's disease (AD) model mice are informative in assessing co-evolving amyloid beta and tau pathologies."}, {"pubmed": 21860087, "text": "Hyperphosphorylated tau and total tau levels in cerebrospinal fluid best represent the cortical profile of patients with vascular dementia compared to those with Alzheimer's disease. the best."}, {"pubmed": 21881826, "text": "Data reveal a new player in tau exon 10 alternative splicing regulation and uncover a previously unknown mechanism of PSF in regulating tau pre-mRNA splicing."}, {"pubmed": 21888627, "text": "Quantitative measurement of tau expression has prognostic value in breast cancer patients: with high expression associated with longer median time to tumor progression"}, {"pubmed": 21898123, "text": "Possible interactions between genetic factors in the MAPT region and the leucine-rich repeat kinase (LRKK)2 gene influence the clinical course of Parkinson disease patients."}, {"pubmed": 21907761, "text": "We observed an early neurodegenerative effect of this altered tau protein that was characterized by a specific decrease in neurogenesis in the ventral dentate gyrus."}, {"pubmed": 21910444, "text": "A large number of distance restraints obtained from NMR paramagnetic relaxation enhancement in combination with ensemble conformer calculations demonstrate that pseudophosphorylation causes an opening of the transient folding of Tau."}, {"pubmed": 21911695, "text": "In individuals with normal cognition and higher levels of cerebrospinal fluid tau and phosphorylated tau at baseline, time to incident cognitive impairment is moderated by education and brain volume as predicted by the cognitive/brain reserve hypothesis."}, {"pubmed": 21919991, "text": "Ubiquitin targeting of tau protein occurs at neurofibrillary tangles in the early and intermediate maturation stages."}, {"pubmed": 21931162, "text": "the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein"}, {"pubmed": 21934536, "text": "Zinc induces S214 phosphorylation in tau through zinc induces S214 phosphorylation in tau through extracellular signal-regulated kinase (ERK) activation and interferes with microtubule polymerization."}, {"pubmed": 21934724, "text": "Axonal leakage-a novel type of axonopathy, was usually accompanied with the extensive swollen axons and varicosities, and was associated with the origin and development of beta-amyloid plaques and hyperphosphorylated tau in the brains of Alzheimer patients."}, {"pubmed": 21942206, "text": "Hyperphosphorylation of tau isoforms can play a major role in determining the isoform composition of microtubule-associated protein tau aggregates in disease."}, {"pubmed": 21943955, "text": "The results of this study indicated that the P364S mutation enhances the fibrillogenic properties of tau protein."}, {"pubmed": 21945393, "text": "Tau(wt) and Tau(P301L) alter kinase activities, but they differentially induce inflammation, Tau modification and alpha-Synuclein phosphorylation."}, {"pubmed": 21949350, "text": "These findings suggest therapeutic targets other than mitigation of tau phosphorylation."}, {"pubmed": 21966400, "text": "Fibrillization of human tau is accelerated by exposure to lead via interaction with His-330 and His-362"}, {"pubmed": 21969238, "text": "Suggest possible role for tau protein as a prognostic factor to predict progression from optic neuritis to multiple sclerosis."}, {"pubmed": 21976528, "text": "Hypothalamic-pituitary-adrenal axis dysregulation in Alzheimer's disease neuropathogenesis suggests that prolonged stress may increase Abeta and tau hyperphosphorylation."}, {"pubmed": 21978388, "text": "Properties of the monomeric form of 14-3-3zeta protein and its interaction with tau and HspB6. This interaction requires phosphorylation of tau protein and HspB6."}, {"pubmed": 21980472, "text": "independent relationship between amyloid-beta and tau in controlled cortical impact model (CCI) of traumatic brain injury"}, {"pubmed": 21983102, "text": "VCP may be involved in regulating post-translational processing of tau in Alzheimer's disease"}, {"pubmed": 22002427, "text": "This study demonistrated that 2 transgenic mouse models for tauopathy in which approximately endogenous levels expressed E391-truncated human tau are sufficient to initiate early stages of tau pathology."}, {"pubmed": 22002658, "text": "Data indicate that Abeta-associated volume loss occurs only in the presence of phospho-tau in humans at risk for dementia."}, {"pubmed": 22022446, "text": "The vocalization disorder of old Tau.P301L mice could be, at least in part, reminiscent of language disorders of elderly suffering tauopathy."}, {"pubmed": 22027014, "text": "The results of this study demonistrated that common variants at AbetaPP, PSEN1, and PSEN2 and MAPT are unlikely to make strong contributions to susceptibility for late onset Alzheimer's disease."}, {"pubmed": 22039514, "text": "pathological synergistic effect between tau and alpha-syn may amplify the deleterious process and spread the damage in neurodegenerative diseases that show co-occurrence of both pathologies"}, {"pubmed": 22039833, "text": "Addition of Hsp70 to a mixture of oligomeric and fibrillar tau aggregates prevents the toxic effect of these tau species on fast axonal transport."}, {"pubmed": 22057275, "text": "exosome-mediated secretion of phosphorylated tau may play a significant role in the abnormal processing of tau and in the genesis of elevated CSF tau in early AD."}, {"pubmed": 22072628, "text": "Phosphorylation in the proline-rich region of the disordered Tau protein strongly decrease the capacity of Tau to polymerize tubulin into microtubules."}, {"pubmed": 22085312, "text": "Data suggest that sequences throughout tau (in addition to PHF6/PHF6*) can seed amyloid formation or affect aggregation kinetics/thermodynamics."}, {"pubmed": 22102449, "text": "Unfolded protein response activation is intimately connected with the accumulation and aggregation of p-tau in the hippocampus of tauopathies."}, {"pubmed": 22104010, "text": "Our findings strongly confirm SNCA and MAPT as major Parkinson disease susceptibility genes"}, {"pubmed": 22109955, "text": "This study provides a prospective detailed clinical picture a family with PSP-like syndrome. It shows that G303V mutation in exon 10 of the tau gene can be responsible for PSP-like features with an autosomal dominant pattern of transmission."}, {"pubmed": 22116524, "text": "Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies."}, {"pubmed": 22127750, "text": "The study denomistrated that Genetic screening identified patients bearing MAPT mutaton but still the majority of FTLD cases with an inherited familial trait are negative to genetic analyses."}, {"pubmed": 22159117, "text": "This study concluded that mutant protein Tau modulates cognition and morphology of spines similarly and in both directions, with pathology later in life coinciding with increased phosphorylation and relocalization of Tau from axons to soma and processes."}, {"pubmed": 22170881, "text": "disposition of Abeta and tau is likely important in both LRRK2-related and sporadic Parkinson disease, even during early phases of the disease"}, {"pubmed": 22174735, "text": "Tau-targeted immunization slows the progression of neurofibrillary tangles pathology in mice."}, {"pubmed": 22176350, "text": "The tau gene loci rs10675722 allele with short tandem repeats may increase the risk for Alzheimer disease and vascular dementia."}, {"pubmed": 22177996, "text": "Despite specific tau pathology, tau gene transfer surprisingly does not cause obvious neuronal loss or behavioral impairment in rats."}, {"pubmed": 22193445, "text": "Inhibition of PARP-1 could decrease tau phosphorylation in HEK293/tau441 cells probably through decreasing GSK-3 activity."}, {"pubmed": 22213792, "text": "Low cerebrospinal fluid (CSF) levels of total-tau and phosphorylated-tau in clinic patients with mild cogntive impairment (MCI) predict conversion from mild cognitive impairment (MCI) to Alzheimer dementia"}, {"pubmed": 22214313, "text": "The presence of widespread astrocytic tau pathology suggests that ALS with cognitive impairment may initially be characterized by astrocytic pathology."}, {"pubmed": 22221882, "text": "This study showed that the MAPT association with pathologically proven parkinson disease and strongest risk factor for progressive supranuclear palsy."}, {"pubmed": 22229117, "text": "Review of the role of tau in Alzheimer disease and potentinal targeted therapies."}, {"pubmed": 22232001, "text": "In differentiated neuronal A1 cells, the overexpression of Amyloid-beta protein precursor modulates tau phosphorylation, altering the ratio between cytoskeletal and nuclear pools, and correlates with cell death."}, {"pubmed": 22233767, "text": "FTDP expression level is abnormally low in frontal cortex of Alzheimer's disease compared to controls."}, {"pubmed": 22235112, "text": "Increased Tau phosphorylation by GABA(A) receptor activity was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not GSK3beta kinase activity."}, {"pubmed": 22236337, "text": "Data indicate that Hsp70/HSPA1A inhibits aggregation of tau in isoform-specific fashion (especially 3R/4R [repeat/alternative splicing] forms) while having little impact on tau isoforms to mediate microtubule assembly."}, {"pubmed": 22269004, "text": "analysis of how Abeta toxicity and tau are physiologically connected, and how membrane trafficking may play an important role in the pathogenesis of Alzheimer's disease [review]"}, {"pubmed": 22272245, "text": "Data suggest that KLC1 is required for normal neural differentiation, ensuring proper metabolism of AD-associated molecules APP and Tau and for proliferation of neural precursors (NPs)."}, {"pubmed": 22291015, "text": "Intramolecular disulfide bonds retard tau aggregation by stabilizing conformations that lack beta-strand content in subsequences that are aggregation-prone."}, {"pubmed": 22291217, "text": "There was evidence of an association between the MAPT H1 haplotype (rs1052553 A-allele) and Alzheimer's type pathology (table 2), with and without adjustment for age, sex and APOE genotype."}, {"pubmed": 22294156, "text": "results show that human tau protein may alter the GCs-mediated regulation of PKA activity and CREB phosphorylation"}, {"pubmed": 22303461, "text": "LRRK2 plays an important role as a physiological regulator for phosphorylation-mediated dissociation of tau from microtubules."}, {"pubmed": 22304362, "text": "Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils"}, {"pubmed": 22310385, "text": "Transfection of a series of MAPT promoter deletions revealed unique functional domains. The distal-most had different activities in neuronal vs. non-neuronal cells"}, {"pubmed": 22312444, "text": "generation of a transgenic mouse model that differentially expresses pathological human tau in the entorhinal cortex, and examination of the distribution of tau pathology at different timepoints"}, {"pubmed": 22337826, "text": "The tau protein isoform with three microtubule binding domains (3R-Tau)is a marker of new axons generated from the subgranular zone in the hippocampal dentate gyrus."}, {"pubmed": 22343013, "text": "Moreover, the levels of DnaJA1 and Hsp70 seem to play against each other with regard to tau: as DnaJA1 levels increase, tau levels are reduced, but this can be prevented if Hsp70 levels are simultaneously induced."}, {"pubmed": 22344634, "text": "The results of this study did not find a significant association between MAPT haplotype and rates of cognitive decline."}, {"pubmed": 22359235, "text": "Low stathmin and high MAP-tau are associated with increased microtubule stability and better prognosis in breast cancer."}, {"pubmed": 22366795, "text": "Patterns of atrophy therefore differed across subjects with C9ORF72, tau and progranulin mutations and sporadic frontotemporal dementia"}, {"pubmed": 22366796, "text": "Acetylation of tau at lysine 280 is a pathological modification that may contribute to tau-mediated neurodegeneration by both augmenting losses of normal tau properties"}, {"pubmed": 22367970, "text": "Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons"}, {"pubmed": 22396417, "text": "Overexpression of wild-type Tau or mutated forms in which these sites had been changed to either unphosphorylatable alanines or phosphomimetic aspartates inhibits mitochondrial movement in the neurite processes of PC12 cells."}, {"pubmed": 22401494, "text": "hTau40s strong interaction with anionic lipids induces tau structural compaction and membrane disruption"}, {"pubmed": 22403409, "text": "The protein phosphatase PP2A/Balpha binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn."}, {"pubmed": 22406198, "text": "Three proteins, ATP synthase, Adenosine kinase and Regucalcin showed significantly decreased levels in the plasma of tau transgenic mouse, which was further confirmed by Western blotting"}, {"pubmed": 22419736, "text": "Data indicate that the neuronal adenylate kinase-1 (AK1) is induced by Abeta(42) to increase abnormal tau phosphorylation via AMPK-GSK3beta and contributes to tau-mediated neurodegeneration."}, {"pubmed": 22460328, "text": "data suggest an essential role of Bip in GSK-3beta dependent tau hyperphosphorylation in endoplasmic reticulum stress by promoting the binding of GSK-3beta to tau"}, {"pubmed": 22461630, "text": "Trans-cellular propagation of Tau aggregation by fibrillar species."}, {"pubmed": 22464332, "text": "Study provides direct evidence that Pin1 accelerates cis-to-trans conversion, preventing pathogenic cis p-tau accumulation and tau pathology in Alzheimer's disease."}, {"pubmed": 22490326, "text": "A cerebrospinal fluid model transforms values for tau and amyloid beta(1-42) detected by the xMAP platform, showing that patients with autopsy-confirmed Alzheimer's and frontotemporal lobar degeneration are differentiated with high sensitivity."}, {"pubmed": 22492994, "text": "evidence that CHIP binds, ubiquitinates and regulates expression of histone deacetylase 6 (HDAC6); demonstrated HDAC6 levels correlate with tau burden, while a decrease in HDAC6 activity or expression promotes tau clearance; evidence that loss of HDAC6 activity augments the efficacy of an Hsp90 inhibitor and drives degradation of tau"}, {"pubmed": 22496370, "text": "Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomes."}, {"pubmed": 22521809, "text": "Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein"}, {"pubmed": 22530600, "text": "Amyloidbeta42, total-tau(181), and phosphorylated-tau present a gradient of cerebrospinal fluid (CSF) concentrations between healthy elderly controls, depressed, and patients with Alzheimer's disease."}, {"pubmed": 22532069, "text": "Tau-induced impairments are reversible after switching-OFF pro-aggregant Tau in mice expressing pro-aggregant full-length human Tau."}, {"pubmed": 22535953, "text": "human HTRA1 degrades aggregated and fibrillar tau, a protein that is critically involved in various neurological disorders"}, {"pubmed": 22539343, "text": "aggregation propensity correlated with genetic risk reported for multiple tauopathies, implicating aggregation as one candidate mechanism rationalizing the correlation between Tau expression patterns and disease."}, {"pubmed": 22556362, "text": "the first genetic evidence and functional studies supporting the role of MAPT p.A152T as a rare risk factor for both FTD-s and Alzheimer's disease"}, {"pubmed": 22561167, "text": "Authors discuss the qualifications of tau protein as a possible \"prionoid\" mediator of lesion spread based on recent characterizations of the secretion, uptake and transneuronal transfer of human tau isoforms in a variety of tauopathy models, and in human patients. [Review]"}, {"pubmed": 22595371, "text": "This study suggested that the A152T variant is a risk factor associated with the development of atypical neurodegenerative conditions with abnormal tau accumulation."}, {"pubmed": 22595621, "text": "In the analysis of both the Parkinson's group (PD) and related dementia subgroup and the entire PD sample, significant negative cerebrospinal fluid-grey matter volume correlations for tau and phospho-tau are found."}, {"pubmed": 22613722, "text": "Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A stability and microtubule-associated protein phosphorylation."}, {"pubmed": 22615831, "text": "Phosphorylation and cleavage of tau favored its secretion by Hela cells."}, {"pubmed": 22637478, "text": "is the dominant stimulus for Tau phosphorylation. Hence, ExoY is a promiscuous cyclase and edema factor that uses cAMP and, to some extent, cGMP to induce the hyperphosphorylation and insolubility of endothelial Tau."}, {"pubmed": 22648764, "text": "CSF Abeta and CSF tau were observed to have independent effects on neuroimaging and CSF tau had a direct effect on baseline cognition independent of brain structure and function."}, {"pubmed": 22659094, "text": "On the basis of the aggregation behaviours of a series of MBD and full-length tau mutants, a possible self-association model of tau is proposed and the relationship between the aggregation form and the association pathway is discussed."}, {"pubmed": 22668776, "text": "We demonstrate that tau secretion and its suppression by low temperature also occurs in human neurons"}, {"pubmed": 22677170, "text": "Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10"}, {"pubmed": 22699846, "text": "A P332S mutation changes the PGGG motif of the third repeat domain of tau, reducing the ability of tau to bind microtubule. From a clinical point of view, this mutation is associated with considerable intrafamilial phenotypic variation."}, {"pubmed": 22701727, "text": "Fibril-forming motifs play a key role in the fibrillization of human Tau protein and could be the determinants of amyloidogenic proteins tending to misfold."}, {"pubmed": 22723018, "text": "Genetic risk factors for neurodegenerative diseases at the MAPT locus are likely to operate by changing mRNA splicing in different brain regions, as opposed to the overall expression of the MAPT gene."}, {"pubmed": 22764226, "text": "These findings reveal a novel mechanism involving methylation-dependent pathways in L-dopa induces PP2A hypomethylation and increases Tau phosphorylation, which may be potentially detrimental to neuronal cells."}, {"pubmed": 22767602, "text": "Phosphorylation of SRp55 by Dyrk1A suppressed its ability to promote Tau exon 10 inclusion."}, {"pubmed": 22797329, "text": "combination of the V337M and R406W mutations of tau accelerates human tau phosphorylation and induces tau pathology as well as cognitive deficits."}, {"pubmed": 22802095, "text": "These results support the hypothesis that haplotype-specific variation in the MAPT 3' UTR underlies an Abeta-independent mechanism for neurodegeneration in tangle-predominant dementia."}, {"pubmed": 22819391, "text": "H1 haplotype is associated with increased SNCA deposition in Lewy body dementia."}, {"pubmed": 22833681, "text": "tau interacts in a phosphorylation-dependent manner with the PSD95-Fyn-NMDA receptor complex at the postsynaptic site"}, {"pubmed": 22853691, "text": "Adults with ALS from a small Chinese Han pedigree had mutations of risk regions in 3',5' UTR, and in introns 9, 10, 11, 12. One single nucleotide polymorphism of A to G at 138278 at 3' UTR of the gene was over-expressed in fALS."}, {"pubmed": 22862303, "text": "Solid-state nuclear magnetic resonance study demonstrates beta-sheet core of Tau paired helical filaments."}, {"pubmed": 22862741, "text": "Changes in cerebrospinal fluid isoforms reflect the pathological changes in tau isoform homeostasis in the degenerative brain that are relevant for differential clinical diagnosis."}, {"pubmed": 22867711, "text": "Synaptic hyperphosphorylated tau oligomers may be an important mediator of the proteotoxicity that disrupts synapses in Alzheimer's disease."}, {"pubmed": 22910909, "text": "Hyperphosphorylation of Tau induced by naturally secreted amyloid-beta at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3beta signaling pathway."}, {"pubmed": 22911817, "text": "The MAPT H1 rs1052553 is not associated with the risk for developing familial essential tremor in the Spanish population."}, {"pubmed": 22927204, "text": "These results suggest that rs7768046 and rs913275 both influence CSF tau levels in an Alzheimer's disease-associated manner."}, {"pubmed": 22936006, "text": "We showed that pathogenic forms of tau are degraded via the proteasome."}, {"pubmed": 22940644, "text": "Overall, a model is emerging whereby subtle alterations in MAPT splicing, driven by genetic variation, gradually increases an individual's risk of disease"}, {"pubmed": 22941973, "text": "Under reducing condition, the Tris-buffer fraction of transgenic tau demonstrates by western blotting to contain both 50-60 kDa normally-sized and 64 kDa tau. Both are thermo-stable, but the 64 kDa tau shows a higher degree of phosphorylation."}, {"pubmed": 22952452, "text": "These results suggest that an increase in tau phosphorylation at Ser262 through PAR-1 contributes to tau-mediated neurodegeneration under a pathological condition in which axonal mitochondria is depleted"}, {"pubmed": 22975846, "text": "AMPH1 protein level is reduced in brain regions known to accumulate aggregates of hyperphosphorylated tau proteins."}, {"pubmed": 22976542, "text": "tau protein expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy; patients negative for tau expression were more likely to achieve pathological complete response."}, {"pubmed": 22984603, "text": "Data indicate that transgenic tau P301S neonatal slices displayed a constant high vitality level, while the vitality of adult slice cultures decreased significantly upon cultivation."}, {"pubmed": 23001634, "text": "The results of the present study suggest that the SNP rs1052553 in MAPT is not related with the risk for restless legs syndrome"}, {"pubmed": 23012332, "text": "Compared with Alzheimer's disease, elevated tau or reduced amyloid-beta1-42 are usually not found in other forms of neurodegenerative dementia."}, {"pubmed": 23019339, "text": "Tau protein diffuses along the microtubule lattice"}, {"pubmed": 23028730, "text": "The mechanism of cell death induced by APP and its c-terminal fragments and tau was investigated."}, {"pubmed": 23034520, "text": "The disparity between total-tau levels encountered in Alzheimer's disease and other neurodegenerative conditions is not due to differential recognition of tau assembly forms or the extent of degeneration."}, {"pubmed": 23036273, "text": "Hippocampal injection of IgG triggers underlying changes in tau phosphorylation, amyloidbeta deposition, tau-related protein kinase GSK-3beta and AKT in the brains of transgenic db/db diabetic mice."}, {"pubmed": 23041958, "text": "Overview of the role of tau protein in Alzheimer disease pathogenesis. [Review Article]"}, {"pubmed": 23043292, "text": "The FTDP-17 mutants had very different effects on the aggregation and microtubule interactions of tau."}, {"pubmed": 23047372, "text": "A role revealed for tau in genome and chromosome stability is ascribed to its function as a microtubule-associated protein as well as a protein protecting chromatin integrity through interaction with DNA."}, {"pubmed": 23053136, "text": "we report mixed tau and TDP-43 pathology in a woman with behavioural variant frontotemporal lobar degeneration who had the C9ORF72 mutation, and the p.Ala239Thr variant in MAPT gene not previously associated with tau pathology"}, {"pubmed": 23064258, "text": "Mild cognitive impairment subjects carrying both APOE epsilon4 and MAPT-H1 variants showed gray matter atrophy that could be due to changes in MAPT expression."}, {"pubmed": 23085090, "text": "In conditions of increased or altered expression of tau and its isoforms, a therapy that is not directly affected by changes in tau is desirable."}, {"pubmed": 23087208, "text": "Data suggest that the microtubule (MT)-induced Tau filaments provide a model for Alzheimer's studies."}, {"pubmed": 23105105, "text": "This study demonstrates that cells actively release Tau in the absence of disease or toxicity, and Tau release is modified by changes in the Tau protein that are associated with tauopathies."}, {"pubmed": 23114515, "text": "Although pan-neuronal tau expression augments induction of hsp70 following heat shock, several HSP inducing compounds induce hsp70 protein in mammalian cells in vitro but do not detectably induce hsp70 mRNA or protein in tau expressing Drosophila larvae."}, {"pubmed": 23121543, "text": "Agraphia associated with FTDP-17 is very heterogeneous."}, {"pubmed": 23129775, "text": "Our data integrate Tau protein into the class of amyloidogenic proteins and enforce the hypothesis of a common toxicity-mediating mechanism for amyloidogenic proteins."}, {"pubmed": 23154429, "text": "Chemo- and radiotherapy used in acute lymphoblastic leukemia (ALL) can influence future brain functioning. In a prospective study we analysed the cognitive functions of ALL survivors in relation to Tau protein as a marker of white matter injury."}, {"pubmed": 23157676, "text": "Pin1 accelerates cis to trans conversion to prevent the accumulation of the pathogenic cis p-tau conformation in AD, providing the first structural evidence for how Pin1 protects against AD."}, {"pubmed": 23160422, "text": "Overview of development of abnormal tau in brainstem nuclei in the development and progression of Alzheimer disease. [Review Article]"}, {"pubmed": 23225000, "text": "Various aspects of structure and biochemistry of tau, fibril formation and clinical perspectives, including therapeutic strategies are reviewed in this chapter"}, {"pubmed": 23234879, "text": "Aggregates of hyperphosphorylated tau are visibly linked to the degree of cognitive impairment in Alzheimer's disease in these first human brain images."}, {"pubmed": 23237806, "text": "These results suggest that ER stress increases total tau protein and its mechanism is due to the decrease in the binding between tau and CHIP, which delays the degradation of tau protein through the ubiquitin-proteasome pathway."}, {"pubmed": 23247080, "text": "This study demonistration that THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia."}, {"pubmed": 23254634, "text": "Tau cleavage in diabetic conditions (especially in type 2 diabetes) may be a key link for the increased incidence of Alzheimer's disease in diabetic patients."}, {"pubmed": 23264626, "text": "Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits"}, {"pubmed": 23269837, "text": "Tau fibrils showed a approximately 16-nm-thick fuzzy coat that resembles a two-layered polyelectrolyte brush, which is formed by the unstructured short C-terminal and long N-terminal domains. Mechanical and adhesive properties of the fuzzy coat are modulated by pH."}, {"pubmed": 23276384, "text": "A novel ketone ester can ameliorate proteopathic and behavioral deficits in a transgenic Alzheimer disease model."}, {"pubmed": 23317568, "text": "Our results suggest that MAPT, PGRN and APOE play limited roles in frontotemporal lobar degeneration pathogenesis among Indians"}, {"pubmed": 23332171, "text": "Tau ablation in knockout mice does not impair cognition and causes only minor motor deficits that are much more subtle than those associated with the aging process."}, {"pubmed": 23332172, "text": "Reduction of tau phosphorylation in the brain is modulated by 5-lipoxygenase."}, {"pubmed": 23338682, "text": "C9orf72-associated frontotemporal lobar degeneration patients present with early-onset behavioral variant with disinhibition compared to MAPT mutation carriers."}, {"pubmed": 23340677, "text": "The consequences of tau hyperphosphorylation on both neuronal and astrocytic metabolism and amino-acid neurotransmitter homeostasis were assessed in transgenic mice expressing the pathogenic mutation P301L in the human tau gene."}, {"pubmed": 23358800, "text": "It involved in the same cascade of the malignant progression of gliomas."}, {"pubmed": 23362255, "text": "Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites"}, {"pubmed": 23396350, "text": "yeast studies have provided major new insights into the effects of tau and Abeta and, at the same time, offered new approaches to rapidly search for chemicals that may be involved in prevention of Alzheimer's disease--{REVIEW}"}, {"pubmed": 23418567, "text": "Data indicate that double transgenic (Tg-FDD-Tau) mice showed a significant decrease in synaptophysin levels."}, {"pubmed": 23423488, "text": "DNA methylation, dysregulation of miR- 34c-5p, and MAPT expression are critical factors in the chemoresistance of gastric cancer to paclitaxel"}, {"pubmed": 23443659, "text": "Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation."}, {"pubmed": 23446558, "text": "Used immunohistochemical methods to study Tau protein expression levels in gastric cancer specimens; used Western blot to detect the level of Tau protein expression in gastric cancer cell lines and to check the efficacy of paclitaxel in vitro application."}, {"pubmed": 23458258, "text": "Studies indicate residue-specific information about amyloid intermediate states of IAPP, alpha-synuclein, and tau were characerized with Forster resonance energy transfer (FRET)."}, {"pubmed": 23475578, "text": "Tau overexpression is significantly associated with lower Gleason score in prostate cancer patients."}, {"pubmed": 23475817, "text": "frontotemporal lobar degeneration patients with tau inclusions appear to have relatively greater white matter disease at autopsy than those patients with TDP-43"}, {"pubmed": 23479202, "text": "Cerebrospinal fluid Abeta trimers are elevated in individuals at risk for Alzheimer disease and show stronger relationships with tau than does Abeta1-42, a surrogate for Abeta fibril deposition."}, {"pubmed": 23487739, "text": "From a genetic screen, we found that a histone deacetylase 6 (HDAC6) null mutation rescued tau-induced MT defects in both muscles and neurons."}, {"pubmed": 23499461, "text": "These data support a causative link between the phosphorylation and conformational state of tau, microtubuli-based transport, and the vulnerability of human neurons to oxidative stress."}, {"pubmed": 23507417, "text": "This results are consistent with a recently published study that also did not find significant interactions of either smoking or caffeine intake with SNPs in SNCA, MAPT, or LRRK2 genes."}, {"pubmed": 23515417, "text": "A mutant associated with a K280 deletion (a mutation that causes a heritable form of neurodegeneration/dementia in the context of full length TAU) is seen to aggregate more readily than its wild-type counterpart."}, {"pubmed": 23518664, "text": "Sequence variant MAPT p.A152T is associated with a variety of frontotemporal dementia spectrum disorders and is identified in patients with clinical Alzheimer's disease."}, {"pubmed": 23528367, "text": "[review] Soluble forms of both amyloid beta and tau protein act at the synapse to cause neural network dysfunction, and that these two pathological proteins may act in concert to cause synaptic pathology."}, {"pubmed": 23554879, "text": "PINCH is increased and binds to hp-Tau. These studies address a new mechanism by which AD and HIV may intersect and identify PINCH as a contributing factor to the accumulation of hyperphosphorylated Tau."}, {"pubmed": 23562579, "text": "Prolyl oligopeptidase colocalizes with alpha-synuclein, beta-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases"}, {"pubmed": 23566348, "text": "Phosphorylated tau levels in cerebrospinal fluid (CSF) from Alzheimer's disease patients correlate with elevated BACE1 levels."}, {"pubmed": 23576620, "text": "Cerebrospinal fluid Tau biomarker signals underlying Alzheimer disease pathology at least several years before the appearance of dementia symptoms."}, {"pubmed": 23585562, "text": "tau is a good substrate for PSK1 and PSK2 phosphorylation with mass spectrometric analysis of phosphorylated tau revealing more than 40 tau residues as targets of these kinases."}, {"pubmed": 23585566, "text": "Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease"}, {"pubmed": 23597931, "text": "The CSF biomarker tau is important and useful as part of the diagnostic procedure for detecting AD and other dementia in elderly patients displaying psychotic symptoms."}, {"pubmed": 23621301, "text": "Contribution of dyslipidemia and cholesterol metabolism towards tau pathology during obesity is an interesting avenue to follow."}, {"pubmed": 23624859, "text": "Here, authors report that mammalian tau proteins possess intrinsic enzymatic activity capable of catalyzing self-acetylation."}, {"pubmed": 23631819, "text": "Negative tau protein seems to be both good prognostic factor and a predictor of response to paclitaxel/platinum-based chemotherapy in EOC patients."}, {"pubmed": 23640887, "text": "Involvement of brain acidosis in the etiopathogenesis of Alzheimer disease, and the asparaginyl endopeptidase-I2(PP2A)-protein phosphatase 2A-Tau hyperphosphorylation pathway."}, {"pubmed": 23659998, "text": "Tau could induce conformational changes of microtubules, favoring recovery of microtubule self-assembly."}, {"pubmed": 23664753, "text": "Its heterozygous variation causes Parkinsonism. (review)"}, {"pubmed": 23666174, "text": "Intermediate phosphorylated tau-181 cerebrospinal fluid levels are included with amyloid beta-peptide ratios in the differential diagnosis of Alzheimer's disease and dementia."}, {"pubmed": 23666762, "text": "Tau phosphorylation at Ser(2)(2) is mediated by MARK4. MARK4-tau interactions are of functional importance in the progression of Alzheimer disease."}, {"pubmed": 23681778, "text": "Negative Tau protein expression may be an effective predictor for taxane-containing neoadjuvant chemotherap."}, {"pubmed": 23684085, "text": "[review] The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies."}, {"pubmed": 23715095, "text": "The presence of phosphorylated-tau is likely to be involved in the changes to dendritic spines and the loss of synapses that leads to cognitive decline in Alzheimer's disease."}, {"pubmed": 23717682, "text": "levels of Tau-A showed an inverse correlation to cognitive function, which could indicate that this marker is a serum marker with pathological relevance for AD"}, {"pubmed": 23721814, "text": "The results indicate that the tauV337M mutation in mice disrupts, selectively, a subset of processes related to executive function."}, {"pubmed": 23727081, "text": "Further evidence that specific variations in MAPT (rs3785883) and PPP3R1 (rs1868402) are associated with accelerated progression of Alzheimer's disease"}, {"pubmed": 23789343, "text": "Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease"}, {"pubmed": 23794287, "text": "Loss of presenilin (PS)1 function propagates tau accumulation through impairment of cargo-receptor protein p62-dependent tau degradation."}, {"pubmed": 23798570, "text": "Exogenous progestorone (9300-93,000 pg/ml) had a significant effect on overall Tau and nuclear TDP-43 levels, reducing total Tau levels by approximately 1.5-fold and increasing nuclear TDP-43 by 1.7- to 2.0-fold."}, {"pubmed": 23798682, "text": "GSK3alpha, GSK3beta, and MAPK13 were found to be the most active tau kinases, phosphorylating tau at all four epitopes."}, {"pubmed": 23824268, "text": "Amyloid beta may be released from axons of abnormal tau brainstem neurons in Alzheimer's disease."}, {"pubmed": 23827424, "text": "Total tau protein in CSF is an accurate diagnostic biomarker for brain injuries in children."}, {"pubmed": 23900411, "text": "50% of patients with Parkinson disease also develop sufficient numbers of amyloid-beta plaques and tau-containing neurofibrillary tangles for a secondary diagnosis of Alzheimer's disease."}, {"pubmed": 23911736, "text": "These results suggest that MAPT rs1052553 polymorphism is not related with the risk for relapsing bout onset MS."}, {"pubmed": 23943618, "text": "alterations in the membrane localization of PP2A and Tau following down-regulation of LCMT1 may lead to PP2A and Tau dysfunction in AD."}, {"pubmed": 23948895, "text": "Different forms of tau aggregates are involved in the different pathological changes that occur in tauopathies."}, {"pubmed": 23948900, "text": "Transgenic mice expressing 3-fold higher human tau display normal and fast axonal transport rates."}, {"pubmed": 23948901, "text": "Expression of human tau protein in Drosophila melanogaster induces behavioral motor and olfactory learning deficits."}, {"pubmed": 23948904, "text": "Dyrk1A enhances tau expression by stabilizing its mRNA."}, {"pubmed": 23948912, "text": "In transgenic mice with tau mutations, spatial memory is impaired at 9 months of age but non-spatial memory as early as 6 months."}, {"pubmed": 23948915, "text": "Tau hyperphosphorylation by DAPK1 renders brain cells more resistant to kinase-induced apoptotic cell death."}, {"pubmed": 23948919, "text": "A heterozygous guanine to cytosine mutation at the first base of codon 389 in MAPT is identified in a case of juvenile frontotemporal dementia with parkinsonism."}, {"pubmed": 23948940, "text": "Insoluble human tau isolated from transgenic rats is able to infect cortical neurons in the area of injection."}, {"pubmed": 23951236, "text": "GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals."}, {"pubmed": 23951348, "text": "The results demonstrate that in the interactions of Abeta and mutated tau oligomers, polymorphic mutated tau-Abeta17-42 oligomeric complexes were observed."}, {"pubmed": 23959642, "text": "17q21 inversion arose within the modern human lineage. The data also indicate that archaic hominins that coexisted in Eurasia probably shared the same MAPT subhaplotype, and this can be found in almost 2% of chromosomes from European ancestry."}, {"pubmed": 23962722, "text": "study describes a novel mechanism in which the acetylation of tau on KXGS motifs inhibits phosphorylation on this same motif and also prevents tau aggregation; also demonstrated KXGS motifs are hypoacetylated in patients with Alzheimer Disease"}, {"pubmed": 23999428, "text": "Age-associated increases in FKBP51 levels and its interaction with Hsp90 promote neurotoxic tau accumulation."}, {"pubmed": 24018212, "text": "is one of the major genes linked to frontotemporal lobar degeneration."}, {"pubmed": 24037441, "text": "In Alzheimer's brain, down-regulation of the protein kinase A (PKA) pathway could lead to dysregulation of tau exon 10, contributing to tau pathogenesis."}, {"pubmed": 24041972, "text": "evaluation of the genetic contribution of MAPT variations to the pathogenesis of frontotemporal dementia(FTD) and determined the frequency distribution of MAPT haplotypes in FTD, other dementia groups and controls; study reports the absence of pathogenic mutations in MAPT, in a south Indian FTD cohort"}, {"pubmed": 24050961, "text": "REVIEW:  research on cell-to-cell propagation of tau pathology, believed to be central to disease progression; and discussion of tau immunotherapy in the light of these findings"}, {"pubmed": 24063855, "text": "Increase in mRNA levels of the TAU gene is associated with Alzheimer's disease."}, {"pubmed": 24069608, "text": "Altered MAP2 and tau expression in mesial temporal lobe epilepsy (MTLE) and decreased tau expression in MTLE with psychosis were found."}, {"pubmed": 24072703, "text": "Structural determinants of Tau aggregation inhibitor potency."}, {"pubmed": 24076100, "text": "Performed a detailed analysis of tau misprocessing in a new transgenic mouse model combining APP, PS1 and tau mutations."}, {"pubmed": 24076336, "text": "REVIEW: role for tau at the synapse in Alzheimer's disease pathogenesis"}, {"pubmed": 24081456, "text": "The rate of MAPT mutation-positive FTLD in this series was 15.4%. Categories designating the risk level for hereditary cause were termed high, medium, low, apparent sporadic, and unknown significance."}, {"pubmed": 24085246, "text": "Patients with Alzheimer disease had higher levels of CSF tau and phosphorylated-tau than healthy controls and non-AD demented controls."}, {"pubmed": 24086739, "text": "A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function."}, {"pubmed": 24089520, "text": "Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau protein pathology."}, {"pubmed": 24098548, "text": "Protein disulfide isomerase interacts with tau protein and inhibits its fibrillization."}, {"pubmed": 24101602, "text": "Altered CpG methylation in sporadic Alzheimer's disease is associated with MAPT dysregulation."}, {"pubmed": 24116116, "text": "Results indicate that tau in cerebral spinal fluid (CSF) occurs as a series of fragments and that discrimination of Alzheimer's disease from control is dependent on the subset of tau species measured."}, {"pubmed": 24121548, "text": "A novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration."}, {"pubmed": 24146816, "text": "Expression of Tau40 induces activation of cultured rat microglial cells suggesting a novel role for human Tau40."}, {"pubmed": 24150109, "text": "study identified 3 tau mutations (4R P301L, 4R deltaN296, and 4R R406W) that reduce kinesin translocation velocity along microtubules relative to WT tau; data provide support for the notion that aberrant modulation of kinesin translocation is a component of tau-mediated neuronal cell death and dementia"}, {"pubmed": 24163366, "text": "Tau antibody uptake is primarily receptor-mediated, these antibodies are mainly found in neurons with Tau aggregates, and their intracellular interaction leads to clearance of Tau pathology."}, {"pubmed": 24212387, "text": "Abnormal cerebrospinal fluid biomarker values for phosphorylated-tau protein predict more rapidly changing dementia scores in Alzheimer's disease patients."}, {"pubmed": 24218087, "text": "mutated human tau expressed in mouse is associated with chromosome instability"}, {"pubmed": 24225352, "text": "Pulse pressure elevation is associated with increased cerebrospinal fluid (CSF)levels of phosphorylated-tau in cognitively normal older adults."}, {"pubmed": 24235150, "text": "Data indicate that fibrils consisting of endogenous and exogenous Tau are released from cells and their potential to spread Tau pathology."}, {"pubmed": 24251416, "text": "The binding of Tau to MTs provides support for a model in which Tau's hot spots of MT interaction bind independently of each other and are differentially affected by phosphorylation."}, {"pubmed": 24253235, "text": "The results of this study indicate that MAPT haplotypes influence motor features in PD by showing that H1/H1 PD patients are significantly more likely to present a NTD clinical phenotype characterized by widespread pathological degeneration"}, {"pubmed": 24256615, "text": "The stabilities of Tau protein domains hints at mechanistic differences in the aggregation pathways."}, {"pubmed": 24268156, "text": "interplay between velocity and travel distance of Kinesin-based transport in the presence of Tau"}, {"pubmed": 24268747, "text": "The study indicates that serum tau protein levels measured on postnatal days 3 and 7 can predict neurological prognosis following neonatal asphyxia."}, {"pubmed": 24270207, "text": "Tau phosphorylation is accelerated in the brains of Alzheimer's disease patients who also have psychosis."}, {"pubmed": 24278307, "text": "The APP/PS1/htau mice displayed mild, age-dependent, Amyloid beta plaques and tau hyperphosphorylation, thus successfully recapitulating the late-onset Alzheimer's disease pathological hallmarks."}, {"pubmed": 24278327, "text": "Tau likely induces spine loss in a calcium-independent manner."}, {"pubmed": 24337498, "text": "Neuropathological characterization of two siblings carrying the MAPT S305S mutation demonstrates features resembling argyrophilic grain disease."}, {"pubmed": 24364857, "text": "The acidic fragment of human Abeta (Abeta1-11) and a phosphorylated fragment of beta-Casein induced tau fibrillization in vitro."}, {"pubmed": 24372973, "text": "not find evidence for association of MAPT H1 haplotype with essential tremor in studied population."}, {"pubmed": 24375821, "text": "This study demonstrated that leukocyte and brain DNA methylation suggest that hypermethylation of the MAPT promoter is neuroprotective by reducing MAPT expression, which could be modified by vitamin E in a haplotype-specific manner."}, {"pubmed": 24387985, "text": "Its mutation is rare cause of frontotemporal dementia in Korean population."}, {"pubmed": 24389033, "text": "Axonal tau mRNA is associated with granules distributed throughout the axon, including the growth cone. Tau mRNA-containing axonal particles are associated with elongation factor 1A."}, {"pubmed": 24389273, "text": "we observed a synergistic interaction between annonacin exposure and the presence of the R406W-tau mutation, which resulted in reduced degradation, increased phosphorylation and redistribution of neuronal tau."}, {"pubmed": 24401901, "text": "CSF tau protein levels were significantly lower in patients with Alzheimer's subtype posterior cortical atrophy compared to those with amnestic or logopenic progressive aphasia subtypes."}, {"pubmed": 24406748, "text": "This study showed novel P301S tau Tg mouse model of cognition deficies. These mice demonstrate age-dependent abnormalities in tau phosphorylation, insoluble tau accumulation, altered expression of neuronal proteins,motor dysfunction."}, {"pubmed": 24430504, "text": "Interactions between alpha-Syn and Tau cause disruption of cytoskeletal organization, axonal transport defects and aberrant synaptic organization that contribute to neuronal dysfunction and death associated with Parkinson's disease."}, {"pubmed": 24440055, "text": "Study seeks to elucidate the Abeta-dependent changes in wild-type human tau that cause synaptic loss and cognitive decline in Alzheimer's disease, focusing on changes in synaptic proteins in the Fyn kinase pathway"}, {"pubmed": 24444746, "text": "O-GlcNAc modification of full-length tau impairs the rate and extent of its aggregation without perturbing its activity toward microtubule polymerization."}, {"pubmed": 24448233, "text": "The study provides direct structural information regarding DeltaK280 tau R2 repeat mutant aggregates and their extensions in the N- and C-terminii by one residue."}, {"pubmed": 24464041, "text": "Heterochromatin loss appears to be a toxic effector of tau-induced neurodegeneration."}, {"pubmed": 24492862, "text": "Ratio of phosphorylated to total tau in the cerebrospinal fluid (CSF) is a candidate biomarker providing objective support for diagnosis of amyotrophic lateral sclerosis."}, {"pubmed": 24493463, "text": "The soluble building blocks of the abnormal brain structures in Alzheimer disease pathogeneisis are tau for neurofibrillary tangles and amyloid-beta (Abeta) peptides for plaques."}, {"pubmed": 24498342, "text": "Data indicate that neuronal expression of protein Tau affected the functional and structural organization of the entorhinal-hippocampal complex, in particular synapses and myelinated axons in the stratum lacunosum moleculare (SLM) in mice."}, {"pubmed": 24502945, "text": "A functional fragment of Tau forms bundled ribbon-like fibrils. Nucleation of its fibril formation is faster than for full-length Tau. In contrast to full-length Tau, without cysteines, the fragment still forms fibers."}, {"pubmed": 24519386, "text": "Tau had no prognostic value in either group."}, {"pubmed": 24559475, "text": "OGlcNAcylation of tau opposes neurofibrillary tangle formation, because of its confirmation of the disordered structure of sequences with unmodified serine and threonine residues, while phosphorylation is associated with neurofibrillary tangle formation."}, {"pubmed": 24559644, "text": "Variants of the MAPT gene have been suggested to be associated with Parkinson's disease (PD) and to modify the risk for leucine-rich repeat kinase 2 (LRRK2) Parkinsonism."}, {"pubmed": 24561013, "text": "Collectively, these data indicate that autophagic gridlock contributes to the development of pathology in aging and neurodegeneration."}, {"pubmed": 24566866, "text": "Combination of increased total-tau levels and increased total tau to phosphorylated-tau serves as a clinically useful diagnostic test for Creutzfeldt-Jakob disease."}, {"pubmed": 24581495, "text": "Study obtained a structural model of Hsp90 in complex with its natural disease-associated substrate, the intrinsically disordered Tau protein. Hsp90 binds to a broad region in Tau that includes the aggregation-prone repeats."}, {"pubmed": 24623856, "text": "FKBP52 appears to be an endogenous candidate that directly interacts with the pathogenic Tau-P301L and modulates its function in vitro and in vivo"}, {"pubmed": 24646911, "text": "Data indicate that dysfunction of tau protein may contribute to collapse of cytoskeleton."}, {"pubmed": 24656848, "text": "The results of this study suggest that rs4728029 of modifies the relationship between PTau and both ventricular dilation and cognition, perhaps through an altered neuroinflammatory response"}, {"pubmed": 24675496, "text": "Based on MAP-tau expression, there was no significant difference in disease-free survival in the breast cancer patients who received anthracycline and taxane-containing adjuvant chemotherapy."}, {"pubmed": 24687422, "text": "At low near-physiological levels, Tau is co-transported along with short microtubules from cell bodies into axons by cytoplasmic dynein and kinesin family members at rates of slow axonal transport. [review]"}, {"pubmed": 24722794, "text": "The sensitivity of gastric cancer patients to paclitaxel treatment was inversely correlated with the mRNA and protein expression of MAPT."}, {"pubmed": 24741064, "text": "results suggest that tau may be an important biomarker for predicting long-term outcome in patients with severe aneurysmal subarachnoid haemorrhage."}, {"pubmed": 24779391, "text": "We conclude that the MAPT rs242562 is associated with PD in central China in the background of MAPT H1/H1 diplotype."}, {"pubmed": 24808015, "text": "Tauopathy phenotypes include lower motor neuron disease and implicate tau degradation pathway defects in motor neuron degeneration."}, {"pubmed": 24818585, "text": "Microbleeds are present with cerebrospinal fluid (CSF) beta-amyloid 42 (Abeta42), total tau, and tau phosphorylated at threonine 181 (P-tau181) as well as a subset of apolipoprotein E (APOE) epsilon4 carriers and noncarriers."}, {"pubmed": 24821615, "text": "study describes the P364S MAPT mutation-associated tauopathy clinical course in two sisters, in whom postmortem analysis revealed striking composite neuronal tau inclusions"}, {"pubmed": 24825901, "text": "Although the repeat domain generally aggregates more readily than full-length Tau, its aggregation was greatly slowed down by phosphorylation or pseudo-phosphorylation at the KXGS motifs, concomitant with an extended phase of oligomerization."}, {"pubmed": 24853415, "text": "Suggest that DAPK1 is a novel regulator of tau protein abundance, and that DAPK1 upregulation might contribute to tau-related pathologies in Alzheimer disease."}, {"pubmed": 24857020, "text": "Prion-like propagation of tau aggregation underlie the stereotyped progression of neurodegenerative tauopathies."}, {"pubmed": 24861427, "text": "We find no predilection or predisposition towards an accompanying TDP-43 pathology in patients with FTLD-tau, irrespective of presence or absence of MAPT mutation, or that genetic changes associated with FTLD-TDP predispose towards excessive tauopathy."}, {"pubmed": 24865638, "text": "In MAPT transgenic mice, memory deficits precede the onset of locomotor dysfunction and coincide with the appearance of conformationally changed, S202-phosphorylated tau and reduced spine density in the absence of neuronal cell loss in the hippocampus."}, {"pubmed": 24869773, "text": "lysine methylation is part of the normal modification signature of tau protein in the human brain. In addition to indirect effects owing to PTM cross-talk, lysine methylation can directly affect tau biology by lowering aggregation propensity."}, {"pubmed": 24909306, "text": "Expression of wild type human Tau partially rescued the neurodegenerative phenotype caused by the loss of endogenous dTau, suggesting that the functions of Tau proteins are functionally conserved from flies to humans"}, {"pubmed": 24915991, "text": "This study show that NFTs do not significantly alter postsynaptic function of the host neurons which is required for the experience-dependent Arc expression."}, {"pubmed": 24923570, "text": "MAPT gene has four haplotype blocks in the Taiwanese population, each of around 40 kbp. In both European study and our study, the SNP rs242557 showed association with Alzheimer's disease"}, {"pubmed": 24929931, "text": "The results demonstrate a complex interaction between tau and AICD involving activation of GSK3beta in promoting cell death, and the ability of Hirano bodies to modulate this process."}, {"pubmed": 24965601, "text": "suggest a protective role for cellular prion protein in Alzheimer's disease by downregulating tau expression, and they point to this protein as being crucial in the molecular events that lead to neurodegeneration in Alzheimer's disease"}, {"pubmed": 24977637, "text": "Isoflurane may induce cognitive dysfunction by enhancing phosphorylation of hippocampal tau protein at Ser262 site, and this effect is more significant in transgenic APP695 mice."}, {"pubmed": 25001178, "text": "MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease."}, {"pubmed": 25012224, "text": "A probabilistic generative model predicts with high confidence that the cerebrospinal fluid biomarkers become abnormal in a distinct sequence: amyloid-beta1-42, phosphorylated tau, total tau."}, {"pubmed": 25051234, "text": "These findings suggest that an intracellular form CLU and BIN1 interaction might impact Tau function in neurons and uncover potential new mechanisms underlying the etiology of Tau pathology in in Alzheimer's disease."}, {"pubmed": 25112570, "text": "Catecholamine-differentiatied cells lack tau and grow neurites in serum-free media. Serum induces neurite retraction. Transfection with green fluorescent protein-Tau conferred resistance to the retraction caused by serum."}, {"pubmed": 25128526, "text": "Inactivation of nuclear localization signal causes retention of I2PP2A in the cell cytoplasm, where it promotes Tau hyperphosphorylation by affecting PP2A signaling."}, {"pubmed": 25131590, "text": "Due to multiple post-translational modifications, heterogeneous tau species with a wide range of apparent molecular masses are implicated in human disease proceses. [Review]"}, {"pubmed": 25143394, "text": "Results suggests that expression of mutant Htt leads to Tau hyperphosphorylation, relocalization and sequestration through direct protein-protein interactions in inclusion-like compartments in the vicinity of the microtubular organizing center."}, {"pubmed": 25151619, "text": "This study demonstrated that insoluble phospho-tau species are correlated with PPI deficits in a tau mouse model of Alzheimer disease."}, {"pubmed": 25178429, "text": "Variants of MAPT and SNCA were not associated with, but APOE epsilon4 allele was only associated with, lower performance on word list learning and semantic verbal fluency"}, {"pubmed": 25229151, "text": "helical tau structure in the context of intact lipid bilayers"}, {"pubmed": 25241929, "text": "PICALM modulates autophagy activity and tau accumulation"}, {"pubmed": 25284680, "text": "Data suggest that tau protein exhibits polymerization/aggregation in presence of heparin while undergoing two distinct stages of changes in secondary structure in the process of stabile amyloid fibril formation."}, {"pubmed": 25305495, "text": "results of this meta-analysis suggested that MAPT_238bp/STH Q7R polymorphisms might modulate the risk of Parkinson's disease susceptibility"}, {"pubmed": 25306292, "text": "The H2 allele of the extended MAPT haplotype negatively affects the course of psychotic symptoms in AD independently of disease severity."}, {"pubmed": 25319522, "text": "Transgenic mice expressing human four-repeat tau lacking the N-terminal sequences (4R0N) with a P301L mutation demonstrated that P301L tau expression increased potassium-evoked glutamate release in the dentate gyrus and CA3 and significantly decreased glutamate clearance and maze learning."}, {"pubmed": 25326800, "text": "AEP acts as a crucial mediator of tau-related clinical and neuropathological changes."}, {"pubmed": 25330988, "text": "Study found normal tau protein to be symmetrically distributed across presynaptic and postsynaptic terminals in the normal human brain; misfolded tau in Alzheimer's disease-affected brains was also symmetrically distributed on both sides of the synapse"}, {"pubmed": 25331948, "text": "Syk regulates amyloid-beta production via NF-kappaB-dependent mechanisms and Tau phosphorylation by controlling the activation of GSK3beta"}, {"pubmed": 25339173, "text": "Tau highly phosphorylated in cells increases oligomerization without pronounced aggregation."}, {"pubmed": 25377499, "text": "Results suggest that analyzing of the MAPT gene is essential for diagnosing familial dementia, even if amyloid markers such as Abeta42 in the cerebrospinal fluid and amyloid imaging are positive, or if neuropathological findings indicate a diagnosis of AD."}, {"pubmed": 25378699, "text": "Tau SUMOylation induces tau hyperphosphorylation at multiple AD-associated sites. Tau hyperphosphorylation promotes its SUMOylation inhibiting tau degradation. Enhanced SUMO-immunoreactivity costains with hyperphosphorylated tau in AD cerebral cortex."}, {"pubmed": 25384392, "text": "These studies demonstrate that Tau deletion affects intracellular Abeta1-42 clearance, leading to extracellular plaque."}, {"pubmed": 25393609, "text": "In brain from Alzheimer's disease patients, tau was found to be highly localized to synaptic terminals in cortex."}, {"pubmed": 25394490, "text": "alpha-Syn and Tau together cooperated with one another to increase the magnitude or rate of phosphorylation of the other by GSK-3beta."}, {"pubmed": 25406315, "text": "We show that seeding is conferred by aggregated Tau that enters cells through macropinocytosis and seeds the assembly of endogenous Tau into filaments."}, {"pubmed": 25416970, "text": "Studies suggest that granular tau oligomers may be involved in neuronal loss."}, {"pubmed": 25424384, "text": "The clinical utility of the CSF biomarkers amyloid-beta-1-42, t-tau, and p-tau (phosphorylated tau protein) for Alzheimer's disease diagnosis has been well documented; progress in use of these biomarkers for early diagnosis is discussed. [REVIEW]"}, {"pubmed": 25436420, "text": "(-)-epigallocatechin gallate (EGCG), a green tea polyphenol that was previously found to reduce Abeta aggregation, inhibits the aggregation of tau K18DeltaK280 into toxic oligomers at ten- to hundred-fold substoichiometric concentrations"}, {"pubmed": 25443551, "text": "Mutations in MAPT in three sib-pairs were identified with progressive supranuclear palsy."}, {"pubmed": 25465240, "text": "olfactory deprivation by olfactory bulbectomy hastens tau pathology and cholinergic system impairment in htau mice possibly via activation of cdk5."}, {"pubmed": 25468336, "text": "The diffusion of bound tau was negligible in vivo, in contrast to an earlier report that tau diffuses along the microtubule lattice in vitro."}, {"pubmed": 25476420, "text": "Cells treated with exogenous proteasomes are efficient in degrading overexpressed human tau, resulting in decreased levels of tau aggregates."}, {"pubmed": 25524708, "text": "Late-appearing phosphorylation on Ser(238) rather than hyperphosphorylation per se is essential for Tau toxicity underlying premature mortality in adult flies."}, {"pubmed": 25573097, "text": "Thr175-phosphorylated tau induces pathologic fibril formation via GSK3beta-mediated phosphorylation"}, {"pubmed": 25574752, "text": "report suggests that frontotemporal lobar degeneration with IVS10+3G>A MAPT mutation causes damage mainly to the central nervous system"}, {"pubmed": 25574843, "text": "miR-219 binds directly to the 3'-UTR of the tau mRNA and represses tau synthesis at the post-transcriptional level."}, {"pubmed": 25575131, "text": "This study support the notion that age-related vascular injury or tissue microinfarcts lead to loss of tau proteins with the consequent impact on phosphorylation and accumulation of the neurofibrillary pathology of vascular dementia."}, {"pubmed": 25577413, "text": "results suggest that common variation in MAPT is not only associated with the dementia of Parkinson's disease but also differences in the neural circuitry underlying aspects of cognition in normal aging"}, {"pubmed": 25588407, "text": "There were significant differences in CSF tau and phosphor-tau between patients with Alzheimer's disease and non-demented controls."}, {"pubmed": 25621407, "text": "In professional ice hockey players, serum levels of Tau-C were significantly higher in post-concussion samples compared with pre-concussive."}, {"pubmed": 25658796, "text": "The data suggest that reduction of tau expression may sensitize ovarian carcinoma to the paclitaxel treatment."}, {"pubmed": 25659102, "text": "An oral administration of PE859 resulted in the significant reduction of sarkosyl-insoluble aggregated tau along with the prevention of onset and progression of the motor dysfunction in JNPL3 P301L-mutated human tau transgenic mice."}, {"pubmed": 25687137, "text": "Pathogenetic tau truncation may contribute to synaptic deterioration in Alzheimer disease by aberrant recruitment of Parkin and UCHL-1 to mitochondria."}, {"pubmed": 25687773, "text": "association of both Alzheimer's disease and Parkinson's disease with the A allele of rs393152 within the extended MAPT region on chromosome 17"}, {"pubmed": 25691742, "text": "urea halts aggregation, TMAO promotes the formation of compact oligomers (including helical oligomers) through a newly proposed mechanism of redistribution of water around the perimeter of the peptide."}, {"pubmed": 25725586, "text": "High Tau-protein and low PTEN expression showed a significant association with poor response to H + P chemotherapy in patients with HER2-positive advanced breast cancer."}, {"pubmed": 25765123, "text": "Mutations in MAPT, one of three genes most commonly associated with FTD are not associated with progressive apraxia of speech (PAOS) and primary progressive aphasia (PPA)"}, {"pubmed": 25772164, "text": "The accumulation of misfolded tau in rat neurons induces overexpression of Hsp27 in astrocytes."}, {"pubmed": 25773385, "text": "Tau expression was identified as an independent factor to predict the sensitivity of tumors to taxane-containing palliative chemotherapy in recurrent and metastatic breast cancer"}, {"pubmed": 25791428, "text": "These results have implicated that mTor is involved in regulating tau distribution in subcellular organelles and in the initiation of tau secretion from cells to extracellular space."}, {"pubmed": 25804954, "text": "LRRK2 and tau do not interact to exacerbate behavioral, biochemical or pathological abnormalities in neurodegeneration and that LRRK2 and tau exert their pathogenic effects through independent mechanisms."}, {"pubmed": 25822823, "text": "individual effect of six different isoforms of tau on cell proliferation and the possible mechanisms by transient expression of eGFP-labeled tau isoform plasmid"}, {"pubmed": 25826665, "text": "Structural determinants have been defined for alternative splicing regulation of the MAPT pre-mRNA."}, {"pubmed": 25842390, "text": "By interacting with tau at the intracellular level, the 3-O-sulphated heparan sulphates produced by HS3ST2 might act as molecular chaperones allowing the abnormal phosphorylation of tau"}, {"pubmed": 25847153, "text": "Study demonstrated that downregulation of tau severely impairs process outgrowth, oligodendrocyte differentiation, and sheet formation, and that MBP mRNA transport to the distal cellular extensions is disturbed"}, {"pubmed": 25863267, "text": "A strategy focused on MAPT, APP, NCSTN and BACE1 to build blood classifiers for Alzheimer's disease."}, {"pubmed": 25863528, "text": "Accumulation of hyperphosphorylated and aggregated microtubule-associated protein tau (MAPT) is a central feature of a class of neurodegenerative diseases termed tauopathies."}, {"pubmed": 25880550, "text": "Increased CSF Tau was associated with greater levels of neurocognitive impairment in HIV-associated neurocognitive disorder."}, {"pubmed": 25881209, "text": "development of tauopathy in rTg4510 mice involves the accumulation of a pool of pathological tau that carries multiple post-translational modifications"}, {"pubmed": 25882706, "text": "Active Hsc70 requires active tau to regulate microtubule assembly in vivo, suggesting that tau acts in some ways as a co-chaperone for Hsc70 to coordinate microtubule assembly."}, {"pubmed": 25886404, "text": "Very high total-tau protein CSF levels were significantly associated with a definitive Creutzfeldt-Jakob disease"}, {"pubmed": 25887395, "text": "results indicate that a clear minimum size (n = 3) of Tau seed exists for spontaneous propagation of Tau aggregation from the outside to the inside of a cell, whereas many larger sizes of soluble aggregates trigger uptake and seeding"}, {"pubmed": 25895963, "text": "changes in serum tau protein levels in patients with EHEC encephalopathy were consistent with abnormalities on brain MRI and were positively correlated with proinflammatory cytokine levels"}, {"pubmed": 25899925, "text": "mutant G309D PINK1 significantly reduced phosphorylation of GSK3beta at serine 9, suggesting that alterations in GSK3beta activity play an essential role in mutant G309D PINK1-induced tau phosphorylation at the PHF-1 site"}, {"pubmed": 25900293, "text": "Study showed that pathologically confirmed globular glial tauopathy may be caused by MAPT mutations, a novel MAPT mutation (c.951G>C, p.K317N) is pathogenic"}, {"pubmed": 25908520, "text": "This review synthesizes the current knowledge, the localization and the main functions of the Tau protein focused on the testis. [Review]"}, {"pubmed": 25912737, "text": "Fibril-forming motifs could be the determinants of Tau protein tending to misfold in living cells, thereby inducing neuronal apoptosis and causing the initiation and development of Alzheimer disease."}, {"pubmed": 25918155, "text": "findings suggest that truncation/activation of Dyrk1A by Ca(2+)/calpain I might contribute to Tau pathology via promotion of exon 10 exclusion and hyperphosphorylation of Tau in AD brain"}, {"pubmed": 25930997, "text": "POLDIP2 plays a crucial role in Tau aggregation via the impairment of autophagy activity, providing insight into Tau aggregation in Tau pathology."}, {"pubmed": 25953777, "text": "Our findings therefore highlight a novel important role of tau in the pathogenic process and clinical expression of Huntington's disease."}, {"pubmed": 25959626, "text": "findings suggest that rescuing LRP5/6-mediated Wnt signaling improves neuronal cell survival and reduces tau phosphorylation, which support the hypothesis that Wnt signaling might be an attractive therapeutic strategy for managing AD"}, {"pubmed": 25960998, "text": "This study suggests that, in both ethnic groups, SNCA gene variants influence the age at onset of Parkinson's disease and alpha-synuclein plays a key role in the disease course of PD.MAPT polymorphisms did not enhance such association in either entire cohort"}, {"pubmed": 25963821, "text": "tau allows Abeta oligomers to inhibit axonal transport through activation of GSK3beta, possibly by facilitating aberrant neuronal activity."}, {"pubmed": 25974414, "text": "the Gln124-Tau fragment displays a stronger ability to bind and stabilize microtubules, suggesting that the Tau N-terminal domain could play a direct role in the regulation of microtubule stabilization."}, {"pubmed": 25982997, "text": "Data suggest that tau inclusion pathology follows a non-stochastic process where conformationally distinct misfolded tau fibrils with specific clinico-pathologic properties display differential seeding potential"}, {"pubmed": 25998110, "text": "clinical characteristics associated with mutations in MAPT often include Behavioral variant of Frontotemporal dementia with parkinsonistic features.The associated brain protein pathology is tau positive."}, {"pubmed": 26014385, "text": "LRRK2 regulates intracellular Tau levels, contributing to the progression of the pathology caused by the LRRK2-mediated proteasome impairment."}, {"pubmed": 26034266, "text": "Tau binds to microtubules via small groups of evolutionary conserved residues. The binding sites are formed by residues essential for the pathological aggregation of Tau, suggesting competition between physiological interaction and pathogenic misfolding."}, {"pubmed": 26077951, "text": "MAPT is associated with corticobasal degeneration."}, {"pubmed": 26083267, "text": "In this review the current knowledge of the role of TAU and protein aggregate formation in oligodendrocyte cell culture systems is summarized. [review]"}, {"pubmed": 26103986, "text": "Data show that overexpression of the 14-3-3sigma isoform resulted in a disruption of the tubulin cytoskeleton mediated by binding Tau protein."}, {"pubmed": 26119563, "text": "Data show that activation of EphB2 receptor kinase arrests tau protein hyperphosphorylation through phosphatidylinositol 3-kinase (PI3K)/Akt protein-mediated glycogen synthase kinase-3beta (GSK-3beta) inhibition."}, {"pubmed": 26134402, "text": "the difference of only two amino acids in tau and MAP2 sequences may determine their different fates in tauopathies"}, {"pubmed": 26143746, "text": "These findings indicate distinct neurodegenerative changes in FTD caused by mutant TAU and highlight the unique opportunity to use neurons differentiated from patient-specific iPSCs to identify potential targets for drug screening ."}, {"pubmed": 26161867, "text": "these data support a role for the activation of caspase-3 and proteolytic cleavage of Tau antibody in vascular dementia."}, {"pubmed": 26165593, "text": "Atomic structure has shown that phosphorylated Tau threonine231 selectively engages in a salt bridge with arginine230."}, {"pubmed": 26170022, "text": "MAPT gene expression, including repeated motifs, CpG island/methylation, haplotypes at the DNA level, key regions involved in mRNA expression and stability, and the splicing patterns of different mRNA isoforms are reviewed. Review."}, {"pubmed": 26176913, "text": "cis P-tau is a major early driver of disease after TBI and leads to tauopathy in chronic traumatic encephalopathy and Alzheimer's disease"}, {"pubmed": 26177386, "text": "These findings suggest that, in addition to mediating fibrillization, cofactors decorating the surface of Tau fibrils may modulate biological interactions and thereby influence the spreading of Tau pathology in the human brain."}, {"pubmed": 26188647, "text": "the tau isoforms with exon-2 and exon-10 segments increase in CSF of sporadic Creutzfeldt-Jakob disease and some types of genetic Creutzfeldt-Jakob disease."}, {"pubmed": 26198711, "text": "Sex steroid hormones distinctively increase mitochondrial bioenergetics in APP/ABETA and TAU-overexpressing cells."}, {"pubmed": 26200045, "text": "We report on a female patient presenting with primary progressive aphasia and her brother presenting with psychosis. Both siblings had an R5H-mutation in exon 1 of the MAPT-gene"}, {"pubmed": 26208804, "text": "repression of BAG2 expression or BAG2 activity by cold-sensitive pathways, as modeled in undifferentiated and differentiated cells, respectively, may be a causal factor in the accumulation of cytotoxic hyperphosphorylated tau protein."}, {"pubmed": 26220942, "text": "The previously unreported faster maturation of MAPT mutant human neurons, the developmental expression of 4R tau and the morphological alterations may contribute to disease development."}, {"pubmed": 26237304, "text": "The total tau concentration relates to symptoms of postconcussive disorder"}, {"pubmed": 26258756, "text": "Reduced miR-512 and the elevated expression of its targets cFLIP and MCL1 localize to neurons with hyperphosphorylated Tau protein in Alzheimer disease."}, {"pubmed": 26268594, "text": "LRRK2 facilitates tau phosphorylation indirectly by recruiting tau or cdk5 rather than by directly phosphorylating tau"}, {"pubmed": 26269332, "text": "The human Tau interactome binding to the ribonucleoproteome, to chaperones and the proteasome has been reported."}, {"pubmed": 26297556, "text": "The results strongly suggests that the MAPT c.915 +15 A>C variant is a pathogenic mutation and that it causes frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) in this pedigree by shifting tau transcription to overproduce 4R tau similar to other FTDP-17 mutations."}, {"pubmed": 26303052, "text": "MAPT rs242557 is marginally associated with PD."}, {"pubmed": 26330509, "text": "This article gives a brief history of tau and the current understanding of tau in neurodegenerative diseases."}, {"pubmed": 26333800, "text": "MAPT p.A152T is a rare low penetrance variant associated with Lewy Body Disease."}, {"pubmed": 26373282, "text": "Neural stem cells from patients with the N279K tau mutation displayed impaired endocytic trafficking. Flotillin-1 was significantly increased in frontal and temporal, but not occipital, cortices of PPND/FTDP-17 patients with this mutation."}, {"pubmed": 26381172, "text": "investigated the basic tau protein structure of wild-type (WT) and tau proteins with lysine residues mutation at glutamic residue (Q2K) on tau protein at atomistic scale"}, {"pubmed": 26402096, "text": "Selective identification of ER proteins that associate with tau in Alzheimer's Disease and control brains"}, {"pubmed": 26403791, "text": "This article reviews the current knowledge and hypotheses from relevant studies on tau toxicity, emphasizing the roles of phosphorylations, metal ions, folding and clearance control underlining tau etiology and their regulations. [review]"}, {"pubmed": 26408675, "text": "Studies showed that high tau protein expression is associated with a good prognosis in breast cancer but its predictive value for response to chemotherapy remains uncertain, mostly due to interaction with ER status. [review]"}, {"pubmed": 26426266, "text": "study found a novel mutation (c.1008G>C, p.Q336H) in a patient with Pick disease(PiD); findings indicate p.Q336H mutation in exon 12 of MAPT causes hereditary PiD with neuropathologic, biochemical and clinical phenotype indistinguishable from sporadic PiD"}, {"pubmed": 26444794, "text": "The results of this study suggest that the MAPT H1 haplotype increases the risk of Parkinson's disease (PD),progressive supranuclear palsy , and non-APOE varepsilon4 Late-Onset Alzheimer's Disease."}, {"pubmed": 26473392, "text": "FTD patients with MAPT mutation were younger, and showed more behavioral disinhibition, repetitive and stereotyped behaviours, semantic impairment and temporal predominance of atrophy. MAPT cases had tau pathology."}, {"pubmed": 26534959, "text": "Tat associates with TAU RNA, further demonstrating that Tat interferes with host RNA metabolism in the absence of viral infection."}, {"pubmed": 26538150, "text": "Study showed that the banding patterns of C-terminal fragments of tau are different among different tauopathies, and the trypsin-resistant band patterns are also distinct among the diseases"}, {"pubmed": 26540742, "text": "Results of this study showed that there was no deficit in the performance of the TgTauP301L compared to the wild type mice and there had been no change in the animals' performance compared to at 5-months."}, {"pubmed": 26542680, "text": "These findings suggest an isoform-dependent biological role for regulation by Tau, with longer isoforms conferring microtubule steric stabilization."}, {"pubmed": 26556772, "text": "Results showed that phosphorylated tau is not an exclusive biomarker of neuropathological changes in post-traumatic brain but also a finding in epileptics without a history of repetitive traumatic brain injury"}, {"pubmed": 26576485, "text": "This study demontrated that Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation."}, {"pubmed": 26581847, "text": "transgenic Drosophila models of AD expressing wild-type and mutant forms of hMAPT exhibit a progressive neurodegeneration which was manifested in the form of early death and impairment of cognitive ability"}, {"pubmed": 26601739, "text": "Its genetic variation influences Parkinson disease risk, age of onset, and progression."}, {"pubmed": 26608845, "text": "tau also forms non-toxic insoluble oligomers in vivo in addition to toxic oligomers."}, {"pubmed": 26610265, "text": "Results demonstrate the differential effects of Alzheimer's disease biomarkers p-tau and amyloid-beta on brain functional connectivity networks, supporting a possible division of labour between the cardinal pathologies"}, {"pubmed": 26621125, "text": "Results of the present study demonstrate the influence of extracellular matrix and especially perineuronal nets on dispersion and internalization of exogenously applied Tau-protein"}, {"pubmed": 26655600, "text": "Glycation could modulate Tau phosphorylation and change the protein aggregation property in vitro."}, {"pubmed": 26655856, "text": "Although the can detect and identify some minor conformers in the cis form, they show that all prolines are for over 90% in the trans conformation."}, {"pubmed": 26682901, "text": "CSF biomarkers NFL and T-tau both reflect development of SCI after endovascular aortic repair, but do not rise until after clinical signs of SCI appear"}, {"pubmed": 26701291, "text": "Leptin resistance-induced obesity and diabetes accelerates the development of tau pathology"}, {"pubmed": 26704708, "text": "Results suggest that TauC3 facilitates early memory impairment in transgenic mice accompanied with tau oligomer formation"}, {"pubmed": 26712030, "text": "the structural and dynamic characteristics of transiently evolving protein aggregates and interprotein packing as a function of aggregation time, along the third repeat domain and C terminus of Deltatau187 of human tau, is reported."}, {"pubmed": 26742856, "text": "Data show that targeted high-resolution mass spectrometry (MS)-based strategy can quantify tau in cerebrospinal fluid (CSF) and could be applied to tau monitoring in CSF."}, {"pubmed": 26751493, "text": "Data show increasing evidence that abnormal forms of tau protein are directly involved in the initiation of neurodegenerative processes. [review]"}, {"pubmed": 26751494, "text": "Results show tau deposits with complicated characteristics because of different isoform composition, histopathology, and ultrastructure in various neurodegenerative conditions. [review]"}, {"pubmed": 26751496, "text": "Data show tau protein localized to the nucleus and interacts with the DNA to protect the genome supporting the idea that aberrant modification like in Alzheimer's disease could alter its function and enhance genome vulnerability. [review]"}, {"pubmed": 26776090, "text": "showing that common variants in SNCA and MAPT genes contribute to variability in progression of parkinson disease."}, {"pubmed": 26822478, "text": "Tau inhibits the Eg5 kinesin and cell mitosis."}, {"pubmed": 26824039, "text": "MAPT may play an important role in insulin granule trafficking and indicate the importance of balanced MAPT phosphorylation and dephosphorylation for adequate insulin release."}, {"pubmed": 26837465, "text": "Data support the idea that sequestration of ERalpha by tau protein underlies the loss of estrogen neuroprotection during the course of Alzheimer's disease."}, {"pubmed": 26852117, "text": "Multiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivo."}, {"pubmed": 26876913, "text": "CSF concentrations of T-tau and P-tau in bipolar disorder-mild cognitive impairment patients were similar to those in controls, and significantly lower than those in Alzheimer disease."}, {"pubmed": 26890756, "text": "Results provide evidence that certain tau species are present in peripheral tissues of in Alzheimer's disease; of potential importance, submandibular gland pT231 is progressively less abundant with increasing Braak neurofibrillary tangle stage"}, {"pubmed": 26890779, "text": "Study of topographic distribution of tau and amyloid-beta in a patient with variant Alzheimer's disease with spastic paraparesis by comparing Alzheimer's disease patients, suggests that upper motor neuron dysfunctions may be attributed to excessive abnormal tau accumulation rather than amyloid-beta in the primary motor cortex"}, {"pubmed": 26890785, "text": "Study showed that in clinical practice, extremely high CSF Tau levels are mainly related to diagnosis of Alzheimer's disease. Creutzfeldt-Jakob disease patients represent a minority. Results support a sequential interpretation algorithm for CSF biomarkers in dementia. High CSF Tau levels should alert clinicians to check the p-Tau/Tau ratio to consider a probable diagnosis of Creutzfeldt-Jakob disease."}, {"pubmed": 26903089, "text": "The capacity FKBP52 to oligomerize Tau is not linked to its peptidyl-prolyl isomerase activity."}, {"pubmed": 26916334, "text": "The hTau40(AT) mice mimic pathological hallmarks of tauopathies including a cognitive phenotype combined with pronounced neuroinflammation visible by bioluminescence."}, {"pubmed": 26931567, "text": "In human amyloid precursor protein (hAPP) transgenic mice, co-expression of hTau-A152T enhances risk of early death and epileptic activity, suggesting copathogenic interactions between hTau-A152T and amyloid-beta peptides or other hAPP metabolites."}, {"pubmed": 26931569, "text": "HumanTau(AT) causes excitotoxicity mediated by NR2B-containing NMDA receptors due to enhanced extracellular glutamate."}, {"pubmed": 26940749, "text": "These results indicate that pseudo-acetylation of the single K280 residue is sufficient to exacerbate Tau neurotoxicity in vivo, suggesting that acetylated K280-Tau species contribute to the pathological events leading to neurodegeneration in Alzheimer's disease."}, {"pubmed": 26940799, "text": "Data suggest that an important step in the misfold- ing of Tau is the intramolecular compaction of aggregation-prone regions of Tau. Notably, formation of an intramolecular crosslink between the two native cysteines at position 291 and 322 delays aggregation of Tau, indicating that a specific con- formational change triggers Tau misfolding, while disulfide bond formation locks Tau into an aggregation-incompetent state."}, {"pubmed": 26951396, "text": "Orexin-A is associated with increased phosphorylated P-Tau in normal elderly individuals. Increases in orexin-A and P-Tau might be a consequence of the reduction in the proportion of the deeper, more restorative slow wave sleep and rapid eye movement sleep reported with aging."}, {"pubmed": 26977398, "text": "This study demonstrated that there appears to be a differential pattern of cerebellar atrophy in the major genetic forms of FTD, the area connected via the thalamus to the prefrontal cortex and to the vermis in MAPT."}, {"pubmed": 26984927, "text": "The assay is reproducible across users and works with different commercially available iPSC lines, representing a highly translational tool for the identification of novel treatments against tauopathies, including Alzheimer's disease"}, {"pubmed": 26996940, "text": "Surprisingly, the authors discover that Pin1 does not promote phosphorylated tau-induced microtubule formation in vitro, refuting the commonly accepted model in which Pin1 binding and catalysis on the A180 epitope restores the function of the Alzheimer's associated phosphorylated tau in tubulin assembly."}, {"pubmed": 26996941, "text": "Importantly, site-specific measurements of Pin1-catalysis of CDK2/CycA-phosphorylated full-length tau reveal a number of sites that are catalyzed simultaneously with different efficiencies."}, {"pubmed": 27000837, "text": "tissue-specific downregulation of the Drosophila homolog of human c-myc proto-oncogene (dMyc) suppresses tau-mediated morphological and functional deficits by reducing abnormal tau hyperphosphorylation and restoring the heterochromatin loss."}, {"pubmed": 27003210, "text": "This study supported that BIN1 contributes to the risk of Alzheimer's disease by altering neural degeneration (abnormal tau, brain atrophy and glucose metabolism) but not Abeta pathology"}, {"pubmed": 27023670, "text": "These results suggest that stabilization of microtubule-unbound tau by phosphorylation at Ser262/356 via the PAR-1/MARK may act in the initial steps of tau mismetabolism in AD pathogenesis"}, {"pubmed": 27030011, "text": "This study demonstrates that extracellular vesicles can transmit tau pathology."}, {"pubmed": 27031470, "text": "In 3xTg-AD transgenic mice, carrying three transgenes encoding APPSWE, S1M146V, and TauP301L proteins, accumulation of Abeta triggers an inflammatory environment revealed by the activation of astrocytes, the expression of inflammatory cytokines (TNF-alpha and IL-18), which might be involved in the activation of SAPK/JNK and Cdk5, leading to a sequential hyperphosphorylation of TauP301L as a function of age"}, {"pubmed": 27041503, "text": "findings suggest a novel mechanism by which pathogenic tau causes synaptic dysfunction and cognitive decline in Alzheimer's disease pathogenesis"}, {"pubmed": 27044754, "text": "FRMD4A RNAi or inhibition of cytohesins strongly upregulated secretion of endogenous tau. These results suggest that FRMD4A, a genetic risk factor for late-onset Alzheimer's disease, regulates tau secretion by activating cytohesin-Arf6 signaling."}, {"pubmed": 27061069, "text": "Study shows that the microtubule-associated protein tau H1 haplotype was associated with Parkinson's disease susceptibility."}, {"pubmed": 27080260, "text": "Data show that a homogeneous population of Tau fibrils composed of the truncated version K18 (residues 244-372) gradually converted to a new set of fibril conformers when subjected to multiple cycles of seeding and growth."}, {"pubmed": 27082848, "text": "In the Brazilian population studied, the frequency of GRN mutations was 9.6% and that of MAPT mutations was 7.1%. Among familial cases of FTD, the frequency of GRN mutations was 31.5% and that of MAPT mutations was 10.5%."}, {"pubmed": 27098667, "text": "PD patients homozygous for the H1 haplotype have a higher burden of neocortical LB pathology."}, {"pubmed": 27099072, "text": "our data demonstrate that htau accumulation decreases cell viability and causes degeneration via enhancing mitofusin-associated mitochondrial fusion, which provides new insights into the molecular mechanisms underlying tauopathies."}, {"pubmed": 27100392, "text": "Mutations in tau gene is the genetic causes of frontotemporal lobar degeneration."}, {"pubmed": 27118310, "text": "that the mutant Tau(A152T) induces neuronal dysfunction, morphological alterations in neurons akin to aging phenotype and reduced life-span independently of aggregation"}, {"pubmed": 27129267, "text": "tau inclusions are dynamic structures constantly undergoing \"fission\" and \"fusion,\" which facilitate stable propagation of tau pathology in dividing cells."}, {"pubmed": 27167086, "text": "Study focused functional consequences of human tau accumulation: aging htau mice (deficient of murine tau but express all six human tau isoforms) compared with murine tau knock-out and C57Bl/6J mice; reduced food-burrowing performance was the most robust aspect of the htau phenotype with aging, htau phenotype appeared stronger than the mtau(-/-) phenotype at young ages but milder with aging."}, {"pubmed": 27193083, "text": "Study identified the binding site between tau and fyn-SH3 may facilitate the development of compounds that can inhibit tau-fyn interactions, which presents an alternative therapeutic strategy for Alzheimer's disease; and provide evidence that a physiological correlation between phosphorylated tau at S202, S262, and S396/404 and fyn is not present in Alzheimer's disease brain."}, {"pubmed": 27210553, "text": "Increasing 4R-tau expression without change to total tau in human tau-expressing mice induced more severe seizures and nesting behavior abnormality, increased tau phosphorylation, and produced a shift toward oligomeric tau."}, {"pubmed": 27221467, "text": "MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease."}, {"pubmed": 27226637, "text": "Using deletion mutants, the acidic C-terminal region of alpha-synuclein and the basic central region of Tau were identified as binding regions. Introduction of alpha-synuclein fibrils into cells overexpressing Tau induced Tau aggregation, raising the possibility that alpha-synuclein fibrils interact with Tau, inhibit its function to stabilize microtubules, and also promote Tau aggregation, leading to dysfunction of neu..."}, {"pubmed": 27234211, "text": "Central nervous system (CNS)-derived tau in L1CAM-containing exosomes was characterized extensively in human plasma, including by single molecule array technology with 303 subjects.  In human plasma, tau was explicitly identified within L1CAM exosomes. In contrast to Alzheimer's patients, L1CAM exosomal tau was significantly higher in Parkinson's patients than controls and correlated with cerebrospinal fluid tau."}, {"pubmed": 27255602, "text": "Silencing GSK-3beta may have a positive effect on inhibiting the pathologic progression of Alzheimer disease through down-regulating the level of p-Tau"}, {"pubmed": 27261198, "text": "In fact, DnaJC5 overexpression induced tau release in cells, neurons, and brain tissue, but only when activity of the chaperone Hsc70 was intact and when tau was able to associate with this chaperone."}, {"pubmed": 27277673, "text": "Results find that overexpression of hTau increases intracellular calcium, which in turn activates calpain-2 and induces degradation of alpha4 nAChR."}, {"pubmed": 27298345, "text": "Inhibition of CaN attenuated the hTau-induced CREB dephosphorylation with improved synapse and memory functions."}, {"pubmed": 27311648, "text": "Mutation of MAPT is a common cause of FTD in mainland China."}, {"pubmed": 27312416, "text": "Tau protein, along with amyloidBeta42 and GFAP, were increased in plasma up to 90 days after traumatic brain injury compared with controls."}, {"pubmed": 27336847, "text": "MAPT-AS1 and DNMT1 have been identified as potential epigenetic regulators of MAPT expression in PD across four different brain regions. Our data also suggest that increased MAPT expression could be associated with disease state, but not with PD neuropathology severity."}, {"pubmed": 27338164, "text": "Study demonstrated that tau alteration in P301S mice is sufficient for the formation of Tau-immunopositive nuclear indentations, results also indicate that phosphorylation independent tau antibodies are more suitable when screening for neurons with nuclear indentations and excess tau by monitoring Tau-immunopositive nuclear indentation incidence"}, {"pubmed": 27339073, "text": "Study established a new Alzheimer disease transgenic mouse model (5xfAD mice crossed with Thy-Tau22 transgenic mice) that exhibit a greater than three-fold increase in misfolded and hyperphosphorylated tau, and increased microgliosis, yet decreased amyloid burden. Results suggest that tau-induced increases in microglial number, and phagocytic activity may explain the reductions in amyloid burden."}, {"pubmed": 27357003, "text": "Results suggest that t-Tau protein assay is of significant importance as a second marker in identifying 14-3-3 false-positive results among sporadic Creutzfeldt-Jakob disease probable cases"}, {"pubmed": 27357347, "text": "18F-AV-1451 positron emission tomography can be used to accurately quantify in vivo the regional distribution of hyperphosphorylated tau protein in MAPT mutation carriers."}, {"pubmed": 27383765, "text": "tau isoforms have different propensities to undergo lysine acetylation, with auto-acetylation occurring more prominently within the lysine-rich microtubule-binding repeats"}, {"pubmed": 27389622, "text": "This study demonstrated that transient hypoxia may acutely increase the levels of Abeta42 and T-tau in plasma of healthy adults."}, {"pubmed": 27435172, "text": "Results demonstrate a strong association between progranulin deficiency and reduction of Tau protein expression that could lead to severe neuronal and glial dysfunctions; also indicate that this frontotemporal lobar degeneration (FTLD)-TDP-GRN subgroup could be part as a distinct entity of FTLD classification."}, {"pubmed": 27456536, "text": "oxidative stress changes the dynamic balance between O-linked beta-N-acetlyglucosamine and phosphorylation on tau proteins."}, {"pubmed": 27456607, "text": "This study demostrated that MAPT rs1052553 not association in patient with essential tremor."}, {"pubmed": 27458716, "text": "age and H2 are associated with higher parkinsonism score and decreased total MAPT RNA expression. Additionally, we found that H2 and parkinsonism are associated with altered expression levels of specific isoforms. These findings may contribute to the understanding of the association between MAPT locus and parkinsonism in elderly subjects and in some extent to age-related neurodegenerative diseases."}, {"pubmed": 27459603, "text": "This study for the first time reports the concentration of Tau and p-Tau181 in serum of AD and MCI patients. The cutoff values of Tau and p-Tau181 of AD and MCI patients with sensitivity and specificity reveal that serum level of these proteins can be used as a predictive marker for AD and MCI."}, {"pubmed": 27459671, "text": "our findings suggest that tau is a common downstream factor in both amyloid-dependent and-independent pathogenic mechanisms and therefore could be a more effective drug target for therapeutic intervention in AD."}, {"pubmed": 27460788, "text": "stress granules and TIA-1 play a central role in the cell-to-cell transmission of Tau pathology."}, {"pubmed": 27463540, "text": "Association of human and mouse P-tau with amyloid PrPSc did not diminish survival time following prion infection in these mice. By analogy, human P-tau may not affect prion disease progression in humans."}, {"pubmed": 27466319, "text": "A phosphomimetic mutation S262E within tau microtubule-binding sites impairs EB1/tau interaction. This S262E-tau mutant does not inhibit the formation of EB comets. Our results further show that the parameters of microtubule dynamics change depending on the combined activities of EB1 and tau proteins. Taken together, our data support a novel mechanism by which tau directly regulates EB1 properties at microtubule ends."}, {"pubmed": 27466814, "text": "As in human AD, mature tau pathology in the EC and the presence of tau pathology in the neocortex correlated with cognitive impairment. 3D volume imaging is an ideal technique to easily monitor the spread of pathology over time in models of disease progression"}, {"pubmed": 27520374, "text": "The data suggest that miR-106b inhibits Amyloid-beta (1-42)-induced tau phosphorylation at Tyrosine 18 by targeting Fyn."}, {"pubmed": 27520376, "text": "These results suggest that tau phosphorylation at Ser262 plays the predominant role in tau stabilization when PAR-1/MARK activity."}, {"pubmed": 27521751, "text": "Study reports behavioral changes in P301S mutant tau transgenic mouse, including disinhibition-like behavior in the elevated plus maze and hyperactivity in the open field arena. Neuropathological and behavioral changes in P301S tau transgenic mice resemble features of human frontotemporal dementia."}, {"pubmed": 27529406, "text": "The studies findings indicate that p.E372G is a pathogenic microtubule-associated protein tau mutation that causes microtubule-associated protein tau similar to p.G389R."}, {"pubmed": 27548710, "text": "The data indicate that microtubule-bound tau is resistant to 14-3-3zeta-induced tau aggregation and suggest that tau phosphorylation promotes tau aggregation in the brain by detaching tau from microtubules and thus making it accessible to 14-3-3zeta."}, {"pubmed": 27567921, "text": "In primary-culture fetal astrocytes, streptozotocin increases phosphorylation of Tau at Ser396. alpha-boswellic acid reduced hyperphosphorylated tau (Ser404).  Interruption in astroglial Reelin/Akt/Tau signaling pathways may have a role in Alzheimer disease."}, {"pubmed": 27581842, "text": "According to the flow-related diverging dynamics of blood-derived and brain-derived proteins in CSF, the concentrations of Tau and pTau tended to be lower in lumbar compared to cisternal CSF fractions after a spinal tap of 40 ml. The differences reached statistical significance for pTau only. The small differences will not affect clinical interpretation of markers of dementia in the vast majority of cases"}, {"pubmed": 27582388, "text": "the presence of a C-terminal pseudorepeat region (PRR) greatly increased MT binding by a greater-than-sixfold reduction of the dissociation rate. Bioinformatic analysis revealed that the PRR contained a highly conserved motif of 18 amino acids. Disease-associated tau mutations in the PRR (K369I, G389R) did not influence apparent MT binding but increased its dynamicity."}, {"pubmed": 27594585, "text": "Our findings unmask tau-mediated perturbations of specific pathways associated with neuronal vulnerability, revealing potential early disease biomarkers and therapeutic targets for FTD and other tauopathies."}, {"pubmed": 27594586, "text": "Our studies also provide mechanistic insight into the increased level and activity of secreted MMP-9 in cortical neurons derived from FTD patient-specific iPSCs with MAPT mutations. The increase seems to be mediated by ERK-pathway activation."}, {"pubmed": 27601475, "text": "NO-linked chemical modification on cysteine residues of tau could block tau aggregation, and therefore, increasing 8-nitro-cGMP levels in the brain could become a potential therapeutic strategy for Alzheimer's disease."}, {"pubmed": 27605009, "text": "results show that neuroinflammation promotes neuronal autophagy and that chronic mild TLR4 stimulation attenuates Alzheimer's disease-related tauopathy, likely by activating neuronal autophagy"}, {"pubmed": 27625986, "text": "This study demonstrated that no significant group differences in the total group or the MAPT group at follow-up."}, {"pubmed": 27632209, "text": "a complete screening for mutations in MAPT, GRN and C9ORF72 genes revealed a frequency of 5.4% of pathogenic mutations in a random cohort of 93 Turkish index patients with dementia"}, {"pubmed": 27638048, "text": "the chemical environment of the extracellular matrix as well as localization of distinct glycosaminoglycans may influence deposition behavior of Tau amyloidosis"}, {"pubmed": 27641626, "text": "frontotemporal dementia and parkinsonism linked to chromosome 17 tau with a mutation in the C-terminal region had different banding patterns, indicating a different phosphorylation pattern."}, {"pubmed": 27650389, "text": "Established evidence from the prion field combined with the most recent tau and amyloidogenic protein research suggests that tau is a prion-like protein, capable of seeding the spread of pathology throughout the brain.  [review]"}, {"pubmed": 27662293, "text": "This pilot study using lumbar CSF, the p-tau/t-tau ratio, but not t-TDP-43 levels, were significantly different between FTLD-TDP and FTLD-tau patients."}, {"pubmed": 27662303, "text": "Study found that found tau proteins cross the blood-brain barrier in both the brain-to-blood and blood-to-brain directions. For Tau-410, studyfound a saturable component for the transport into brain. Study found most tau proteins to be stable in blood and brain and that the tau proteins, especially Tau 121-227, are sequestered by brain."}, {"pubmed": 27671197, "text": "Here Multi Walled Carbon Nanotubes are modified and then decorated with the secondary antibody for tau protein."}, {"pubmed": 27697694, "text": "There is a link between regional MAPT expression and selective vulnerability of functional brain networks to neurodegeneration."}, {"pubmed": 27705964, "text": "This study is a reappraisal of the strong association of APOE variability with Alzheimer's dementia in southern India when compared to other dementia groups, while the transcriptional differences between MAPT haplotypes have a limited role in Indian dementia patients."}, {"pubmed": 27709663, "text": "Regions other than the constitutive promoter may be involved in microtubule-associated protein tau gene regulation in tauopathies."}, {"pubmed": 27714074, "text": "our study demonstrated that miR-186 regulates the chemoresistance of NSCLC cells by modulating the MAPT expression level both in vitro and in vivo."}, {"pubmed": 27770234, "text": "The data of this study provided strong evidence that soluble forms of tau and Abeta co-localise early in AD and are closely linked to disease progression and cognitive decline."}, {"pubmed": 27779468, "text": "The authors found that TRIM28 regulates alpha-Synuclein and tau nuclear levels and that its reduction rescues toxicity in animal models of tau- and alpha-Synuclein-mediated degeneration."}, {"pubmed": 27809932, "text": "Study suggests that Tau may contribute to the formation and function of the highly dynamic tunneling nanotubes that may be involved in the prion-like propagation of Tau assemblies."}, {"pubmed": 27814296, "text": "These findings of this study demonstrated that reduced bone mineral density occurs earlier than overt degeneration in a tau-based Alzheimer's Disease model and that pathological changes in tau phosphorylation occur in the serotonin-producing neurons of the brainstem raphe in these mice."}, {"pubmed": 27834536, "text": "The development of NFTs within the cholinergic nucleus basalis neurons could contribute to an axonal disconnection in chronic traumatic encephalopathy."}, {"pubmed": 27840953, "text": "Increased expression levels of MAPT and GRIN3A may lead to the abnormal pathologic condition of nerve tissue in macrodactyly and, to a certain extent, may have potential applications in nerve regeneration."}, {"pubmed": 27859539, "text": "clinicopathologic study shows inter- and intra-familial clinicopathologic heterogeneity of FTDP-17 due to MAPT p.P301L mutation, including globular glial tauopathy in one patient."}, {"pubmed": 27878366, "text": "Study quantified tau seeding activity in fresh-frozen brain samples derived from 40 individuals at different Braak stages, across four brain regions, and detected proteopathic tau seeding activity across specimens more extensively than is typically observed by histopathology or biochemical studies alone."}, {"pubmed": 27890528, "text": "Zn2 + enhances Tau aggregation-induced apoptosis and toxicity in neuronal cells."}, {"pubmed": 27905268, "text": "A 56-year-old patient suffering from frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). The history included a three-generation pedigree and the patient was found to be a MAPT mutation carrier. The diagnosis was hindered by late appearance of the hypokinetic movement disorder."}, {"pubmed": 27908967, "text": "Our data suggest that although (18)F-AV-1451 SUVR curves do not reach a plateau and are still increasing in AD, an SUVR calculated over an imaging window of 80-100 min (as currently used in clinical studies) provides estimates of paired helical filament tau burden in good correlation with BPND, whereas SUVR sensitivity to regional cerebral blood changes needs further investigation."}, {"pubmed": 27911827, "text": "Extracts from tauopathy patient samples, which contain four-repeat (4R) tau prions, were transmitted to HEK293 cells expressing 4R tau fused to YFP. These studies demonstrated that prion propagation in HEK cells requires isoform pairing between the infecting prion and the recipient substrate."}, {"pubmed": 27974162, "text": "Tau forms prion strains that propagate in cells.  Inoculation of PS19 transgenic tau (P301S) mice with these strains causes strain-specific intracellular pathology in distinct cell types and brain regions, and induces different rates of network propagation. In this system, strains alone are sufficient to account for diverse neuropathological presentations, similar to those that define human tauopathies."}, {"pubmed": 28011949, "text": "The presence of tau protein, low BDNF concentrations, and moderate/serious neurological state during the first 24 hours of stroke can be considered as negative prognosis for the patient's functional condition, and the coincidence of high BDNF concentrations and absence of tau in blood during the acute phase of an ischemic stroke is a predictor of patient's good state in 3 months after stroke."}, {"pubmed": 28049840, "text": "when misfolded tau assemblies enter the cell, they can be detected and neutralized via a danger response mediated by tau-associated antibodies and the cytosolic Fc receptor tripartite motif protein 21 (TRIM21)"}, {"pubmed": 28062722, "text": "Elevated plasma tau concentration within 6 hours following a sport-related concussion was related to having a prolonged return to play, suggesting that tau levels may help inform return to play; tau-related changes occur in both sexes, as well as within a variety of sports"}, {"pubmed": 28077166, "text": "Findings implicate a toxic axis of phosphorylation events beginning with Thr175 phosphorylation, dependent on further phosphorylation at Thr231, which appears to be neuron specific and which may be common to the tauopathies."}, {"pubmed": 28100725, "text": "MAPT H1c haplotype (rs242557) has previously been identified as a genetic risk factor for progressive supranuclear palsy and corticobasal degeneration. The current findings suggest that plasma tau concentration could be an endophenotype for identifying risk for 4-repeat tauopathies in older individuals."}, {"pubmed": 28111080, "text": "In a transgenic mouse model expressing mutant human tau predominantly in the EC that the formation of mature tangles in old mice was associated with excitatory cell loss and deficits in grid cell function, including destabilized grid fields and reduced firing rates, as well as altered network activity. Overt tau pathology in the aged mice was accompanied by spatial memory deficits."}, {"pubmed": 28131192, "text": "Study associating lesser motor fluctuations (MFs) and non-motor predominance with cerebrospinal fluid (CSF) tau and CSF Abeta, as well as with timing to, and risk of, dementia in Parkinson's disease (PD). Hence, patients with absent-to-mild MFs had older age at PD onset, higher CSF tau markers and shorter time-to-dementia, whereas those with non-motor predominance had lower CSF Abeta and greater longitudinal dementia-r..."}, {"pubmed": 28157099, "text": "Study detected high levels of both tau and p-tau in dendritic spine of P301L transgenic mice, a model of tauopathy. p-tau correlated with a significant reduction of post-synaptic makers and its levels are higher in female than in male mice: the increased p-tau was consistent with a proportional decrease in the post-synaptic marker levels analyzed. P301L-tg females showed a more severe synaptopathy compared to males."}, {"pubmed": 28202670, "text": "Studies indicate that protein aggregation of alpha-synuclein and microtubule associated protein tau (tau) is intimately linked to the effects of leucine-rich repeat kinase 2 (LRRK2) mutations in Parkinson's disease (PD) brains."}, {"pubmed": 28213439, "text": "common in cognitively normal older adults. However, evidence of pathological effects on episodic memory has largely been limited to beta-amyloid (Abeta). Because Abeta and tau often cooccur in older adults, previous research offers an incomplete understanding of the relationship between pathology and episodic memory."}, {"pubmed": 28236345, "text": "Patients with Kii amyotrophic lateral sclerosis and parkinsonism-dementia complex (Kii ALS/PDC) had dislocated, multinucleated Purkinje cells and various tau pathologies in the cerebellum. These cerebellar abnormalities may provide new insights into the pathomechanism of Kii ALS/PDC and may provide a neuropathological marker for the condition."}, {"pubmed": 28281308, "text": "Study indicates that there are at least two common patterns of TDP-43 and tau protein misfolding in human brain aging. In patients lacking substantial Alzheimer's disease pathology, cerebral age-related TDP-43 with sclerosis (CARTS) cases tend to have tau neurofibrillary tangles in the hippocampal dentate granule neurons, providing a potential proxy indicator of CARTS."}, {"pubmed": 28281838, "text": "Besides being associated with tau pathology, CSF YKL-40 adds to the growing array of biomarkers reflecting distinct molecular brain mechanisms potentially useful for stratifying individuals for biomarker-guided, targeted anti-inflammatory therapies emerging from precision medicine."}, {"pubmed": 28287136, "text": "Study identifies a potential \"two-hit\" mechanism in which tau acetylation disengages tau from microtubules (MT) and also promotes tau aggregation. Thus, therapeutic approaches to limit tau K280/K281 acetylation could simultaneously restore MT stability and ameliorate tau pathology in Alzheimer's disease and related tauopathies."}, {"pubmed": 28322917, "text": "The authors observed that Tau binds tightly to Dolastatin-10 tubulin rings and promotes the formation of Dolastatin-10 ring stacks, implying that Tau can crosslink MT protofilaments laterally."}, {"pubmed": 28334939, "text": "findings are in agreement with the pathology literature, which suggests that tau tangles but not amyloid-beta plaques correlate with cognition and clinical symptoms of early Alzheimers disease patients"}, {"pubmed": 28335005, "text": "TDP-43 suppressed tau expression by promoting its mRNA instability through the UG repeats of its 3-UTR.  Neurodegenerative diseases-causing TDP-43 mutations affected tau mRNA instability differentially, in that some promoted and others did not significantly affect tau mRNA instability.The level of TDP-43, which is decreased in AD brains, was found to correlate negatively with the tau level in human brain."}, {"pubmed": 28402959, "text": "MAPT is associated with risk of neurodegenerative diseases, suggesting crucial roles of tau in neurodegenerative processes."}, {"pubmed": 28413156, "text": "Exposure of the amino terminus of tau protein is a pathological event in multiple tauopathies."}, {"pubmed": 28456996, "text": "Results show that polyethyleneimine and polypeptide arginine significantly inhibit tau peptides and protein aggregation. The study could be applied to understand tau protein aggregation mechanism in the presence of cationic polymers."}, {"pubmed": 28462717, "text": "Screening of MAPT, GRN and CHCHD10 genes in Chinese patients with frontotemporal dementia (FTD) identified about 4.9% mutation carriers. Among the known FTD causative genes tested, MAPT and CHCHD10 play the most important roles in Chinese patients with sporadic FTD."}, {"pubmed": 28482642, "text": "2N4R or 2N3R tau oligomers provoked aggregation of endogenous intracellular tau much more effectively than monomers or fibrils, or of oligomers made from other tau isoforms, and that a mixture of all six isoforms most potently provoked intracellular tau accumulation. These effects were associated with invasion of tau into the somatodendritic compartment."}, {"pubmed": 28487370, "text": "These findings suggest that TDP-43 promotes tau exon 10 inclusion and 4R-tau expression and that disease-related changes of TDP-43, truncations and mutations, affect its function in tau exon 10 splicing, possibly because of TDP-43 mislocalization to the cytoplasm."}, {"pubmed": 28492240, "text": "Tau binds to synaptic vesicles via its N-terminal domain and interferes with presynaptic functions."}, {"pubmed": 28500862, "text": "These data provide evidence that amyloid beta acts to enhance tau pathology by increasing the formation of tau species capable of seeding new aggregates."}, {"pubmed": 28536263, "text": "Data suggest that a presumed diffusion barrier within axon initial segment (AIS) regulates wild-type Tau sorting: retrograde (axon-to-soma) and anterograde (soma-to-axon) sorting of Tau. Tau isoforms without N-terminal inserts are sorted efficiently into axons; a longer isoform (2N4R-Tau) is partially retained in cell bodies/dendrites and accelerates spine/dendrite growth."}, {"pubmed": 28575131, "text": "Dual co-expression of human fetal Tau with PKA in Escherichia coli results in multisite Tau phosphorylation including also naturally occurring sites which were not previously considered in the context of 14-3-3 binding. Tau protein co-expressed with PKA displays tight functional interaction with 14-3-3 isoforms of a different type."}, {"pubmed": 28585125, "text": "An imbalanced regulation in protein kinases and protein phosphatases is the direct cause of tau hyperphosphorylation in Alzheimer's disease; GSK-3beta and PP2A are the most implicated. (Review)"}, {"pubmed": 28587664, "text": "Study describes a protocol to extract and measure tau seeding activity from small volumes (.04 mm(3)) of formaldehyde-fixed tissue immediately adjacent to that used for immunohistochemistry, validated this method with the PS19 transgenic mouse model, and easily observed seeding well before the development of phospho-tau pathology. Also accurately isolated two tau strains, DS9 and DS10, from fixed brain tissues in mice."}, {"pubmed": 28594853, "text": "the influence of the p.A152T MAPT variant on the clinical and neuropathological features of these Basque GRN families, is reported."}, {"pubmed": 28595035, "text": "axonal impairment in temporal lobe epilepsy may be mediated by NMDAR via GSK-3beta and Cdk5. In addition, inhibiting either NMDARs or GSK-3beta lowered the relative tau phosphorylation level by reversing the decrease of total tau without affecting phosphorylated tau S396 and T231."}, {"pubmed": 28634382, "text": "Results found the expression of the exogenous mutant tau protein restricted in medial entorhinal cortex (MEC) at one month in mouse. Its expression induces endogenous tau hyperphosphorylation and accumulation in hippocampus and cortex and inhibits neuronal activity, leading to hippocampus-dependent memory deficit. These data suggest a novel mechanism of early Alzheimer's disease initiated by tau accumulation in MEC."}, {"pubmed": 28636842, "text": "Microtubule associated protein tau (tau) is shown to prefer binding to AT-rich sequence."}, {"pubmed": 28654636, "text": "Data show that cyclophilin 40 (CyP40) interacts with and dissolves amyloids forming proteins tau and alpha-synuclein aggregates."}, {"pubmed": 28678775, "text": "cryo-electron microscopy (cryo-EM) maps at 3.4-3.5 A resolution and corresponding atomic models of paired helical and straight tau filaments from the brain of an individual with Alzheimer's disease"}, {"pubmed": 28689993, "text": "We propose that the H2 haplotype, which expresses reduced 4R tau compared with the H1 haplotype, may exert a protective effect as it allows for more fluid mitochondrial movement along axons with high energy requirements, such as the dopaminergic neurons that degenerate in PD."}, {"pubmed": 28696204, "text": "The authors found that as already shown for oligomeric Abeta, also oligomeric Tau can bind to amyloid precursor protein (APP). Moreover, efficient intra-neuronal uptake of oligomeric Abeta and oligomeric Tau requires expression of APP."}, {"pubmed": 28714390, "text": "A decrease in CDK5 and MAPT gene expression was found in Alzheimer's disease (AD) patients' brains, significant differences were found in CDK5 expression in the hippocampus and the entorhinal cortex. In both cases, mRNA was lower in the AD group); however, the same analysis using the MAPT gene revealed no significant statistical differences."}, {"pubmed": 28734998, "text": "ROS produced by 1,2-diacetylbenzene causes tau hyperphosphorylation via GSK-3beta phosphorylation and it might be related to impaired memory deficit."}, {"pubmed": 28751743, "text": "Frontotemporal dementia patients manifest significant reduction of the GluR3 subunit in the postsynaptic fraction due to autoantibodies along with increased levels of neuronal Tau."}, {"pubmed": 28755476, "text": "The results emphasize an additional level of complexity in the regulation of the interaction between BIN1 and Tau dependent on the BIN1 isoforms."}, {"pubmed": 28760828, "text": "Data suggest that a switch in post-translational processing of Tau from acetylation at Lys321 to phosphorylation at Ser324 coordinately regulates Tau aggregation and may be relevant in tauopathy and Alzheimer disease; acetylation/phosphorylation of Tau appears to be controlled by HDAC6 (histone deacetylase 6 protein)."}, {"pubmed": 28779908, "text": "Study confirmed that Western diet did not exacerbate tau pathology in hTau mice, observed that voluntary treadmill exercise attenuates tau phosphorylation, and reported that caloric restriction seems to exacerbate tau aggregation compared to control and obese hTau mice."}, {"pubmed": 28784767, "text": "Data show that aggregation of the Tau protein correlates with destabilization of the turn-like structure defined by phosphorylation of Ser202/Thr205."}, {"pubmed": 28789904, "text": "The identification of mutations in MAPT, the gene that encodes tau, causing dementia and parkinsonism established the notion that tau aggregation is responsible for the development of disease."}, {"pubmed": 28819043, "text": "Increasing microtubule acetylation rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in Drosophila."}, {"pubmed": 28819146, "text": "The authors identify conditions, where the microtubule-binding repeats of Tau undergo a phosphorylation-dependent liquid-liquid phase separation, leading to molecular crowding in the formed Tau liquid droplets and characterize them by NMR and other biophysical methods."}, {"pubmed": 28827321, "text": "Aha1 colocalized with tau pathology in brain tissue, and this association positively correlated with Alzheimer disease progression."}, {"pubmed": 28833749, "text": "Amyloidogenesis process of Tau protein has been summarized. (Review)"}, {"pubmed": 28841372, "text": "The results indicated that vitamin B12 interacts with tau protein and prevents fibrillization of tau protein. Blocking the cysteine residues of tau confirmed the cysteine-mediated binding of vitamin B12 to tau and showed that binding to cysteine is essential for inhibitory effect of vitamin B12 on tau aggregation."}, {"pubmed": 28842559, "text": "plasma tau is not altered in the examined cohort of subjects at increased risk for AD. In addition, the lack of correlation between tau in plasma and CSF in the examined cohort suggests that tau levels are affected by different factors in both biofluids."}, {"pubmed": 28844006, "text": "Assessed the subcellular localization of tau45-230 fragment using tau45-230-GFP-transfected hippocampal neurons as well as neurons in which this fragment was endogenously generated under experimental conditions that induced neurodegeneration. Results suggested that tau45-230 could exert its toxic effects by partially blocking axonal transport along microtubules, contributing to the early pathology of Alzheimer's disease."}, {"pubmed": 28854366, "text": "deletion or inhibition of the cytoplasmic shuttling factor HDAC6 suppressed neuritic tau bead formation in neurons."}, {"pubmed": 28854881, "text": "Levels of tau correlated with severity and outcome of stroke in both plasma and CSF."}, {"pubmed": 28855586, "text": "The simultaneous pseudo-acetylation of human Tau at lysines 163, 280, 281 and 369 drastically decreased Tau phosphorylation and significantly reduced its binding to microtubules in vivo. These molecular alterations were associated with ameliorated amyloid beta toxicity."}, {"pubmed": 28893863, "text": "The findings reveal the ability of Bin1 to modify actin dynamics and provide a possible mechanistic connection between Bin1 and tau-induced pathobiological changes of the actin cytoskeleton."}, {"pubmed": 28919467, "text": "Comparison of the distributions of tau pTyr18 and double-phosphorylated Syk in the transgenic mouse brain and human hippocampus showed that the phosphorylation of tyrosine 18 in tau already occurs at an early stage of tauopathy and increases with the progression of neurodegeneration. Syk appears unlikely to be a major kinase that phosphorylates tyrosine 18 of tau at the early stage of tauopathy."}, {"pubmed": 28934750, "text": "These findings suggest a relative homogeneous clinicopathological phenotype in P301L MAPT mutation carriers in our series. This phenotype might help in the differential diagnosis from other tauopathies and be a morphological hint for genetic testing. The haplotype analysis results suggest a founder effect of the P301L mutation in this area."}, {"pubmed": 28947735, "text": "Tau depletion impairs the survival of CDA-deficient cells by favoring cellular DNA damage and replication stress."}, {"pubmed": 28947837, "text": "CSF tau proteins and their index differentiated between Alzheimer's disease or other dementia patients and cognitively normal subjects, while CSF levels of neurofilaments expressed as their index seem to contribute to the discrimination between patients with neuroinflammation and normal controls or AD patients"}, {"pubmed": 28974363, "text": "Study showed a gradual accumulation of nuclear tau in human cells during aging and its general co-localization with the DAPI-positive heterochromatin, which seems to be related to aging pathologies (neurodegenerative or cancerous diseases), where nuclear AT100 decreases drastically, a condition very evident in the more severe stages of the diseases."}, {"pubmed": 28974731, "text": "We suggest that these new MAPT isoforms can be translated into normal or amino-terminal-truncated tau proteins. We further suggest that activation of MAPT's alternative promoter under pathological conditions leads to the production of truncated proteins, changes in protein localization and function, and thus neurodegeneration."}, {"pubmed": 28984110, "text": "more selective group of neurons appears to be affected in frontotemporal lobar degeneration (FTLD)-TDP and FTLD-FUS than in FTLD-tau"}, {"pubmed": 28986260, "text": "Investigated the role of membrane surface charge on the binding affinity of individual tau repeat segments, and whether these segments exhibit lytic activity. While neutral membranes exhibited weak interactions with each tau repeat segment, segments R2 and R3 exhibited relatively strong binding with anionic membranes with favorable entropy and a negative value of specific heat capacity."}, {"pubmed": 29021554, "text": "although chronic and abundant expression of TAU(P301L) starting from early embryonic development led to hyperphosphorylation, TAU(P301L) did not form oligomers and neurofibrillary tangles, and did not cause elevated apoptosis and microglial activation."}, {"pubmed": 29022701, "text": "Furthermore, we describe how a variety of transgenic animal strains, each with distinct utility, have been used to identify both genetic and pharmacological modifiers of toxicity in C. elegans. [review]"}, {"pubmed": 29039655, "text": "atomic force microscopy reveal that full length human tau, when assembled into dense surface-bound layers, can participate in attractive electrostatic interactions consistent with the previously reported dimerization model. However, modulating the ionic strength of the surrounding solution can change the structure of these layers to produce purely repulsive interactions consistent with a polyelectrolyte brush structure."}, {"pubmed": 29042562, "text": "Cis phosphorylated tau (cis P-tau) is induced in cortical axons and cerebrospinal fluid and positively correlates with axonal injury and clinical outcome."}, {"pubmed": 29044200, "text": "These data suggest that CK1epsilon is involved in the regulation of tau phosphorylation, the alternative splicing of tau exon 10, and cognitive performance. Up-regulation of CK1epsilon might contribute to tau pathology by hyperphosphorylating tau and by dysregulating the alternative splicing of tau exon 10 in AD."}, {"pubmed": 29053786, "text": "Insulin is accumulated and retained as oligomers in hyperphosphorylated tau-bearing neurons in Alzheimer's disease and in several of the most prevalent human tauopathies."}, {"pubmed": 29062035, "text": "CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease"}, {"pubmed": 29076559, "text": "The results of the current study indicate that variations in microtubule-associated protein tau influence cognition in progressive supranuclear palsy."}, {"pubmed": 29082658, "text": "Cognitive impairment in progressive supranuclear palsy is associated with severity of progressive supranuclear palsy-related tau pathology."}, {"pubmed": 29084565, "text": "We identified common splice factors hnRNP F and hnRNP Q regulating the haplotype-specific splicing of MAPT exon 3 through intronic variants rs1800547 and rs17651213"}, {"pubmed": 29098924, "text": "MAPT rs242557G/A genetic polymorphism is associated with susceptibility to sporadic AD, and individuals with a GG genotype of rs242557G/A might be at a lower risk."}, {"pubmed": 29100980, "text": "Patients with diffuse Lewy body disease had more severe pathology of each type and a shorter duration of illness than individuals with transitional Lewy body disease. The three pathologies accounted for 25% of the total variance of duration of illness, with 19% accounted for by alpha-synuclein alone or in combination with tau and Abeta."}, {"pubmed": 29126968, "text": "evidence that JNK signaling pathway is an upstream regulator of hyperosmotic stress-induced Tau cleavage and apoptosis in SH-SY5Y through the control of caspase-3 activation."}, {"pubmed": 29138281, "text": "we show that important downstream pathways, including autophagy and the unfolded protein response, are coregulated with neurotoxicity and actin cytoskeletal stabilization in brains of flies expressing wild-type human and various FTDP-17 tau mutants, supporting a conserved mechanism of neurotoxicity of wild-type tau and FTDP-17 mutant tau in disease pathogenesis"}, {"pubmed": 29153990, "text": "We find that both the generation of Abeta and the responsiveness of TAU to A-beta are affected by neuronal cell type, with rostral neurons being more sensitive than caudal neurons."}, {"pubmed": 29162800, "text": "Report that the interaction of Tau with vesicles results in the formation of highly stable protein/phospholipid complexes. These complexes are toxic to primary hippocampal cultures and are detected by MC-1, an antibody recognizing pathological Tau conformations. The core of these complexes is comprised of the PHF6* and PHF6 hexapeptide motifs, the latter in a beta-strand conformation."}, {"pubmed": 29190730, "text": "findings suggest that elevated plasma t-tau levels reflect AD pathology and therefore have potential as an objective biomarker to detect dementia in adult DS"}, {"pubmed": 29207020, "text": "These observations indicate the ability of QUE to decrease tau protein hyperphosphorylation and thereby attenuate the associated neuropathology... these results support the potential of QUE as a therapeutic agent for AD and other neurodegenerative tauopathies."}, {"pubmed": 29259137, "text": "P301L and S320F mutation of Tau showed robust protein aggregation."}, {"pubmed": 29282277, "text": "defects in MAPT lead to aberrant mitotic spindle function, abnormal chromosome segregation, and apoptosis"}, {"pubmed": 29282296, "text": "Inhibition of galectin-8- and NDP52-dependent autophagy increased seeded tau aggregation."}, {"pubmed": 29298892, "text": "Data suggest that both the small heat shock protein HspB1/Hsp27 and the constitutive chaperone Hsc70/HspA8 interact with tau to prevent tau-fibril/amyloid formation. Chaperones from different families play distinct but complementary roles in prevention of tau-fibril/amyloid formation. (HspB1 = heat shock protein family B small member 1; Hsc70 = heat shock protein family A Hsp70)"}, {"pubmed": 29353234, "text": "found that compared with family control subjects, preclinical MAPT mutation carriers had a lower incidence of DSM-defined major depressive disorder and anxiety disorders, but a higher incidence of depressive symptoms that did not fit DSM criteria for major depressive disorder."}, {"pubmed": 29358399, "text": "High tau expression is associated with blood vessel abnormalities and angiogenesis in Alzheimer's disease."}, {"pubmed": 29370822, "text": "Dominance of 4R over three-repeat (exon 10-) tau isoforms contrasts with earlier reports of R406W patients and was not sufficiently explained by the presence of H1/H2 haplotypes in two of the autopsied patients. R406W patients often show a long course of dementia with marked memory deficits. Both neuropathological results and imaging findings revealed that the ventromedial temporal lobes were extensively affected."}, {"pubmed": 29382714, "text": "Data suggest that an eleven-amino acid sequence (18-28) unique to extreme N-terminus of TAU from humans and non-human primates is linked to differential interactions of TAU with a small subset of partners in cortical nerve tissue (here, cell lysates from Tau knockout mice)."}, {"pubmed": 29440563, "text": "AV-1451 has unique binding properties for Alzheimer disease (AD)-like tau pathology in vivo among MAPT mutation carriers. Tau PET imaging with AV-1451 demonstrated different binding intensities for MAPT carriers with mutations known to form primarily pathologic aggregates composed of 4R tau isoforms relative to mutations that are known to produce AD-like mixed 3R/4R isoform aggregates."}, {"pubmed": 29508283, "text": "a 2.0-kDa peptide which biochemically and immunologically resembles the injected amino terminal tau 26-44 was endogenously detected in vivo, being present in hippocampal synaptosomal preparations from Alzheimer's disease subjects."}, {"pubmed": 29571875, "text": "This study showed that Pathogenic mutations in the microtubule-associated protein tau gene were not found using two single nucleotide polymorphisms in patient with chronic progressive degenerative parietal ataxia."}, {"pubmed": 29574628, "text": "genetic manipulation of Sirt3 revealed that amyloid-beta increased levels of total tau acetylated tau through its modulation of Sirt3."}, {"pubmed": 29584657, "text": "Because neurofibrillary tangles are aberrant intracellular inclusions formed in the AD patients by hyperphosphorylated tau, it was initially proposed that phosphorylated and/or aggregated intracellular tau protein was causative of neuronal death. However, recent studies suggest a toxic role for non-phosphorylated and non-aggregated tau when it is located in the brain extracellular space. [review]"}, {"pubmed": 29630971, "text": "Solven ionic strength, temperature and polarity altered tau conformation dynamics."}, {"pubmed": 29634760, "text": "MAPT alternative splicing is associated with Neurodegenerative Diseases."}, {"pubmed": 29644863, "text": "TAU attaches to brain lipid membranes where it self-assembles in a cation-dependent manner."}, {"pubmed": 29684490, "text": "Study demonstrated the presence of the smaller Tau isoform (352 amino acids), whose amount increases in differentiated SK-N-BE cells, with Tau-1/AT8 nuclear distribution related to the differentiation process."}, {"pubmed": 29686045, "text": "We found amyloid measures to be sensitive early on in predicting subsequent early tau deposition"}, {"pubmed": 29704492, "text": "Data show that the formation of early heterotypic oligomeric complex of alpha-syn and tau K18 can promote maturation into fibrils through binding-induced misfolding and aggregation. These results suggest that the alpha-syn:tau ratio critically governs the rate of the amyloid formation. alpha-Syn and tau K18 together aggregate at a much faster rate with a much shorter lag phase compared to the individual proteins."}, {"pubmed": 29705343, "text": "Methamphetamine can impair the endoplasmic reticulum-associated degradation pathway and induce neuronal apoptosis through endoplasmic reticulum stress, which is mainly mediated by abnormal CDK5-regulated Tau phosphorylation."}, {"pubmed": 29729314, "text": "Study reports the identification of new bona fide human brain circular RNAs produced from the MAPT locus."}, {"pubmed": 29734651, "text": "Our data show that the hyperacetylation of Tau by p300 histone acetyltransferase (HAT) disfavors liquid-liquid phase separation , inhibits heparin-induced aggregation, and impedes access to LLPS-initiated microtubule assembly"}, {"pubmed": 29740938, "text": "The study reviewed two congenital myotonic dystrophy type 1 patients, with a case showing severe cognitive dysfunction and atypical pathology associated with predominant 4-repeat tauopathy. The exact mechanism of 4-repeat tau dominancy is not yet known."}, {"pubmed": 29756641, "text": "This study demonstrated that MAPT-H2 variants were associated with PD (odds ratios: 0.62-0.65; P = 0.010-0.019), but not with rapid eye movement sleep behavior disorder."}, {"pubmed": 29768194, "text": "Synaptic dysfunction caused by presenilin-1 mutant and amyloid precusor protein duplication secretomes is mediated by Abeta peptides, whereas trisomy of chromosome 21 (trisomy 21) neuronal secretomes induce dysfunction through extracellular tau."}, {"pubmed": 29793546, "text": "This study demonstrated that the Presymptomatic MAPT carriers showed greater atrophy in the medial temporal region in patient with Frontotemporal Dementia than control subjects."}, {"pubmed": 29794074, "text": "Study reports that the risk of developing cancer is significantly higher in families affected by genetic tauopathies, and a high proportion of tau protein interactors are involved in cellular processes particularly relevant to cancer. These findings disclose a novel role of tau as a risk factor for cancer, providing new insights in the various pathologic roles of mutated tau."}, {"pubmed": 29849029, "text": "A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment"}, {"pubmed": 29852407, "text": "Study found that FTDP-17 mutations enhance tau oligomer formation and that P301L tau oligomers form smaller tau oligomers than wilt type, V337M, and R406W oligomers."}, {"pubmed": 29865854, "text": "BDNF and Tau as biomarkers of severity in multiple sclerosis"}, {"pubmed": 29874575, "text": "These results implicate transposable element activation and associated genomic instability in Tau-mediated Alzheimer's disease mechanisms."}, {"pubmed": 29883958, "text": "To confirm the neuroprotective role of 24-OH, in vivo experiments were run on mice that express human tau without spontaneously developing tau pathology (hTau mice), by means of the intracerebroventricular injection of 24-OH."}, {"pubmed": 29889066, "text": "This study showed that the MAPT mutation in Frontotemporal Dementia had the most atrophic hippocampi, with the subfields showing the largest difference from controls."}, {"pubmed": 29912295, "text": "Findings indicate that in normal aging, low levels of tau are associated with a phase of increased metabolism, while high levels of tau in the presence of amyloid-beta are associated with hypometabolism at downstream sites."}, {"pubmed": 29982754, "text": "High Levels of Phosphorylated Tau is associated with Neurocognitive Sequelae in Adult Childhood Leukemia Survivors."}, {"pubmed": 30001506, "text": "Review of recent advances on tau in the dendritic compartments, with implications for understanding and treatment of AD and related neurological conditions. [Review Article]"}, {"pubmed": 30001606, "text": "In vitro neuroprotective effects of naringenin nanoemulsion against beta-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation."}, {"pubmed": 30006151, "text": "Data suggest that tau may directly participate in the pathophysiology of mitochondria-related activities by interfering with ER-mitochondria communication, reinforcing the concept that an early involvement of mitochondrial dysfunctions, Ca2+ dyshomeostasis and ER-mitochondria Ca2+ cross-talk impairment might have a role in the pathogenesis of Alzheimer's disease."}, {"pubmed": 30010122, "text": "The MAPT mutation of Frontotemporal Dementia, the main significant areas were in the temporo-parietal and frontal lobes as well as bilateral cuneus."}, {"pubmed": 30021167, "text": "CIP2A-mediated PP2A inhibition drives tau/APP hyperphosphorylation and increases APP beta-cleavage and Abeta production."}, {"pubmed": 30024984, "text": "Full-length Tau when cross-seeded in the presence of polyglutamate with amyloid seeds obtained de novo from its two fragments: K18 and K18DeltaK280 converts into daughter fibrils whose only initial generations are controlled by the conformational memory effect. In the following rounds of seeding, the phenotypes carried by mother seeds \"lose\" to the phenotype that emerges spontaneously in FL Tau fibrils self-assembling ..."}, {"pubmed": 30079475, "text": "Results indicate that the trans isomer of microtubule associated protein tau (Tau) peptide is aggregation-prone and that the WW domain of peptidyl-prolyl-isomerase Pin1 (Pin1) effectively inhibits its aggregation."}, {"pubmed": 30103978, "text": "Bred hemizygous mice that express P301L tau (TauP301L) and detected hyper-phosphorylated tau (p-tau) predominantly in the hippocampus, cortex, brainstem and thalamus. (13)C/(1)H MRS reveals astrocytic dysfunction via reduced glial aspartate and impaired glutamate-glutamine cycle. An increase in glutamate and GABA and decrease in glutamine were observed in homozygous mice compared to hemizygous and control littermates."}, {"pubmed": 30106598, "text": "4',6-diamidino-2-phenylindole (DAPI) staining was positive in 3R/4R (3-repeat/4-repeat) tau deposits in Alzheimer's disease, myotonic dystrophy, and neurodegeneration with brain iron accumulation, and in 4R tau deposits in corticobasal degeneration, but negative in 4R tau deposits in frontotemporal dementia with parkinsonism-17 and progressive supranuclear palsy."}, {"pubmed": 30111714, "text": "This article presents key studies of tau in oligodendrocytes and select important studies of tau in neurons. The extensive work on tau in neurons has considerably advanced the understanding of how tau promotes either health or disease.  [review]"}, {"pubmed": 30142893, "text": "Microtubule hyperacetylation enhances KL1-dependent micronucleation under a Tau deficiency in mammary epithelial cells."}, {"pubmed": 30158706, "text": "findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers"}, {"pubmed": 30179693, "text": "It was revealed that Al2O3 NPs bind to tau protein and form a static complex and fold the structure of tau toward a more packed structure. Molecular docking and molecular dynamic investigations revealed that NPs bind to the hydrophilic residues of the tau segments and promote some marginal structural folding of tau segment"}, {"pubmed": 30232451, "text": "results show that senescent cells have a role in the initiation and progression of tau-mediated disease, and suggest that targeting senescent cells may provide a therapeutic avenue for the treatment of these pathologies"}, {"pubmed": 30242125, "text": "EPR analysis indicated that fibrils seeded with truncated and mutated Tau, but not htau40, are structurally disordered in the second half of repeat four and onward. These findings suggest that the disorder in this region diminishes the ability of 4R Tau fibrils to recruit 3R Tau monomers, revealing a new mechanism for Tau cross-seeding barriers."}, {"pubmed": 30252906, "text": "Among hip fracture patients, 88.6% of the cognitively normal (Clinical Dementia Rating-CDR 0; n = 70) and 98.8% with mild cognitive impairment (CDR 0.5; n = 81) fell in the abnormal biomarker categories by CSF Abeta42/40 ratio, p-tau, and t-tau measures."}, {"pubmed": 30257460, "text": "Abnormal filamentous aggregates that are formed by tangled tau protein turn out to be classic amyloid fibrils, meeting all the criteria defined under the fuzzy oil drop model in the context of amyloid characterization. The model recognizes amyloids as linear structures where local hydrophobicity minima and maxima propagate in an alternating manner along the fibril's long axis."}, {"pubmed": 30329219, "text": "These results indicate that MAPT haplotype-tagging polymorphisms and MAPT haplotypes should be further tested as potential genetic biomarkers of AD."}, {"pubmed": 30339920, "text": "data suggest that H1/H2 MAPT haplotype is not a risk factor to Parkinson Disease in Mexican mestizo population."}, {"pubmed": 30365112, "text": "Abeta and tau may be considered as novel biomarkers of sleep disorder in AD pathology, and that they function by regulating the expression levels of orexin A and adenosine A1R."}, {"pubmed": 30374196, "text": "This study reveals distinct genetic profiles that may confer vulnerability to tau and amyloid beta in vivo propagation in the human brain."}, {"pubmed": 30394813, "text": "Increased MAPT expression correlated with increased overall survival in pediatric neuroblastomas."}, {"pubmed": 30423399, "text": "Study shows that phosphorylation of serine 305 in tau inhibits aggregation."}, {"pubmed": 30425303, "text": "Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression"}, {"pubmed": 30442948, "text": "Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology."}, {"pubmed": 30458895, "text": "Cognitive dysfunction of preclinical behavioral variant frontotemporal dementia in MAPT carriers."}, {"pubmed": 30526844, "text": "Seed competent tau monomer thus adopts multiple, stable seed-competent conformations, each of which encodes a limited number of strains."}, {"pubmed": 30535461, "text": "Analysis of RNASeq data representing samples from the Cancer Genome Atlas revealed that high expression of the MAPT gene is very strongly associated with increased overall and diseasefree survival in lowgrade glioma but not in breast cancer or melanoma."}, {"pubmed": 30546007, "text": "Study demonstrates that MAPT p.R406W is sufficient to induce changes in GABA-mediated signaling and synaptic function, which may contribute to the pathogenesis of frontotemporal lobar degeneration with tau and other primary tauopathies."}, {"pubmed": 30554614, "text": "In an survey of South African rugby players, the tau rs2435200 AA genotype was significantly associated with reduced susceptibility to concussion, while the rs2435200 AG genotype was associated with increased susceptibility of sustaining multiple concussions."}, {"pubmed": 30556160, "text": "miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3beta in Alzheimer's disease."}, {"pubmed": 30563962, "text": "Study found that higher tau pathology in the right entorhinal cortex was associated with more frequent feelings of lacking companionship, feeling left out or feeling isolated."}, {"pubmed": 30566579, "text": "Comparison of Amyloid beta and Tau Spread Models in Alzheimer's Disease."}, {"pubmed": 30573872, "text": "All seven Huntington's disease patients showed presence of neuronal microtubule associated protein tau (tau) pathology."}, {"pubmed": 30590647, "text": "These data support a role for phosphorylation of the variant threonine in A152T tau toxicity and suggest a mechanism involving impaired retrograde axonal transport contributing to human neurodegenerative disease."}, {"pubmed": 30606258, "text": "A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response."}, {"pubmed": 30644730, "text": "Lithium treatment inhibits cis p-tau formation, resulting in diminished cell death. Bipolar Disorder and healthy human brain samples and detected cis p-tau in the patients' brains. Results show that tauopathy, observed in bipolar disorder, is being mediated through cis p-tau and that a conformer could be the cause of neurodegeneration upon the disease."}, {"pubmed": 30659115, "text": "Tau regulates the microtubule-dependent migration of glioblastoma cells via the Rho-ROCK signaling pathway."}, {"pubmed": 30668577, "text": "report novel data using affinity chromatography analysis indicating that the sequence containing tau residues 18 to 28 acts a binding motif for End Binding proteins and that this interaction could facilitate tau secretion to the extracellular space"}, {"pubmed": 30674342, "text": "Providing new insight into the role of A152T in modifying risk of tauopathy, as well as validating the TauA152T-AAV model, we demonstrate that the presence of soluble pT153-positive tau species in human postmortem brain tissue differentiates A152T carriers from noncarriers, independent of disease classification."}, {"pubmed": 30679382, "text": "the sleep-wake cycle regulates interstitial fluid (ISF) , and sleep deprivation increases ISF and CSF tau as well as tau pathology spreading."}, {"pubmed": 30708351, "text": "rs242557 risk variant correlated with increased hippocampus tau deposition in non-demented elders"}, {"pubmed": 30718279, "text": "Heat shock protein 104 (HSP104) chaperones soluble Tau via a mechanism distinct from its disaggregase activity."}, {"pubmed": 30742061, "text": "Mutations in the MAPT gene that encodes tau can cause frontotemporal dementia with parkinsonism linked to chromosome 17, providing the clearest evidence that tauopathy plays a causal role in neurodegeneration. [review]"}, {"pubmed": 30745358, "text": "These results indicate that tau filament ends engage in a range of homotypic interactions involving monomers, oligomers, and filaments. They further indicate that, in the case of tau protein, fibril annealing and fragmentation along with primary nucleation and elongation are the major processes controlling filament size distribution."}, {"pubmed": 30783169, "text": "Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity."}, {"pubmed": 30792413, "text": "Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein."}, {"pubmed": 30793898, "text": "The disease-causing +19G mutation in the tau pre-mRNA exon 10 5' splice site hairpin causes a significant structural rearrangement in the bottom stem. This change in hairpin structure results in enhanced hairpin top stem stability, which leads to a decreased level of exon 10 inclusion."}, {"pubmed": 30809933, "text": "Tau overexpression impairs neuronal endocytosis by decreasing the GTPase dynamin 1 through the miR-132/MeCP2 pathway."}, {"pubmed": 30853336, "text": "findings unravel the essential molecular features of aggregation-resistant tau conformer. Therapeutics stabilizing such conformers in vivo might be of high benefit in arresting tau assembly during AD and other tauopathies."}, {"pubmed": 30882841, "text": "Multiple association signals at the chromosome 17 MAPT locus are implicated in the possible cause of tauopathy."}, {"pubmed": 30893702, "text": "MAPT mutations can cause amyotrophic lateral sclerosis"}, {"pubmed": 30894745, "text": "structures of tau filaments from the brains of three individuals with CTE at resolutions down to 2.3 A, using cryo-electron microscopy"}, {"pubmed": 30901365, "text": "Study provide evidence that increased serum level of TAU protein may be a useful biomarker for diagnosis of diffuse axonal injury (DAI) in the early phase of traumatic brain injury (TBI)."}, {"pubmed": 30922360, "text": "oligomeric Abeta strongly increased AT8 and AT180 phosphorylation of tau and caused a loss of dendritic spines."}, {"pubmed": 30936201, "text": "These results reveal that the sequestration of cytoplasmic molecular chaperones by tau aggregates interferes with two arms of the proteostasis network, likely having profound negative consequences for cellular function."}, {"pubmed": 30947113, "text": "Relationship between baseline CSF Abeta1-42 and tau accumulation was strongest in APOEepsilon4 carriers."}, {"pubmed": 30986567, "text": "Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein."}, {"pubmed": 30992433, "text": "BIN1 rs744373 SNP is associated with increased tau but not beta-amyloid pathology, suggesting that alterations in BIN1 may contribute to memory deficits via increased tau pathology"}, {"pubmed": 31004914, "text": "Study showed that tau accumulation and atrophy presented different regional patterns in atypical Alzheimer disease, with tau spreading into the frontal lobes while atrophy remains in temporoparietal and occipital cortex, suggesting a temporal disconnect between protein deposition and neurodegeneration."}, {"pubmed": 31016584, "text": "HIV and Alzheimer's disease: complex interactions of HIV-Tat with amyloid beta peptide and Tau protein."}, {"pubmed": 31036717, "text": "evidence indicating that the acetylation mimicking mutation (K274Q) induced conformational changes in tau. The results suggested that the acetylation of tau at 274 residues can increase tau aggregation and enhance the cytotoxicity of tau oligomers."}, {"pubmed": 31043574, "text": "Individuals over 80 years of age had the lowest amounts of prion-like Abeta and phosphorylated tau."}, {"pubmed": 31059154, "text": "MAPT duplication as a possible genetic cause of progressive supranuclear palsy, especially in patients presenting with young age at onset"}, {"pubmed": 31068482, "text": "Findings indicate that former athletes with multiple concussions are at increased risk of elevated levels of CSF t-tau and that high CSF t-tau is associated with reduced white matter integrity and worse scores on the trail making test Part B."}, {"pubmed": 31085626, "text": "These findings indicate that hTau accumulation impairs synaptic plasticity through JAK2/STAT1-induced suppression of NMDAR expression, revealing a novel mechanism for hTau-associated synapse and memory deficits."}, {"pubmed": 31086391, "text": "there is an increase in CSF Abeta42 early in Alzheimer's disease before its decline while tau pathology progresses; this pattern is particularly observed in non-APOE4 subjects"}, {"pubmed": 31115229, "text": "Beta-amyloid peptide(1-42) (Abeta1-42) : phosphorylated Tau (p-Tau) ratio has potential for being implemented in the clinical routine for differential diagnosis between AD and other dementias and to distinguish underling pathology such as neurodegenerative disease."}, {"pubmed": 31118310, "text": "Age-related hearing loss was associated with elevated cerebrospinal fluid tau levels."}, {"pubmed": 31189515, "text": "Described is a new role for N-terminal human tau region comprising residues 16 to 26.  That region is present in human Tau but not in mouse or rat Tau. Tau N-terminal end is a binding site for creatine Kinase B."}, {"pubmed": 31201283, "text": "These findings strongly suggest a role for the tau-SHP2 interaction in nerve growth factor-stimulated neuronal development and in Alzheimer's disease."}, {"pubmed": 31211444, "text": "Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease."}, {"pubmed": 31217043, "text": "No associations were identified between MAPT haplotype and Alzheimer's disease, mild cognitive impairment, amyotrophic lateral sclerosis, frontotemporal dementia, Parkinson's disease, or vascular cognitive impairment."}, {"pubmed": 31223056, "text": "MAPT/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration."}, {"pubmed": 31234228, "text": "The rare H1j haplotype was significantly associated with a lower dorsolateral putaminal tyrosine hydroxylase immunoreactivity and therefore greater dopaminergic degeneration compared to other microtubule-associated protein tau haplotypes"}, {"pubmed": 31257249, "text": "Abnormal proteins such as tau or alpha-synuclein that accumulate in brains with dementia have been shown to propagate like prion proteins."}, {"pubmed": 31261380, "text": "Results report the creation of a novel model of tauopathy by combining the frontotemporal dementia (FTD)-associated P301L tau and Pick's disease (PiD)-associated S320F tau variants that leads to accelerated neurofibrillary tangles pathology and early behavioral deficits. Also, overexpression of wild-type tau as well as an FTD-associated tau variant can lead to cognitive deficits even in the absence of tangles."}, {"pubmed": 31263146, "text": "BIN1 favors the spreading of Tau via extracellular vesicles."}, {"pubmed": 31266806, "text": "tau promotes the formation/stabilization of intermediate states in microtubule assembly and disassembly by promoting both longitudinal and lateral tubulin-tubulin contacts."}, {"pubmed": 31266957, "text": "Lysine-rich variants of the Alzheimer's disease-linked protein tau undergo coacervation with RNA in vitro and bind to stress granules in cells."}, {"pubmed": 31271449, "text": "findings demonstrate that plasma total-tau relates to the risk of stroke in a community sample."}, {"pubmed": 31273083, "text": "The pathological human Mtapt interacts better with human Mtapt than with murine Mtapt, suggesting species-specific differences between these orthologous pathogenic proteins."}, {"pubmed": 31291489, "text": "Higher levels of tau (MAPT Protein, Human) in the peripheral blood plasma of service members and veterans with concurrent Mild Traumatic Brain Injury and PTSD provides insights into the possible links between mTBI and the increased neurobiological effects of PTSD."}, {"pubmed": 31300647, "text": "Deep whole-exome sequencing in postmortem hippocampal formation and matched blood samples from patients with Alzheimer's disease (AD) and 11 individuals not affected by AD show that a pathogenic brain somatic mutation in PIN1 leads to a loss-of-function mutation. In vitro mimicking of haploinsufficiency of PIN1 aberrantly increases tau phosphorylation and aggregation."}, {"pubmed": 31306137, "text": "Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease."}, {"pubmed": 31315971, "text": "Frontal lobe neurochemical alterations measured with (1)H MRS precede the symptom onset in MAPT mutation carriers."}, {"pubmed": 31336382, "text": "Platelet Amyloid-beta Protein Precursor (AbetaPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease."}, {"pubmed": 31350262, "text": "CSF phosphorylated tau concentrations specifically predicted amyloid deposition in healthy elderly and a subsequent decline in cognitive status."}, {"pubmed": 31358058, "text": "A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients."}, {"pubmed": 31358628, "text": "These results have significant implications for the structure and dynamics of 4R tau fibrils in vivo."}, {"pubmed": 31362787, "text": "Results indicate an association between Deltatau314 and dementia in Lewy body disease. Cleavage of tau by Casp2 promotes the mislocalization of tau to dendritic spines leading to a reduction in postsynaptic AMPA receptors and excitatory neurotransmission, which suggests a mechanism of the synaptic dysfunction underlying cognitive impairment in Lewy body disease."}, {"pubmed": 31382178, "text": "The development of seizures in patients with Alzheimer's disease was associated with higher CSF total tau protein levels."}, {"pubmed": 31396860, "text": "Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal Dementia."}, {"pubmed": 31423763, "text": "Spontaneous Rupture and Entanglement of Human Neuronal Tau Protein Induced by Piconewton Compressive Force."}, {"pubmed": 31439664, "text": "Tau's interactions with the cell membrane serves as a toxicity pathway and enhance fibrillation into paired helical filaments."}, {"pubmed": 31454761, "text": "HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease."}, {"pubmed": 31456031, "text": "Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology."}, {"pubmed": 31462746, "text": "Dynamical decoration of stabilized-microtubules by Tau-proteins."}, {"pubmed": 31518613, "text": "we show in vitro that UBE2W can modify the N-terminus of both a-synuclein and a tau tetra-repeat domain with a single ubiquitin. We demonstrate that an engineered N-terminal ubiquitin modification changes the aggregation process of both proteins, resulting in the formation of structurally distinct aggregates"}, {"pubmed": 31530263, "text": "Molecular Links Between Alzheimer's Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection Involvement."}, {"pubmed": 31541019, "text": "Higher CSF Tau Levels Are Related to Hippocampal Hyperactivity and Object Mnemonic Discrimination in Older Adults."}, {"pubmed": 31542321, "text": "Extracellular recordings revealed that the V337M tau mutation leads to an abnormal increase in neuronal activity in response to chronic depolarization. In neurons with this mutation, axon initial segment (AIS) plasticity is impaired by the abnormal accumulation of end-binding protein 3 (EB3) in the AIS submembrane region."}, {"pubmed": 31562564, "text": "Purpurin was non-toxic when fed to Drosophila and it significantly ameliorated the AD-related neurotoxic symptoms of transgenic flies expressing WT-FL human Tau (hTau) plausibly by inhibiting Tau accumulation and reducing Tau phosphorylation"}, {"pubmed": 31578281, "text": "It screens uncovered that knockdown of several components of the endosomal sorting complexes required for transport (ESCRT) machinery, including charged multivesicular body protein 6 (CHMP6), or CHMP2A in combination with CHMP2B (whose gene is linked to familial FTD), promote propagation of tau aggregation."}, {"pubmed": 31581367, "text": "Yeast surface display of full-length human microtubule-associated protein tau."}, {"pubmed": 31585367, "text": "Asymptomatic microtubule-associated protein tau mutation carriers had higher mean diffusivity in entorhinal WM, which propagated to the limbic tracts and frontotemporal projections in the symptomatic stage compared with noncarriers"}, {"pubmed": 31597093, "text": "Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease."}, {"pubmed": 31618471, "text": "Are mutations in MAPT associated with GGT type III?"}, {"pubmed": 31626288, "text": "In this study, aging-related tau astrogliopathy (ARTAG) pathology is frequent and correlates with older age and higher Braak stage. ARTAG subtypes exhibit distinct distribution patterns with subpial and subependymal deposition occurring in the amygdala, while white and grey matter astrocytic deposition are distributed throughout cortical regions."}, {"pubmed": 31640778, "text": "Preferential tau aggregation in von Economo neurons and fork cells in frontotemporal lobar degeneration with specific MAPT variants."}, {"pubmed": 31653695, "text": "Reduced microtubule (MT) binding appeared to be the most common dysfunction for the majority of tau variants due to missense mutations, implying that MT-targeting therapies could potentially be effective in the management of tauopathies."}, {"pubmed": 31661961, "text": "Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation."}, {"pubmed": 31663115, "text": "Tau-immunoreactive lesions were found in 38% of patients with focal cortical resection for drug-resistant focal epilepsy."}, {"pubmed": 31685653, "text": "Overexpression of the 0N4R isoform of non-mutant human Tau is pathogenic during postnatal development of transgenic mice, in a manner distinct from classical aging-related tauopathy. Developmental toxicity of non-mutant hTau is associated with strong microtubule binding, which may be a pathological trigger that leads to a disruption of cellular processes and eventual cognitive dysfunction."}, {"pubmed": 31699899, "text": "findings of our study draw attention to a central role of the proline-rich region in Tau function and provide mechanistic insight into Tau-mediated polymerization of tubulin"}, {"pubmed": 31703746, "text": "Studies have demonstrated that the co-expression of TDP-43(M337V) and tau(T175D), two of the most common hallmark neuropathological proteins associated with neurodegeneration can behave in a synergistic manner even when acting at a distance."}, {"pubmed": 31719623, "text": "Contribution of syndecans to cellular uptake and fibrillation of alpha-synuclein and tau."}, {"pubmed": 31721178, "text": "Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain."}, {"pubmed": 31771068, "text": "Amyloid-beta, Tau, and 18F-Fluorodeoxyglucose Positron Emission Tomography in Posttraumatic Stress Disorder."}, {"pubmed": 31774919, "text": "Astrocytic dysfunction in tauopathy appears to precede neurodegeneration and overt tau neuropathology such as phosphorylation, aggregation and formation of neurofibrillary tangles. [review]"}, {"pubmed": 31799623, "text": "Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease."}, {"pubmed": 31812991, "text": "CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults."}, {"pubmed": 31815669, "text": "These findings show that amyloid-beta and tau have different spatial affinities, which can be used to understand how they accumulate in the brain and potentially damage the brain's connections."}, {"pubmed": 31821364, "text": "Human tau expression in Drosophila glial cells does not affect neuromuscular junction synapse formation during development, but is deleterious to the maintenance of glial-axonal interactions in the peripheral nervous system."}, {"pubmed": 31831066, "text": "Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study."}, {"pubmed": 31834353, "text": "Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy."}, {"pubmed": 31836810, "text": "Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Abeta(1-42), pTau and tTau CSF immunoassays."}, {"pubmed": 31886644, "text": "The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA."}, {"pubmed": 31889402, "text": "Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment."}, {"pubmed": 31907603, "text": "Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy."}, {"pubmed": 31911587, "text": "The transmission of distinct tau strains is independent of strain isoform compositions, but instead intrinsic to unique pathological conformations."}, {"pubmed": 31931428, "text": "Plasma levels of Interleukin 18 but not amyloid-beta or Tau are elevated in female depressive patients."}, {"pubmed": 31942037, "text": "MicroRNA-298 reduces levels of human amyloid-beta precursor protein (APP), beta-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties."}, {"pubmed": 31953414, "text": "Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons."}, {"pubmed": 31974309, "text": "Tau binds to disordered N-terminal region (NTR) of HspB1 and lead to productive HspB1 chaperone activity."}, {"pubmed": 31990459, "text": "Serum levels of Abeta42 and tau protein in Parkinson's disease may be a useful marker for the assessment of cognitive impairments"}, {"pubmed": 31991443, "text": "Changes in plasma Abeta concentration are time-dependent, whereas changes in hyperphosphorylated tau protein levels paralleled the clinical progression of mild cognitive impairment"}, {"pubmed": 31995742, "text": "Structural Characterization of Tau in Fuzzy Tau:Tubulin Complexes."}, {"pubmed": 32019137, "text": "Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury."}, {"pubmed": 32019610, "text": "Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease."}, {"pubmed": 32043530, "text": "Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier."}, {"pubmed": 32050258, "text": "Novel tau filament fold in corticobasal degeneration"}, {"pubmed": 32051249, "text": "In AKT-KI(+/+) mice, expressing the pathogenic human Tau mutant (hTau-P301L), the hTau S199 phosphorylation was ameliorated as GSK3beta phosphorylation was regained."}, {"pubmed": 32087764, "text": "A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases."}, {"pubmed": 32096024, "text": "findings show that filamentous tau adopts one fold in Alzheimer's disease and a different fold in Pick's disease, establishing the existence of distinct conformers"}, {"pubmed": 32096026, "text": "Nuclear Magnetic Resonance Spectroscopy Insights into Tau Structure in Solution: Impact of Post-translational Modifications"}, {"pubmed": 32096027, "text": "Regulation of Tau Homeostasis and Toxicity by Acetylation"}, {"pubmed": 32096028, "text": "Review: Tau Clearance Mechanisms"}, {"pubmed": 32096029, "text": "review proposed mechanisms of axonal targeting of Tau and potential influences of the TDB/AIS on the subcellular distribution of Tau"}, {"pubmed": 32096030, "text": "review the evidence that tau affects fast axonal transport and examine several potential mechanisms proposed to underlie this toxicity"}, {"pubmed": 32096031, "text": "Presynaptic Pathophysiology Encoded in Different Domains of Tau: this information could contribute to the understanding of \"normal\" Tau biology and possible therapeutical strategies"}, {"pubmed": 32096032, "text": "findings emphasise the importance of gaining a comprehensive understanding of the diverse roles of tau at distinct intraneuronal locations; an improved knowledge of the impact of synaptic tau under physiological and pathological conditions and how tau localisation impacts on neuronal function will provide valuable insights that may lead to the development of new therapies for the tauopathies"}, {"pubmed": 32096033, "text": "our current understanding of synaptic tau and its functions and illuminate the numerous remaining challenges in this evolving research area"}, {"pubmed": 32096034, "text": "recent advances in understanding the mechanisms of Tau secretion and discusses the role of such mechanisms in the development of Tau pathology"}, {"pubmed": 32096035, "text": "recent advances involving tau and nucleic acids in neuronal and non-neuronal cells"}, {"pubmed": 32096036, "text": "Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease"}, {"pubmed": 32096037, "text": "Relationship Between Tau, beta Amyloid and alpha-Synuclein Pathologies:  discuss how the presence of multiple pathological lesions can affect the pathological and clinical phenotype of neurodegenerative disorders"}, {"pubmed": 32096038, "text": "Associations Between APOE Variants, Tau and alpha-Synuclein"}, {"pubmed": 32096039, "text": "Amyloid-beta and Tau at the Crossroads of Alzheimer's Disease"}, {"pubmed": 32096042, "text": "Tau Accumulation and Network Breakdown in Alzheimer's Disease"}, {"pubmed": 32096044, "text": "Tau, Diabetes and Insulin"}, {"pubmed": 32096046, "text": "Tau Prion-Like Propagation: State of the Art and Current Challenges"}, {"pubmed": 32096047, "text": "REVIEW: Tau Condensates"}, {"pubmed": 32096048, "text": "Liquid-Liquid Phase Separation of Tau Protein in Neurobiology and Pathology"}, {"pubmed": 32096049, "text": "Pathophysiology of Tau and Stress Granules in Disease"}, {"pubmed": 32096050, "text": "description of how tau oligomers are identified, summarization of the differences of tau oligomers among research groups, and discussion of their hypothesized functions"}, {"pubmed": 32096052, "text": "Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy"}, {"pubmed": 32097865, "text": "Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes."}, {"pubmed": 32116257, "text": "The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up."}, {"pubmed": 32123248, "text": "A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals."}, {"pubmed": 32123385, "text": "Plasma phosphorylated tau181 is a noninvasive diagnostic and prognostic biomarker of Alzheimer's disease."}, {"pubmed": 32132570, "text": "Basic Limonoid modulates Chaperone-mediated Proteostasis and dissolve Tau fibrils."}, {"pubmed": 32161412, "text": "These findings provide insights into the pathways linking tau, amyloid-beta and neurodegeneration, and may facilitate clinical trials of tau-based treatments."}, {"pubmed": 32181806, "text": "Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration."}, {"pubmed": 32216967, "text": "Growth arrest specific protein 7 inhibits tau fibrillogenesis."}, {"pubmed": 32219515, "text": "Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation."}, {"pubmed": 32226410, "text": "Behavioral Abnormalities in Knockout and Humanized Tau Mice."}, {"pubmed": 32229582, "text": "Zinc promotes liquid-liquid phase separation of tau protein."}, {"pubmed": 32251304, "text": "Tau protein- induced sequestration of the eukaryotic ribosome: Implications in neurodegenerative disease."}, {"pubmed": 32291284, "text": "Structural basis of the interplay between alpha-synuclein and Tau in regulating pathological amyloid aggregation."}, {"pubmed": 32295833, "text": "Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses."}, {"pubmed": 32303140, "text": "The histopathological staging of tau, but not amyloid, corresponds to antemortem cognitive status, dementia stage, functional abilities and neuropsychiatric symptoms."}, {"pubmed": 32338825, "text": "Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage-gated calcium channels and NADPH oxidase."}, {"pubmed": 32341125, "text": "Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau."}, {"pubmed": 32344399, "text": "Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype."}, {"pubmed": 32366836, "text": "Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer's disease, progressive supranuclear palsy and dementia with Lewy bodies."}, {"pubmed": 32427887, "text": "Tau affects P53 function and cell fate during the DNA damage response."}, {"pubmed": 32430253, "text": "Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer."}, {"pubmed": 32436623, "text": "Tau accumulates in Crohn's disease gut."}, {"pubmed": 32453948, "text": "Hydration and Dynamics of Full-Length Tau Amyloid Fibrils Investigated by Solid-State Nuclear Magnetic Resonance."}, {"pubmed": 32469871, "text": "Since the retinal nerve fiber layer (RNFL) is depleted in established Alzheimer's disease (AD), we tested whether its thickness can predict whether cognitively healthy (CH) individuals have a normal or pathological cerebrospinal fluid (CSF) Ab42 (A) and tau (T) ratio"}, {"pubmed": 32471486, "text": "Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation."}, {"pubmed": 32493775, "text": "Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease."}, {"pubmed": 32499112, "text": "Prediction of human tau 3D structure, and interplay between O-beta-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo."}, {"pubmed": 32538723, "text": "Advent of Proteomic Tools for Diagnostic Biomarker Analysis in Alzheimer's Disease."}, {"pubmed": 32538846, "text": "Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease."}, {"pubmed": 32544086, "text": "Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration."}, {"pubmed": 32560668, "text": "Phosphorylation and oligomerization of alpha-synuclein associated with GSK-3beta activation in the rTg4510 mouse model of tauopathy."}, {"pubmed": 32561678, "text": "Subtypes of dementia with Lewy bodies are associated with alpha-synuclein and tau distribution."}, {"pubmed": 32571418, "text": "Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies."}, {"pubmed": 32572268, "text": "Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease."}, {"pubmed": 32575375, "text": "Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human MAPT Gene Expression."}, {"pubmed": 32605500, "text": "Insights into lncRNAs in Alzheimer's disease mechanisms."}, {"pubmed": 32665603, "text": "Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study."}, {"pubmed": 32679907, "text": "Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer's Disease Progression."}, {"pubmed": 32699110, "text": "Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures."}, {"pubmed": 32708732, "text": "Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core."}, {"pubmed": 32710889, "text": "Microtubule alterations may destabilize photoreceptor integrity: Age-related microtubule changes and pattern of expression of MAP-2, Tau and hyperphosphorylated Tau in aging human photoreceptor cells."}, {"pubmed": 32722166, "text": "Exploring IDP-Ligand Interactions: tau K18 as A Test Case."}, {"pubmed": 32732283, "text": "Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction."}, {"pubmed": 32737201, "text": "Truncation of Tau selectively facilitates its pathological activities."}, {"pubmed": 32751642, "text": "Hsp22 with an N-Terminal Domain Truncation Mediates a Reduction in Tau Protein Levels."}, {"pubmed": 32759167, "text": "Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation."}, {"pubmed": 32759310, "text": "Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort."}, {"pubmed": 32767721, "text": "Association of MAPT subhaplotypes with clinical and demographic features in Parkinson's disease."}, {"pubmed": 32769115, "text": "Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration."}, {"pubmed": 32770092, "text": "Lipid membrane templated misfolding and self-assembly of intrinsically disordered tau protein."}, {"pubmed": 32829532, "text": "Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease."}, {"pubmed": 32855391, "text": "RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction."}, {"pubmed": 32926180, "text": "Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration."}, {"pubmed": 32929646, "text": "Amyloid, tau and risk of Alzheimer's disease: a Mendelian randomization study."}, {"pubmed": 32955735, "text": "Tau phosphorylation by glycogen synthase kinase 3beta modulates enzyme acetylcholinesterase expression."}, {"pubmed": 32967303, "text": "Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology."}, {"pubmed": 32979285, "text": "Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer."}, {"pubmed": 32993812, "text": "Integrated analysis of the aging brain transcriptome and proteome in tauopathy."}, {"pubmed": 33001416, "text": "Distinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures."}, {"pubmed": 33004675, "text": "Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau."}, {"pubmed": 33006106, "text": "Phenotype Heterogeneity and Genotype Correlation of MAPT Mutations in a Chinese PUMCH Cohort."}, {"pubmed": 33016911, "text": "The Impact of Amyloid-beta or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease."}, {"pubmed": 33017638, "text": "The behavioural phenotype of 14-month-old female TAU58/2 transgenic mice."}, {"pubmed": 33058882, "text": "Gene Expression of Disease-related Genes in Alzheimer's Disease is Impaired by Tau Aggregation."}, {"pubmed": 33065281, "text": "TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia."}, {"pubmed": 33068398, "text": "Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease."}, {"pubmed": 33078207, "text": "The structure and phase of tau: from monomer to amyloid filament."}, {"pubmed": 33112398, "text": "Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants."}, {"pubmed": 33169916, "text": "Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Abeta pathology are detected."}, {"pubmed": 33179866, "text": "Fate and propagation of endogenously formed Tau aggregates in neuronal cells."}, {"pubmed": 33183222, "text": "Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils."}, {"pubmed": 33188775, "text": "Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease."}, {"pubmed": 33199433, "text": "Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease."}, {"pubmed": 33212983, "text": "Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease."}, {"pubmed": 33228978, "text": "Association between plasma tau and postoperative delirium incidence and severity: a prospective observational study."}, {"pubmed": 33237772, "text": "HDAC6 ZnF UBP as the Modifier of Tau Structure and Function."}, {"pubmed": 33246331, "text": "Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons."}, {"pubmed": 33247134, "text": "Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals."}, {"pubmed": 33247623, "text": "Brain volumetric deficits in MAPT mutation carriers: a multisite study."}, {"pubmed": 33255694, "text": "Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies."}, {"pubmed": 33262278, "text": "Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation."}, {"pubmed": 33279949, "text": "Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease."}, {"pubmed": 33283854, "text": "CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease."}, {"pubmed": 33287913, "text": "MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features."}, {"pubmed": 33334867, "text": "The Two Cysteines of Tau Protein Are Functionally Distinct and Contribute Differentially to Its Pathogenicity in Vivo."}, {"pubmed": 33371862, "text": "Relationship Between Oxidative Stress, Tau Level and Antioxidant Mechanisms of the KEAP-1/NRF-2/HO-1 in Children with Hydrocephalus."}, {"pubmed": 33380426, "text": "Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation."}, {"pubmed": 33398028, "text": "Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex."}, {"pubmed": 33427873, "text": "Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease."}, {"pubmed": 33431651, "text": "Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3beta and inhibiting Tau hyperphosphorylation."}, {"pubmed": 33433870, "text": "Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations."}, {"pubmed": 33452442, "text": "Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation."}, {"pubmed": 33452693, "text": "Interplay between tau and alpha-synuclein liquid-liquid phase separation."}, {"pubmed": 33453282, "text": "Cu, Fe, and Zn isotope ratios in murine Alzheimer's disease models suggest specific signatures of amyloidogenesis and tauopathy."}, {"pubmed": 33459145, "text": "Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress."}, {"pubmed": 33473181, "text": "Retromer dysfunction at the nexus of tauopathies."}, {"pubmed": 33477465, "text": "From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases."}, {"pubmed": 33496017, "text": "The Lys 280 --> Gln mutation mimicking disease-linked acetylation of Lys 280 in tau extends the structural core of fibrils and modulates their catalytic properties."}, {"pubmed": 33554920, "text": "Significant Overlap of alpha-Synuclein, Amyloid-beta, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank."}, {"pubmed": 33557920, "text": "Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias."}, {"pubmed": 33568215, "text": "Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers."}, {"pubmed": 33597014, "text": "Alzheimer's disease brain contains tau fractions with differential prion-like activities."}, {"pubmed": 33622418, "text": "Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology."}, {"pubmed": 33639278, "text": "Chemometric modeling of the electrochemical data to investigate proline cis/trans isomeration effect on aggregation of Tau protein."}, {"pubmed": 33649324, "text": "Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits."}, {"pubmed": 33663205, "text": "Uncovering the Effect of pS202/pT205/pS208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein."}, {"pubmed": 33686711, "text": "Small heat shock protein 22 kDa can modulate the aggregation and liquid-liquid phase separation behavior of tau."}, {"pubmed": 33707488, "text": "Prediction of tau accumulation in prodromal Alzheimer's disease using an ensemble machine learning approach."}, {"pubmed": 33712071, "text": "Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis."}, {"pubmed": 33712082, "text": "Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue."}, {"pubmed": 33712083, "text": "Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice."}, {"pubmed": 33725124, "text": "Early stages of tau pathology and its associations with functional connectivity, atrophy and memory."}, {"pubmed": 33730588, "text": "The AD tau core spontaneously self-assembles and recruits full-length tau to filaments."}, {"pubmed": 33737516, "text": "Retinal ganglion cell dysfunction in preclinical Alzheimer's disease: an electrophysiologic biomarker signature."}, {"pubmed": 33772783, "text": "Pathogenic MAPT mutations Q336H and Q336R have isoform-dependent differences in aggregation propensity and microtubule dysfunction."}, {"pubmed": 33789730, "text": "Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals."}, {"pubmed": 33794133, "text": "Interaction between the guanylate kinase domain of PSD-95 and the proline-rich region and microtubule binding repeats 2 and 3 of tau."}, {"pubmed": 33798940, "text": "Tau induces formation of alpha-synuclein filaments with distinct molecular conformations."}, {"pubmed": 33804213, "text": "Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes."}, {"pubmed": 33805376, "text": "Tau Is Truncated in Five Regions of the Normal Adult Human Brain."}, {"pubmed": 33809978, "text": "Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297-391) Intermediates."}, {"pubmed": 33915734, "text": "Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 Repression."}, {"pubmed": 33930220, "text": "Liquid-liquid phase separation of tau: From molecular biophysics to physiology and disease."}, {"pubmed": 33930462, "text": "Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism."}, {"pubmed": 33933071, "text": "The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau."}, {"pubmed": 33949133, "text": "Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau."}, {"pubmed": 33952699, "text": "Tau forms oligomeric complexes on microtubules that are distinct from tau aggregates."}, {"pubmed": 33955002, "text": "Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration."}, {"pubmed": 33955104, "text": "Liquid-liquid phase separation of Tau by self and complex coacervation."}, {"pubmed": 33965374, "text": "TBK1 interacts with tau and enhances neurodegeneration in tauopathy."}, {"pubmed": 33980303, "text": "Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease."}, {"pubmed": 34012113, "text": "MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration."}, {"pubmed": 34031605, "text": "Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures."}, {"pubmed": 34071254, "text": "Human Polymerase delta-Interacting Protein 2 (PolDIP2) Inhibits the Formation of Human Tau Oligomers and Fibrils."}, {"pubmed": 34095977, "text": "Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers."}, {"pubmed": 34107054, "text": "Phosphorylation of trans-active response DNA-binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing."}, {"pubmed": 34116706, "text": "Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease."}, {"pubmed": 34119372, "text": "A genome-wide association study of plasma phosphorylated tau181."}, {"pubmed": 34151786, "text": "Plasma Levels of Amyloid-beta Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease."}, {"pubmed": 34158075, "text": "Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22."}, {"pubmed": 34158479, "text": "KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease."}, {"pubmed": 34172279, "text": "The role of frontotemporal dementia associated genes in patients with Alzheimer's disease."}, {"pubmed": 34193922, "text": "Biophysical properties of a tau seed."}, {"pubmed": 34209408, "text": "Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells."}, {"pubmed": 34244499, "text": "Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils."}, {"pubmed": 34246750, "text": "Neurotoxicity of oligomers of phosphorylated Tau protein carrying tauopathy-associated mutation is inhibited by prion protein."}, {"pubmed": 34254442, "text": "Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers."}, {"pubmed": 34262014, "text": "A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies."}, {"pubmed": 34274155, "text": "A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene."}, {"pubmed": 34285331, "text": "Temporal trajectory of biofluid markers in Parkinson's disease."}, {"pubmed": 34289368, "text": "Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia."}, {"pubmed": 34290082, "text": "Regulation of Synapse Weakening through Interactions of the Microtubule Associated Protein Tau with PACSIN1."}, {"pubmed": 34308969, "text": "Membrane interaction and disulphide-bridge formation in the unconventional secretion of Tau."}, {"pubmed": 34310832, "text": "Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline."}, {"pubmed": 34314701, "text": "ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids."}, {"pubmed": 34319403, "text": "Smuggle tau through a secret(ory) pathway."}, {"pubmed": 34330900, "text": "Endo-lysosomal Abeta concentration and pH trigger formation of Abeta oligomers that potently induce Tau missorting."}, {"pubmed": 34342183, "text": "MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology."}, {"pubmed": 34366349, "text": "Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier."}, {"pubmed": 34381050, "text": "The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model."}, {"pubmed": 34400172, "text": "Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease."}, {"pubmed": 34401998, "text": "The Structure Biology of Tau and Clue for Aggregation Inhibitor Design."}, {"pubmed": 34414533, "text": "Generation and Role of Calpain-Cleaved 17-kDa Tau Fragment in Acute Ischemic Stroke."}, {"pubmed": 34426645, "text": "Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau-microtubule interactions and inhibits aggregation."}, {"pubmed": 34446931, "text": "Microglial activation and tau propagate jointly across Braak stages."}, {"pubmed": 34453888, "text": "Interaction of tau with HNRNPA2B1 and N(6)-methyladenosine RNA mediates the progression of tauopathy."}, {"pubmed": 34462532, "text": "Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta."}, {"pubmed": 34473990, "text": "Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture."}, {"pubmed": 34480901, "text": "Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-beta."}, {"pubmed": 34487324, "text": "Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease."}, {"pubmed": 34516970, "text": "P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies."}, {"pubmed": 34531286, "text": "Hippocampal Connectivity with Retrosplenial Cortex is Linked to Neocortical Tau Accumulation and Memory Function."}, {"pubmed": 34537237, "text": "Microsecond Dynamics During the Binding-induced Folding of an Intrinsically Disordered Protein."}, {"pubmed": 34560101, "text": "Myricetin slows liquid-liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity."}, {"pubmed": 34575885, "text": "Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study."}, {"pubmed": 34587152, "text": "Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression."}, {"pubmed": 34592311, "text": "Structural mapping techniques distinguish the surfaces of fibrillar 1N3R and 1N4R human tau."}, {"pubmed": 34593828, "text": "Neuronally-derived tau is increased in experienced breachers and is associated with neurobehavioral symptoms."}, {"pubmed": 34595752, "text": "Low prevalence of amyloid and tau pathology in drug-resistant temporal lobe epilepsy."}, {"pubmed": 34627371, "text": "Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer's continuum."}, {"pubmed": 34638632, "text": "Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease."}, {"pubmed": 34649422, "text": "Dynamic-Inspired Perspective on the Molecular Inhibitor of Tau Aggregation by Glucose Gallates Based on Human Neurons."}, {"pubmed": 34653235, "text": "Tau fibril with membrane lipids: Insight from computational modeling and simulations."}, {"pubmed": 34654465, "text": "Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults."}, {"pubmed": 34737403, "text": "Truncating tau reveals different pathophysiological actions of oligomers in single neurons."}, {"pubmed": 34769068, "text": "Differential Effects of Human P301L Tau Expression in Young versus Aged Mice."}, {"pubmed": 34779076, "text": "Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid."}, {"pubmed": 34784549, "text": "Structural study of the recognition mechanism of tau antibody Tau2r3 with the key sequence (VQIINK) in tau aggregation."}, {"pubmed": 34807233, "text": "Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies."}, {"pubmed": 34838590, "text": "Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation."}, {"pubmed": 34843091, "text": "Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance."}, {"pubmed": 34843548, "text": "Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics."}, {"pubmed": 34854549, "text": "Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau."}, {"pubmed": 34859923, "text": "Human genome-wide analysis and identification of the hyperphosphorylation-elicited interactions between subarachnoid tau protein and phosphoprotein-binding domains."}, {"pubmed": 34913212, "text": "No evidence of aberrant amyloid beta and phosphorylated tau expression in herpes simplex virus-infected neurons of the trigeminal ganglia and brain."}, {"pubmed": 34924376, "text": "Association of APOE varepsilon4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function."}, {"pubmed": 34944022, "text": "NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression."}, {"pubmed": 34944028, "text": "Cannabidiol Inhibits Tau Aggregation In Vitro."}, {"pubmed": 34951131, "text": "Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation."}, {"pubmed": 35000752, "text": "BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance."}, {"pubmed": 35007692, "text": "Association of alpha-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain."}, {"pubmed": 35013160, "text": "Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease."}, {"pubmed": 35020237, "text": "MAPT Q336H mutation: Intrafamilial phenotypic heterogeneity in a new Italian family."}, {"pubmed": 35040015, "text": "Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation."}, {"pubmed": 35041062, "text": "Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt-Jakob disease in clinical practice."}, {"pubmed": 35063084, "text": "Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration."}, {"pubmed": 35093145, "text": "Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease."}, {"pubmed": 35135879, "text": "The pathogenic R5L mutation disrupts formation of Tau complexes on the microtubule by altering local N-terminal structure."}, {"pubmed": 35139894, "text": "A comparison between tau and amyloid-beta cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease."}, {"pubmed": 35169889, "text": "Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles."}, {"pubmed": 35175385, "text": "Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies."}, {"pubmed": 35177665, "text": "A human tau seeded neuronal cell model recapitulates molecular responses associated with Alzheimer's disease."}, {"pubmed": 35246269, "text": "Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization."}, {"pubmed": 35269542, "text": "Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment (171)IPAKTPPAPK(180) Using Molecular Dynamic Simulation and the Markov State Model."}, {"pubmed": 35272005, "text": "Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions."}, {"pubmed": 35348036, "text": "Association between H2 haplotype of microtubule associated protein tau gene (deletion / insertion) with Alzheimer Disease in Tunisian patients."}, {"pubmed": 35348856, "text": "Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations."}, {"pubmed": 35358703, "text": "CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease."}, {"pubmed": 35379354, "text": "Mical modulates Tau toxicity via cysteine oxidation in vivo."}, {"pubmed": 35436464, "text": "P301L tau mutation leads to alterations of cell cycle, DNA damage response and apoptosis: Evidence for a role of tau in cancer."}, {"pubmed": 35443844, "text": "Role of aluminum exposure on Alzheimer's disease and related glycogen synthase kinase pathway."}, {"pubmed": 35469971, "text": "The Plasma Membrane Ca[2+]-ATPase, a Molecular Target for Tau-induced Cytosolic Calcium Dysregulation."}, {"pubmed": 35476595, "text": "TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model."}, {"pubmed": 35513543, "text": "Ultrastructural and biochemical classification of pathogenic tau, alpha-synuclein and TDP-43."}, {"pubmed": 35525497, "text": "Tau Aggregation."}, {"pubmed": 35546164, "text": "Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease."}, {"pubmed": 35550593, "text": "Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice."}, {"pubmed": 35577574, "text": "Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology."}, {"pubmed": 35603448, "text": "Tau acetylation at K280 regulates tau phosphorylation."}, {"pubmed": 35612780, "text": "BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration."}, {"pubmed": 35659876, "text": "Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons."}, {"pubmed": 35695727, "text": "Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid beta Peptide Aggregation In Vitro."}, {"pubmed": 35731895, "text": "In vitro Tau Aggregation Inducer Molecules Influence the Effects of MAPT Mutations on Aggregation Dynamics."}, {"pubmed": 35758417, "text": "Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain."}, {"pubmed": 35789365, "text": "Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers."}, {"pubmed": 35790423, "text": "Differences in Motor Features of C9orf72, MAPT, or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration."}, {"pubmed": 35799293, "text": "Intracellular accumulation of tau inhibits autophagosome formation by activating TIA1-amino acid-mTORC1 signaling."}, {"pubmed": 35868517, "text": "Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington's Disease Brain."}, {"pubmed": 35872252, "text": "Neuronal nuclear tau and neurodegeneration."}, {"pubmed": 35880989, "text": "Tau Mediates Synergistic Influence of Vascular Risk and Abeta on Cognitive Decline."}, {"pubmed": 35938247, "text": "Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition."}, {"pubmed": 35948658, "text": "Astrocyte biomarker signatures of amyloid-beta and tau pathologies in Alzheimer's disease."}, {"pubmed": 35964542, "text": "Amyloid- beta and tau deposition influences cognitive and functional decline in Down syndrome."}, {"pubmed": 35995336, "text": "Controlled Tau Cleavage in Cells Reveals Abnormal Localizations of Tau Fragments."}, {"pubmed": 36038084, "text": "Precocious emergence of cognitive and synaptic dysfunction in 3xTg-AD mice exposed prenatally to ethanol."}, {"pubmed": 36048712, "text": "Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology."}, {"pubmed": 36056171, "text": "Chronic pain causes Tau-mediated hippocampal pathology and memory deficits."}, {"pubmed": 36066634, "text": "Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration."}, {"pubmed": 36067305, "text": "Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties."}, {"pubmed": 36096678, "text": "beta-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury: A Cross-sectional Study."}, {"pubmed": 36120782, "text": "Relationships Between the Deposition of Amyloid-beta and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study."}, {"pubmed": 36162501, "text": "The N-terminal disease-associated R5L Tau mutation increases microtubule shrinkage rate due to disruption of microtubule-bound Tau patches."}, {"pubmed": 36162981, "text": "Potential association between frailty and pTau in community-dwelling older adults."}, {"pubmed": 36171642, "text": "Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum."}, {"pubmed": 36200879, "text": "Neurodegeneration Markers in the Cerebrospinal Fluid of 100 Patients with Schizophrenia Spectrum Disorder."}, {"pubmed": 36229194, "text": "Q351R MAPT mutation is associated with a mixed 3R/4R tauopathy and a slowly progressive cognitive, behavioural and parkinsonian syndrome."}, {"pubmed": 36302379, "text": "Dysfunctional microglia and tau pathology in Alzheimer's disease."}, {"pubmed": 36333294, "text": "Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease."}, {"pubmed": 36343883, "text": "Targeting caspase-2 interactions with tau in Alzheimer's disease and related dementias."}, {"pubmed": 36361631, "text": "Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies."}, {"pubmed": 36361774, "text": "Differential Effects of Human Tau Isoforms to Neuronal Dysfunction and Toxicity in the Drosophila CNS."}, {"pubmed": 36378913, "text": "All the Tau We Cannot See."}, {"pubmed": 36481386, "text": "Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: Possible implication for Alzheimer's disease."}, {"pubmed": 36517915, "text": "Granulovacuolar degeneration bodies are independently induced by tau and alpha-synuclein pathology."}, {"pubmed": 36518085, "text": "Plasma phosphorylated tau181 predicts cognitive and functional decline."}, {"pubmed": 36520044, "text": "Boosting of tau protein aggregation by CD40 and CD48 gene expression in Alzheimer's disease."}, {"pubmed": 36520068, "text": "Intraneuronal tau aggregation induces the integrated stress response in astrocytes."}, {"pubmed": 36533443, "text": "RNA editing of microtubule-associated protein tau circular RNAs promotes their translation and tau tangle formation."}, {"pubmed": 36563857, "text": "Neurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation."}, {"pubmed": 36599286, "text": "MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD."}, {"pubmed": 36617181, "text": "Vascular injury is associated with repetitive head impacts and tau pathology in chronic traumatic encephalopathy."}, {"pubmed": 36620941, "text": "sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease."}, {"pubmed": 36641371, "text": "Identification and functional characterization of novel variants of MAPT and GRN in Chinese patients with frontotemporal dementia."}, {"pubmed": 36688478, "text": "Tau, tau kinases, and tauopathies: An updated overview."}, {"pubmed": 36710682, "text": "Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study."}, {"pubmed": 36759256, "text": "Pathogenic Role of RAGE in Tau Transmission and Memory Deficits."}, {"pubmed": 36807141, "text": "Cofilin promotes tau pathology in Alzheimer's disease."}, {"pubmed": 36847488, "text": "Identification of phosphorylated tau protein interactors in progressive supranuclear palsy (PSP) reveals networks involved in protein degradation, stress response, cytoskeletal dynamics, metabolic processes, and neurotransmission."}, {"pubmed": 36855333, "text": "Tau, beta-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS)."}, {"pubmed": 36878036, "text": "Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency."}, {"pubmed": 36889338, "text": "Receptor for Advanced Glycation End Products: Dementia and Cognitive Impairment."}, {"pubmed": 36898832, "text": "Characterization of the Tau Interactome in Human Brain Reveals Isoform-Dependent Interaction with 14-3-3 Family Proteins."}, {"pubmed": 36906636, "text": "Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue."}, {"pubmed": 36918705, "text": "Friend or foe: role of pathological tau in neuronal death."}, {"pubmed": 36938834, "text": "The relationship between obstructive sleep apnea and circulating tau levels: A meta-analysis."}, {"pubmed": 36946611, "text": "SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease."}, {"pubmed": 36989381, "text": "Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease."}, {"pubmed": 37000265, "text": "Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells."}, {"pubmed": 37037158, "text": "Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis."}, {"pubmed": 37037195, "text": "TDP-43 and tau concurrence in the entorhinal subfields in primary age-related tauopathy and preclinical Alzheimer's disease."}, {"pubmed": 37052232, "text": "Assessment of tau phosphorylation and beta-amyloid pathology in human drug-resistant epilepsy."}, {"pubmed": 37083538, "text": "Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer's disease."}, {"pubmed": 37086756, "text": "Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation."}, {"pubmed": 37104927, "text": "Distinct and joint effects of low and high levels of Abeta and tau deposition on cortical thickness."}, {"pubmed": 37131250, "text": "Mutations in alpha-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases."}, {"pubmed": 37137254, "text": "The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer's disease."}, {"pubmed": 37140480, "text": "Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies."}, {"pubmed": 37143123, "text": "Identical tau filaments in subacute sclerosing panencephalitis and chronic traumatic encephalopathy."}, {"pubmed": 37154939, "text": "Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases."}, {"pubmed": 37164636, "text": "Big Tau: What We Know, and We Need to Know."}, {"pubmed": 37167199, "text": "Conformation and Affinity Modulations by Multiple Phosphorylation Occurring in the BIN1 SH3 Domain Binding Site of the Tau Protein Proline-Rich Region."}, {"pubmed": 37175990, "text": "Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation."}, {"pubmed": 37182866, "text": "Altered Anterior Insular Metabolic Connectivity in Asymptomatic MAPT P301L Carriers."}, {"pubmed": 37182882, "text": "A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry."}, {"pubmed": 37190093, "text": "Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis."}, {"pubmed": 37192625, "text": "Synaptic oligomeric tau in Alzheimer's disease - A potential culprit in the spread of tau pathology through the brain."}, {"pubmed": 37198279, "text": "Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies."}, {"pubmed": 37214541, "text": "Cognitive Performance as a Function of MAPT Haplotype: A Prospective Longitudinal Study of an Essential Tremor Cohort."}, {"pubmed": 37231491, "text": "Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [[18]F]flortaucipir study."}, {"pubmed": 37248300, "text": "Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical Alzheimer's disease."}, {"pubmed": 37248902, "text": "Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies."}, {"pubmed": 37248906, "text": "Memory, Sleep, and Tau Function."}, {"pubmed": 37258650, "text": "Effects of three microtubule-associated proteins (MAP2, MAP4, and Tau) on microtubules' physical properties and neurite morphology."}, {"pubmed": 37264610, "text": "Tau in dementia with Lewy bodies."}, {"pubmed": 37266762, "text": "The Role of Tau Proteoforms in Health and Disease."}, {"pubmed": 37279597, "text": "Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET study."}, {"pubmed": 37354322, "text": "Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy."}, {"pubmed": 37358817, "text": "Infection promotes Ser-214 phosphorylation important for generation of cytotoxic tau variants."}, {"pubmed": 37393505, "text": "Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease."}, {"pubmed": 37402804, "text": "Disease-specific modifications of tau protein."}, {"pubmed": 37413784, "text": "MAPT rs17649553 T allele is associated with better verbal memory and higher small-world properties in Parkinson's disease."}, {"pubmed": 37431188, "text": "Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum."}, {"pubmed": 37466059, "text": "Correlation between insulin-degrading enzyme versus total tau and selected cytokines in patients with Alzheimer s disease compared to non-demented controls."}, {"pubmed": 37467655, "text": "MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset."}, {"pubmed": 37495886, "text": "Individual regional associations between Abeta-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies."}, {"pubmed": 37496076, "text": "Physiological expression of mutated TAU impaired astrocyte activity and exacerbates beta-amyloid pathology in 5xFAD mice."}, {"pubmed": 37499587, "text": "Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease."}, {"pubmed": 37506550, "text": "Spatial cognition is associated with levels of phosphorylated-tau and beta-amyloid in clinically normal older adults."}, {"pubmed": 37511361, "text": "Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome."}, {"pubmed": 37530894, "text": "Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study."}, {"pubmed": 37577852, "text": "The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity."}, {"pubmed": 37603556, "text": "Tau protein aggregation associated with SARS-CoV-2 main protease."}, {"pubmed": 37633469, "text": "Abnormal interaction of Rlip with mutant APP/Abeta and phosphorylated tau reduces wild-type Rlip levels and disrupt Rlip function in Alzheimer's disease."}, {"pubmed": 37639492, "text": "Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults."}, {"pubmed": 37641913, "text": "Activation of transient receptor potential vanilloid 1 ameliorates tau accumulation-induced synaptic damage and cognitive dysfunction via autophagy enhancement."}, {"pubmed": 37703311, "text": "Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology."}, {"pubmed": 37716378, "text": "P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes."}, {"pubmed": 37725589, "text": "Temporal Profiles of P-Tau, T-Tau, and P-Tau:Tau Ratios in Cerebrospinal Fluid and Blood from Moderate-Severe Traumatic Brain Injury Patients and Relationship to 6-12 Month Global Outcomes."}, {"pubmed": 37730697, "text": "Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response."}, {"pubmed": 37730840, "text": "Long non-coding RNA SNHG8 drives stress granule formation in tauopathies."}, {"pubmed": 37735502, "text": "Tau suppresses microtubule-regulated pancreatic insulin secretion."}, {"pubmed": 37739953, "text": "Acetylation discriminates disease-specific tau deposition."}, {"pubmed": 37798679, "text": "Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau."}, {"pubmed": 37806671, "text": "Neurobiological correlation between phosphorylated tau and mood symptoms in memory clinic patients."}, {"pubmed": 37813312, "text": "Tau trajectory in Alzheimer's disease: Evidence from the connectome-based computational models."}, {"pubmed": 37820751, "text": "Apathy-like behaviour in tau mouse models of Alzheimer's disease and frontotemporal dementia."}, {"pubmed": 37837382, "text": "Combined Connectomics, MAPT Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease."}, {"pubmed": 37852722, "text": "Phosphorylated tau in Alzheimer's disease."}, {"pubmed": 37865674, "text": "Tau accumulation in degradative organelles is associated to lysosomal stress."}, {"pubmed": 37875471, "text": "Plasma biomarkers predict Alzheimer's disease before clinical onset in Chinese cohorts."}, {"pubmed": 37878719, "text": "Structure of the nonhelical filament of the Alzheimer's disease tau core."}, {"pubmed": 37891164, "text": "Multivalent Tau/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density."}, {"pubmed": 37891635, "text": "Human tauopathy strains defined by phosphorylation in R1-R2 repeat domains of tau."}, {"pubmed": 37904205, "text": "Distinct tau folds initiate templated seeding and alter the post-translational modification profile."}, {"pubmed": 37955806, "text": "DLK-MAPK Signaling Coupled with DNA Damage Promotes Intrinsic Neurotoxicity Associated with Non-Mutated Tau."}, {"pubmed": 37977223, "text": "c-Src regulates delta-secretase activation and truncated Tau production by phosphorylating the E3 ligase Traf6."}, {"pubmed": 37980663, "text": "Association of Tooth Loss with Alzheimer's Disease Tau Pathologies Assessed by Positron Emission Tomography."}, {"pubmed": 37988169, "text": "Galectin-3 aggravates microglial activation and tau transmission in tauopathy."}, {"pubmed": 38002967, "text": "Navigating the ALS Genetic Labyrinth: The Role of MAPT Haplotypes."}, {"pubmed": 38007650, "text": "Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases."}, {"pubmed": 38007664, "text": "Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech."}, {"pubmed": 38073060, "text": "Tau and neurodegeneration."}, {"pubmed": 38086389, "text": "APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread."}, {"pubmed": 38100415, "text": "Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold."}, {"pubmed": 38123362, "text": "Spatiotemporal Correlation between Amyloid and Tau Accumulations Underlies Cognitive Changes in Aging."}, {"pubmed": 38134678, "text": "The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features."}, {"pubmed": 38148427, "text": "Tau Accumulation in the Spinal Cord Contributes to Chronic Inflammatory Pain by Upregulation of IL-1beta and BDNF."}, {"pubmed": 38164539, "text": "Affection of Motor Network Regions by Tau Pathology Across the Alzheimer's Disease Spectrum."}, {"pubmed": 38181704, "text": "Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3."}, {"pubmed": 38232730, "text": "Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements."}, {"pubmed": 38236720, "text": "Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments."}, {"pubmed": 38254936, "text": "MAPT Locus in Parkinson's Disease Patients of Ashkenazi Origin: A Stratified Analysis."}, {"pubmed": 38275215, "text": "Acetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells."}, {"pubmed": 38286213, "text": "Influence of FTDP-17 mutants on circular tau RNAs."}, {"pubmed": 38287807, "text": "Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review."}, {"pubmed": 38310108, "text": "Local structural preferences in shaping tau amyloid polymorphism."}, {"pubmed": 38334195, "text": "Tau accumulation and atrophy predict amyloid independent cognitive decline in aging."}, {"pubmed": 38336940, "text": "Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease."}, {"pubmed": 38347288, "text": "The contribution of beta-amyloid, Tau and alpha-synuclein to blood-brain barrier damage in neurodegenerative disorders."}, {"pubmed": 38347655, "text": "The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study."}, {"pubmed": 38348772, "text": "Speech patterns during memory recall relates to early tau burden across adulthood."}, {"pubmed": 38377680, "text": "Behavioral and Neurophysiological Implications of Pathological Human Tau Expression in Serotonin Neurons."}, {"pubmed": 38430996, "text": "Chronic pain exacerbates memory impairment and pathology of Abeta and tau by upregulating IL-1beta and p-65 signaling in a mouse model of Alzheimer's disease."}, {"pubmed": 38458997, "text": "Post-translational modification sites are present in hydrophilic cavities of alpha-synuclein, tau, FUS, and TDP-43 fibrils: A molecular dynamics study."}, {"pubmed": 38489191, "text": "Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects."}, {"pubmed": 38489841, "text": "Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats."}, {"pubmed": 38491006, "text": "Complexes of tubulin oligomers and tau form a viscoelastic intervening network cross-bridging microtubules into bundles."}, {"pubmed": 38544341, "text": "Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease."}, {"pubmed": 38552740, "text": "Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway."}, {"pubmed": 38631765, "text": "MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study."}, {"pubmed": 38750228, "text": "G-protein coupled estrogen receptor 1, amyloid-beta, and tau tangles in older adults."}, {"pubmed": 38758288, "text": "Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G."}, {"pubmed": 38835043, "text": "Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau."}, {"pubmed": 38867338, "text": "Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold."}, {"pubmed": 38884806, "text": "Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer's disease."}, {"pubmed": 38897979, "text": "Cysteine in the R3 Tau Peptide Modulates Hemin Binding and Reactivity."}, {"pubmed": 38953578, "text": "CHORDC1, the novel interacting partner of tau protein."}, {"pubmed": 38987603, "text": "CryoET of beta-amyloid and tau within postmortem Alzheimer's disease brain."}], "genomic_pos": [{"chr": "17", "end": 46028334, "ensemblgene": "ENSG00000186868", "start": 45894527, "strand": 1}, {"chr": "HSCHR17_2_CTG5", "end": 730446, "ensemblgene": "ENSG00000277956", "start": 596513, "strand": 1}, {"chr": "HSCHR17_1_CTG5", "end": 893653, "ensemblgene": "ENSG00000276155", "start": 760287, "strand": -1}], "genomic_pos_hg19": [{"chr": "17", "end": 44105700, "start": 43971748, "strand": 1}, {"chr": "HSCHR17_1", "end": 44280402, "start": 44150125, "strand": -1}], "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000226", "qualifier": "involved_in", "term": "microtubule cytoskeleton organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0000226", "pubmed": 1057175, "qualifier": "involved_in", "term": "microtubule cytoskeleton organization"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0000226", "pubmed": 28377597, "qualifier": "involved_in", "term": "microtubule cytoskeleton organization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0001774", "pubmed": 26363795, "qualifier": "involved_in", "term": "microglial cell activation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006475", "pubmed": 28386764, "qualifier": "involved_in", "term": "internal protein amino acid acetylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006919", "pubmed": 26363795, "qualifier": "involved_in", "term": "activation of cysteine-type endopeptidase activity involved in apoptotic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006974", "pubmed": 21131359, "qualifier": "involved_in", "term": "DNA damage response"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007267", "pubmed": 28386764, "qualifier": "involved_in", "term": "cell-cell signaling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0007613", "pubmed": 20655099, "qualifier": "involved_in", "term": "memory"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010288", "qualifier": "involved_in", "term": "response to lead ion"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0010506", "pubmed": 19074461, "qualifier": "acts_upstream_of_or_within", "term": "regulation of autophagy"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010629", "pubmed": 23164821, "qualifier": "involved_in", "term": "negative regulation of gene expression"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010917", "pubmed": 22920254, "qualifier": "involved_in", "term": "negative regulation of mitochondrial membrane potential"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0016072", "pubmed": 28386764, "qualifier": "involved_in", "term": "rRNA metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0019896", "pubmed": 26363795, "qualifier": "involved_in", "term": "axonal transport of mitochondrion"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0021954", "pubmed": 28386764, "qualifier": "involved_in", "term": "central nervous system neuron development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0031110", "pubmed": 27356871, "qualifier": "involved_in", "term": "regulation of microtubule polymerization or depolymerization"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0031113", "pubmed": 1057175, "qualifier": "involved_in", "term": "regulation of microtubule polymerization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0031113", "pubmed": [10640627, 28386764], "qualifier": "involved_in", "term": "regulation of microtubule polymerization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031116", "pubmed": [1421571, 7706316], "qualifier": "involved_in", "term": "positive regulation of microtubule polymerization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0031122", "pubmed": 26363795, "qualifier": "involved_in", "term": "cytoplasmic microtubule organization"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0031175", "qualifier": "involved_in", "term": "neuron projection development"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0031175", "pubmed": 26363795, "qualifier": "involved_in", "term": "neuron projection development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032930", "pubmed": 22920254, "qualifier": "involved_in", "term": "positive regulation of superoxide anion generation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0033044", "pubmed": 28386764, "qualifier": "involved_in", "term": "regulation of chromosome organization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0033673", "pubmed": 20655099, "qualifier": "involved_in", "term": "negative regulation of kinase activity"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034063", "pubmed": 28386764, "qualifier": "involved_in", "term": "stress granule assembly"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034605", "pubmed": 26363795, "qualifier": "involved_in", "term": "cellular response to heat"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034614", "pubmed": 28386764, "qualifier": "involved_in", "term": "cellular response to reactive oxygen species"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045773", "pubmed": 1389180, "qualifier": "involved_in", "term": "positive regulation of axon extension"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0046785", "pubmed": 26996940, "qualifier": "involved_in", "term": "microtubule polymerization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0048143", "pubmed": 26363795, "qualifier": "involved_in", "term": "astrocyte activation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0048167", "pubmed": 28386764, "qualifier": "involved_in", "term": "regulation of synaptic plasticity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0048312", "pubmed": 21854751, "qualifier": "involved_in", "term": "intracellular distribution of mitochondria"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0048699", "pubmed": 8522593, "qualifier": "involved_in", "term": "generation of neurons"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050808", "pubmed": 17270732, "qualifier": "involved_in", "term": "synapse organization"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0050848", "pubmed": 18272392, "qualifier": "involved_in", "term": "regulation of calcium-mediated signaling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0051258", "pubmed": 27044754, "qualifier": "involved_in", "term": "protein polymerization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0061564", "pubmed": 26609151, "qualifier": "involved_in", "term": "axon development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0070507", "pubmed": 15147841, "qualifier": "involved_in", "term": "regulation of microtubule cytoskeleton organization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0070507", "pubmed": 28386764, "qualifier": "involved_in", "term": "regulation of microtubule cytoskeleton organization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0072386", "pubmed": 26363795, "qualifier": "involved_in", "term": "plus-end-directed organelle transport along microtubule"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0090140", "pubmed": 22367970, "qualifier": "involved_in", "term": "regulation of mitochondrial fission"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090258", "pubmed": 22920254, "qualifier": "involved_in", "term": "negative regulation of mitochondrial fission"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0097435", "pubmed": 15654759, "qualifier": "involved_in", "term": "supramolecular fiber organization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0097435", "pubmed": 14769047, "qualifier": "involved_in", "term": "supramolecular fiber organization"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0098930", "pubmed": 28377597, "qualifier": "involved_in", "term": "axonal transport"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0098930", "pubmed": 26363795, "qualifier": "involved_in", "term": "axonal transport"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1900034", "pubmed": 21131359, "qualifier": "involved_in", "term": "regulation of cellular response to heat"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1900452", "pubmed": 28386764, "qualifier": "involved_in", "term": "regulation of long-term synaptic depression"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1902474", "pubmed": 20655099, "qualifier": "involved_in", "term": "positive regulation of protein localization to synapse"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:1902988", "pubmed": 26363795, "qualifier": "involved_in", "term": "neurofibrillary tangle assembly"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1903748", "pubmed": 22920254, "qualifier": "involved_in", "term": "negative regulation of establishment of protein localization to mitochondrion"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1903829", "pubmed": 27356871, "qualifier": "involved_in", "term": "positive regulation of protein localization"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1904428", "pubmed": 19457097, "qualifier": "involved_in", "term": "negative regulation of tubulin deacetylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1904428", "pubmed": 28386764, "qualifier": "involved_in", "term": "negative regulation of tubulin deacetylation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1905689", "qualifier": "involved_in", "term": "positive regulation of diacylglycerol kinase activity"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1990000", "pubmed": 7929085, "qualifier": "involved_in", "term": "amyloid fibril formation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1990090", "pubmed": 28386764, "qualifier": "involved_in", "term": "cellular response to nerve growth factor stimulus"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1990416", "pubmed": 28386764, "qualifier": "involved_in", "term": "cellular response to brain-derived neurotrophic factor stimulus"}], "CC": [{"evidence": "NAS", "gocategory": "CC", "id": "GO:0005576", "pubmed": 28386764, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005634", "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 28386764, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": [23666762, 27356871], "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0005737", "pubmed": [26014385, 27044754], "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005737", "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005739", "pubmed": 28386764, "qualifier": "located_in", "term": "mitochondrion"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 10747907, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005874", "qualifier": "colocalizes_with", "term": "microtubule"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [8522593, 10747907], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "pubmed": 28386764, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0015630", "pubmed": [15147841, 27356871, 28377597], "qualifier": "located_in", "term": "microtubule cytoskeleton"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0015630", "pubmed": [26363795, 28386764], "qualifier": "located_in", "term": "microtubule cytoskeleton"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0016020", "pubmed": 20655099, "qualifier": "colocalizes_with", "term": "membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016607", "qualifier": "located_in", "term": "nuclear speck"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030424", "pubmed": 8642405, "qualifier": "located_in", "term": "axon"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0030424", "pubmed": 26363795, "qualifier": "located_in", "term": "axon"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0030424", "pubmed": 28386764, "qualifier": "located_in", "term": "axon"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030425", "pubmed": [23666762, 25620700], "qualifier": "located_in", "term": "dendrite"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030426", "pubmed": 8642405, "qualifier": "located_in", "term": "growth cone"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0030673", "pubmed": 10747907, "qualifier": "located_in", "term": "axolemma"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034399", "pubmed": 19157893, "qualifier": "located_in", "term": "nuclear periphery"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0036464", "pubmed": 15121898, "qualifier": "located_in", "term": "cytoplasmic ribonucleoprotein granule"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0036477", "pubmed": 20655099, "qualifier": "located_in", "term": "somatodendritic compartment"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0036477", "pubmed": 28386764, "qualifier": "located_in", "term": "somatodendritic compartment"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043005", "qualifier": "is_active_in", "term": "neuron projection"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0043025", "pubmed": 20655099, "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0043197", "pubmed": 28386764, "qualifier": "located_in", "term": "dendritic spine"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0044297", "pubmed": 25620700, "qualifier": "located_in", "term": "cell body"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0044297", "qualifier": "located_in", "term": "cell body"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0044304", "qualifier": "located_in", "term": "main axon"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0045121", "qualifier": "located_in", "term": "membrane raft"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045298", "pubmed": 8642405, "qualifier": "part_of", "term": "tubulin complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0097386", "qualifier": "located_in", "term": "glial cell projection"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0097418", "pubmed": 2484340, "qualifier": "located_in", "term": "neurofibrillary tangle"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0097418", "pubmed": 25620700, "qualifier": "located_in", "term": "neurofibrillary tangle"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:1904115", "qualifier": "located_in", "term": "axon cytoplasm"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003677", "pubmed": 28386764, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003680", "pubmed": 28386764, "qualifier": "enables", "term": "minor groove of adenine-thymine-rich DNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003690", "pubmed": 28386764, "qualifier": "enables", "term": "double-stranded DNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003697", "pubmed": 28386764, "qualifier": "enables", "term": "single-stranded DNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003723", "pubmed": 28386764, "qualifier": "enables", "term": "RNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003779", "pubmed": [22920254, 27306859, 28386764], "qualifier": "enables", "term": "actin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [3111527, 7566652, 9689133, 10987820, 15953362, 16275660, 16446437, 17078951, 17317006, 18292230, 19138662, 19527721, 19647741, 20655099, 21692989, 22367970, 23399914, 23589030, 23666762, 24028865, 24251416, 25051234, 25156556, 26014385, 26402096, 28650319, 28755476, 29764935, 30668577, 31640277, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008017", "qualifier": "enables", "term": "microtubule binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008017", "pubmed": [1918161, 28377597], "qualifier": "enables", "term": "microtubule binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0008017", "pubmed": 10747907, "qualifier": "enables", "term": "microtubule binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0008017", "pubmed": 28386764, "qualifier": "enables", "term": "microtubule binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008017", "pubmed": [26363795, 26609151], "qualifier": "enables", "term": "microtubule binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0017124", "pubmed": 9763511, "qualifier": "enables", "term": "SH3 domain binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019899", "pubmed": [9736630, 12888622, 20133804], "qualifier": "enables", "term": "enzyme binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0019899", "pubmed": 23362255, "qualifier": "enables", "term": "enzyme binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019901", "pubmed": [16923168, 24251416], "qualifier": "enables", "term": "protein kinase binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0019901", "pubmed": 17906291, "qualifier": "enables", "term": "protein kinase binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0030674", "pubmed": 28386764, "qualifier": "enables", "term": "protein-macromolecule adaptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0034185", "pubmed": 7566652, "qualifier": "enables", "term": "apolipoprotein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0034452", "pubmed": 26363795, "qualifier": "enables", "term": "dynactin binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0035091", "pubmed": 28386764, "qualifier": "enables", "term": "phosphatidylinositol binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042802", "pubmed": 15654759, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0042802", "pubmed": [7929085, 14769047, 26014385], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [16446437, 27044754, 30158706, 30894745], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0043565", "pubmed": 28386764, "qualifier": "enables", "term": "sequence-specific DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0051087", "pubmed": 25051234, "qualifier": "enables", "term": "protein-folding chaperone binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0051721", "pubmed": 26363795, "qualifier": "enables", "term": "protein phosphatase 2A binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0051879", "pubmed": 17517623, "qualifier": "enables", "term": "Hsp90 protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0071813", "pubmed": 7972031, "qualifier": "enables", "term": "lipoprotein particle binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0099077", "pubmed": 28386764, "qualifier": "enables", "term": "histone-dependent DNA binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0099609", "pubmed": 15147841, "qualifier": "enables", "term": "microtubule lateral binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:1902936", "pubmed": 28386764, "qualifier": "enables", "term": "phosphatidylinositol bisphosphate binding"}]}, "homologene": {"genes": [[8364, 779920], [9031, 426737], [9544, 574327], [9598, 450177], [9606, 4137], [9615, 480488], [9913, 281296], [10090, 17762], [10116, 29477]], "id": 74962}, "interpro": [{"desc": "Microtubule associated protein, tubulin-binding repeat", "id": "IPR001084", "short_desc": "MAP_tubulin-bd_rpt"}, {"desc": "Microtubule-associated protein Tau", "id": "IPR002955", "short_desc": "Tau"}, {"desc": "Microtubule associated protein MAP2/MAP4/Tau", "id": "IPR027324", "short_desc": "MAP2/MAP4/Tau"}], "ipi": ["IPI00025499", "IPI00026836", "IPI00217976", "IPI00220171", "IPI00220173", "IPI00220174", "IPI00220175", "IPI00293683", "IPI00964662"], "map_location": "17q21.31", "name": "microtubule associated protein tau", "other_names": ["G protein beta1/gamma2 subunit-interacting factor 1", "PHF-tau", "Tau-derived paired helical filament hexapeptide", "microtubule-associated protein tau", "neurofibrillary tangle protein", "paired helical filament-tau", "protein phosphatase 1, regulatory subunit 103"], "pantherdb": {"HGNC": "6893", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "97180", "ortholog_type": "LDO", "panther_family": "PTHR11501", "taxid": 10090, "uniprot_kb": "P10637"}, {"RGD": "69329", "ortholog_type": "LDO", "panther_family": "PTHR11501", "taxid": 10116, "uniprot_kb": "P19332"}, {"Ensembl": "ENSGALG00000000625", "ortholog_type": "LDO", "panther_family": "PTHR11501", "taxid": 9031, "uniprot_kb": "A0A3Q2UDR8"}, {"ZFIN": "ZDB-GENE-081027-2", "ortholog_type": "LDO", "panther_family": "PTHR11501", "taxid": 7955, "uniprot_kb": "E7F9D4"}, {"FlyBase": "FBgn0266579", "ortholog_type": "O", "panther_family": "PTHR11501", "taxid": 7227, "uniprot_kb": "Q9VB15"}, {"dictyBase": "DDB_G0289701", "ortholog_type": "O", "panther_family": "PTHR11501", "taxid": 352472, "uniprot_kb": "Q54H52"}], "uniprot_kb": "P10636"}, "pathway": {"biocarta": [{"id": "biopeptidespathway", "name": "bioactive peptide induced signaling pathway"}, {"id": "p35alzheimerspathway", "name": "deregulation of cdk5 in alzheimers disease"}], "kegg": [{"id": "hsa04010", "name": "MAPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05012", "name": "Parkinson disease - Homo sapiens (human)"}, {"id": "hsa05022", "name": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)"}], "pid": [{"id": "lkb1_pathway", "name": "LKB1 signaling events"}, {"id": "lysophospholipid_pathway", "name": "LPA receptor mediated events"}, {"id": "p38gammadeltapathway", "name": "Signaling mediated by p38-gamma and p38-delta"}, {"id": "reelinpathway", "name": "Reelin signaling pathway"}], "reactome": [{"id": "R-HSA-109581", "name": "Apoptosis"}, {"id": "R-HSA-111465", "name": "Apoptotic cleavage of cellular proteins"}, {"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-1169410", "name": "Antiviral mechanism by IFN-stimulated genes"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-264870", "name": "Caspase-mediated cleavage of cytoskeletal proteins"}, {"id": "R-HSA-438064", "name": "Post NMDA receptor activation events"}, {"id": "R-HSA-442755", "name": "Activation of NMDA receptors and postsynaptic events"}, {"id": "R-HSA-5357801", "name": "Programmed Cell Death"}, {"id": "R-HSA-75153", "name": "Apoptotic execution phase"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-9619483", "name": "Activation of AMPK downstream of NMDARs"}, {"id": "R-HSA-9833482", "name": "PKR-mediated signaling"}], "wikipathways": [{"id": "WP127", "name": "IL-5 signaling pathway"}, {"id": "WP2038", "name": "Regulation of Microtubule Cytoskeleton"}, {"id": "WP2059", "name": "Alzheimer,s disease"}, {"id": "WP2380", "name": "Brain-derived neurotrophic factor (BDNF) signaling pathway"}, {"id": "WP304", "name": "Kit receptor signaling pathway"}, {"id": "WP3286", "name": "Copper homeostasis"}, {"id": "WP382", "name": "MAPK Signaling Pathway"}, {"id": "WP49", "name": "IL-2 signaling pathway"}, {"id": "WP61", "name": "Notch Signaling Pathway Netpath"}]}, "pdb": ["1I8H", "2MZ7", "2ON9", "3OVL", "4E0M", "4E0N", "4E0O", "4FL5", "4GLR", "4NP8", "4TQE", "4Y32", "4Y3B", "4Y5I", "5DMG", "5E2V", "5E2W", "5HF3", "5K7N", "5MO3", "5MP1", "5MP3", "5MP5", "5N5A", "5N5B", "5NVB", "5O3L", "5O3O", "5O3T", "5V5B", "5V5C", "5ZIA", "5ZV3", "6BB4", "6CVJ", "6CVN", "6DC8", "6DC9", "6DCA", "6FBW", "6FI5", "6GK7", "6GK8", "6GX5", "6H06", "6HRE", "6HRF", "6LRA", "6N4P", "6NK4", "6NWP", "6NWQ", "6ODG", "6PXR", "6QJH", "6QJM", "6QJP", "6QJQ", "6TJO", "6TJX", "6VH7", "6VHA", "6VHL", "6VI3", "6XLI", "7EYC", "7KQK", "7MKF", "7MKG", "7MKH", "7NRQ", "7NRS", "7NRT", "7NRV", "7NRX", "7P65", "7P66", "7P67", "7P68", "7P6A", "7P6B", "7P6C", "7P6D", "7P6E", "7PQC", "7PQP", "7QJV", "7QJW", "7QJX", "7QJY", "7QJZ", "7QK1", "7QK2", "7QK3", "7QK5", "7QK6", "7QKF", "7QKG", "7QKH", "7QKI", "7QKJ", "7QKK", "7QKL", "7QKM", "7QKU", "7QKV", "7QKW", "7QKX", "7QKY", "7QKZ", "7QL0", "7QL1", "7QL2", "7QL3", "7QL4", "7R4T", "7R5H", "7SP1", "7U0Z", "7UPE", "7UPF", "7UPG", "7YMN", "7YPG", "8AZU", "8BGS", "8BGV", "8BYN", "8CAQ", "8CAX", "8FNZ", "8FUG", "8FYU", "8G54", "8G55", "8G58", "8KDX", "8OH2", "8OHI", "8OHP", "8OI0", "8OP0", "8OPI", "8ORE", "8ORF", "8ORG", "8OT6", "8OT9", "8OTC", "8OTG", "8OTH", "8OTI", "8OTJ", "8P34", "8PII", "8PPO", "8Q27", "8Q2J", "8Q2K", "8Q2L", "8Q7F", "8Q7L", "8Q7M", "8Q7P", "8Q7T", "8Q88", "8Q8C", "8Q8D", "8Q8E", "8Q8F", "8Q8L", "8Q8M", "8Q8R", "8Q8S", "8Q8U", "8Q8V", "8Q8W", "8Q8X", "8Q8Y", "8Q8Z", "8Q92", "8Q97", "8Q98", "8Q99", "8Q9A", "8Q9B", "8Q9C", "8Q9D", "8Q9E", "8Q9F", "8Q9G", "8Q9H", "8Q9I", "8Q9J", "8Q9K", "8Q9L", "8Q9M", "8Q9O", "8QCP", "8QCR", "8QJJ", "8R3T", "8SEH", "8SEI"], "pfam": "PF00418", "pharmgkb": "PA238", "pharos": {"target_id": 13955, "tdl": "Tclin"}, "pir": ["I52232", "JS0370", "PN0001", "S26663"], "prosite": "PS51491", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF213783", "relationship": "is"}, {"id": "GNF252467", "relationship": "is"}, {"id": "GNF252468", "relationship": "is"}, {"id": "GNF252469", "relationship": "is"}, {"id": "GNF252470", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF036591", "relationship": "is"}, {"id": "GNF038583", "relationship": "is"}, {"id": "GNF038689", "relationship": "similar to"}, {"id": "GNF040407", "relationship": "is"}, {"id": "GNF044455", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF086029", "relationship": "is"}, {"id": "GNF086030", "relationship": "is"}, {"id": "GNF086031", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052236", "relationship": "is"}, {"id": "GNF057005", "relationship": "is"}, {"id": "GNF061838", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070881", "relationship": "is"}, {"id": "GNF070882", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF016424", "relationship": "is"}, {"id": "GNF276206", "relationship": "is"}, {"id": "GNF276207", "relationship": "is"}, {"id": "GNF276485", "relationship": "is"}, {"id": "GNF276504", "relationship": "is"}, {"id": "GNF276505", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF099913", "relationship": "is"}, {"id": "GNF139568", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1", "NG_007398.2", "NT_167251.2", "NT_187663.1"], "protein": ["NP_001116538.2", "NP_001116539.1", "NP_001190180.1", "NP_001190181.1", "NP_001364194.1", "NP_001364195.1", "NP_001364196.1", "NP_001364197.1", "NP_005901.2", "NP_058518.1", "NP_058519.3", "NP_058525.1", "XP_005257419.1", "XP_005257422.1", "XP_005257423.1", "XP_005257424.1", "XP_005257425.1", "XP_005257426.1", "XP_005257427.1", "XP_005257428.1", "XP_047292030.1", "XP_047292031.1", "XP_047292032.1", "XP_047292033.1", "XP_047292034.1", "XP_047292035.1", "XP_047292036.1", "XP_047292037.1", "XP_054172106.1", "XP_054172107.1", "XP_054172108.1", "XP_054172109.1", "XP_054172110.1", "XP_054172111.1", "XP_054172112.1", "XP_054172113.1", "XP_054172114.1", "XP_054172115.1", "XP_054172116.1", "XP_054172117.1", "XP_054172118.1", "XP_054172119.1", "XP_054172120.1", "XP_054172121.1", "XP_054184539.1", "XP_054184540.1", "XP_054184541.1", "XP_054184542.1", "XP_054184543.1", "XP_054184544.1", "XP_054184545.1", "XP_054184546.1", "XP_054184547.1", "XP_054186080.1", "XP_054186081.1", "XP_054186082.1", "XP_054186083.1", "XP_054186084.1", "XP_054186085.1", "XP_054186086.1", "XP_054186087.1", "XP_054186088.1", "XP_054186089.1", "XP_054186090.1", "XP_054186091.1", "XP_054186092.1", "XP_054186093.1"], "rna": ["NM_001123066.4", "NM_001123067.4", "NM_001203251.2", "NM_001203252.2", "NM_001377265.1", "NM_001377266.1", "NM_001377267.1", "NM_001377268.1", "NM_005910.6", "NM_016834.5", "NM_016835.5", "NM_016841.5", "NR_165166.1", "XM_005257362.5", "XM_005257365.5", "XM_005257366.4", "XM_005257367.5", "XM_005257368.5", "XM_005257369.5", "XM_005257370.5", "XM_005257371.5", "XM_047436074.1", "XM_047436075.1", "XM_047436076.1", "XM_047436077.1", "XM_047436078.1", "XM_047436079.1", "XM_047436080.1", "XM_047436081.1", "XM_054316131.1", "XM_054316132.1", "XM_054316133.1", "XM_054316134.1", "XM_054316135.1", "XM_054316136.1", "XM_054316137.1", "XM_054316138.1", "XM_054316139.1", "XM_054316140.1", "XM_054316141.1", "XM_054316142.1", "XM_054316143.1", "XM_054316144.1", "XM_054316145.1", "XM_054316146.1", "XM_054328564.1", "XM_054328565.1", "XM_054328566.1", "XM_054328567.1", "XM_054328568.1", "XM_054328569.1", "XM_054328570.1", "XM_054328571.1", "XM_054328572.1", "XM_054330105.1", "XM_054330106.1", "XM_054330107.1", "XM_054330108.1", "XM_054330109.1", "XM_054330110.1", "XM_054330111.1", "XM_054330112.1", "XM_054330113.1", "XM_054330114.1", "XM_054330115.1", "XM_054330116.1", "XM_054330117.1", "XM_054330118.1"], "translation": [{"protein": "XP_054172108.1", "rna": "XM_054316133.1"}, {"protein": "XP_047292037.1", "rna": "XM_047436081.1"}, {"protein": "XP_054186081.1", "rna": "XM_054330106.1"}, {"protein": "XP_005257426.1", "rna": "XM_005257369.5"}, {"protein": "XP_054184545.1", "rna": "XM_054328570.1"}, {"protein": "XP_054186089.1", "rna": "XM_054330114.1"}, {"protein": "XP_047292034.1", "rna": "XM_047436078.1"}, {"protein": "XP_005257423.1", "rna": "XM_005257366.4"}, {"protein": "NP_001364196.1", "rna": "NM_001377267.1"}, {"protein": "XP_047292032.1", "rna": "XM_047436076.1"}, {"protein": "XP_054184544.1", "rna": "XM_054328569.1"}, {"protein": "NP_005901.2", "rna": "NM_005910.6"}, {"protein": "XP_054172111.1", "rna": "XM_054316136.1"}, {"protein": "NP_001116539.1", "rna": "NM_001123067.4"}, {"protein": "XP_005257419.1", "rna": "XM_005257362.5"}, {"protein": "XP_054186086.1", "rna": "XM_054330111.1"}, {"protein": "NP_001190181.1", "rna": "NM_001203252.2"}, {"protein": "XP_054186082.1", "rna": "XM_054330107.1"}, {"protein": "XP_054172109.1", "rna": "XM_054316134.1"}, {"protein": "XP_054172118.1", "rna": "XM_054316143.1"}, {"protein": "XP_005257422.1", "rna": "XM_005257365.5"}, {"protein": "XP_054172113.1", "rna": "XM_054316138.1"}, {"protein": "XP_054184543.1", "rna": "XM_054328568.1"}, {"protein": "XP_054186080.1", "rna": "XM_054330105.1"}, {"protein": "XP_054186083.1", "rna": "XM_054330108.1"}, {"protein": "XP_005257427.1", "rna": "XM_005257370.5"}, {"protein": "XP_054186092.1", "rna": "XM_054330117.1"}, {"protein": "NP_001364194.1", "rna": "NM_001377265.1"}, {"protein": "XP_054172121.1", "rna": "XM_054316146.1"}, {"protein": "XP_054172120.1", "rna": "XM_054316145.1"}, {"protein": "NP_058519.3", "rna": "NM_016835.5"}, {"protein": "XP_054186084.1", "rna": "XM_054330109.1"}, {"protein": "XP_054186088.1", "rna": "XM_054330113.1"}, {"protein": "NP_058525.1", "rna": "NM_016841.5"}, {"protein": "NP_058518.1", "rna": "NM_016834.5"}, {"protein": "XP_054186087.1", "rna": "XM_054330112.1"}, {"protein": "XP_054172107.1", "rna": "XM_054316132.1"}, {"protein": "NP_001116538.2", "rna": "NM_001123066.4"}, {"protein": "XP_054184541.1", "rna": "XM_054328566.1"}, {"protein": "XP_054172106.1", "rna": "XM_054316131.1"}, {"protein": "XP_054172116.1", "rna": "XM_054316141.1"}, {"protein": "XP_047292036.1", "rna": "XM_047436080.1"}, {"protein": "NP_001364195.1", "rna": "NM_001377266.1"}, {"protein": "NP_001190180.1", "rna": "NM_001203251.2"}, {"protein": "XP_054172112.1", "rna": "XM_054316137.1"}, {"protein": "XP_054172110.1", "rna": "XM_054316135.1"}, {"protein": "XP_054172115.1", "rna": "XM_054316140.1"}, {"protein": "NP_001364197.1", "rna": "NM_001377268.1"}, {"protein": "XP_047292035.1", "rna": "XM_047436079.1"}, {"protein": "XP_047292033.1", "rna": "XM_047436077.1"}, {"protein": "XP_054172117.1", "rna": "XM_054316142.1"}, {"protein": "XP_054184542.1", "rna": "XM_054328567.1"}, {"protein": "XP_054186093.1", "rna": "XM_054330118.1"}, {"protein": "XP_005257425.1", "rna": "XM_005257368.5"}, {"protein": "XP_054184539.1", "rna": "XM_054328564.1"}, {"protein": "XP_005257428.1", "rna": "XM_005257371.5"}, {"protein": "XP_054184540.1", "rna": "XM_054328565.1"}, {"protein": "XP_047292030.1", "rna": "XM_047436074.1"}, {"protein": "XP_054184546.1", "rna": "XM_054328571.1"}, {"protein": "XP_054186091.1", "rna": "XM_054330116.1"}, {"protein": "XP_047292031.1", "rna": "XM_047436075.1"}, {"protein": "XP_054186090.1", "rna": "XM_054330115.1"}, {"protein": "XP_005257424.1", "rna": "XM_005257367.5"}, {"protein": "XP_054186085.1", "rna": "XM_054330110.1"}, {"protein": "XP_054172114.1", "rna": "XM_054316139.1"}, {"protein": "XP_054172119.1", "rna": "XM_054316144.1"}, {"protein": "XP_054184547.1", "rna": "XM_054328572.1"}]}, "reporter": {"HG-U133_Plus_2": ["203928_x_at", "203929_s_at", "203930_s_at", "206401_s_at", "225379_at", "233117_at"], "HG-U95Av2": ["113_i_at", "114_r_at", "310_s_at", "331_at", "38629_at"], "HTA-2_0": ["TC17000592.hg.1", "TC17002241.hg.1", "TC17_ctg5_hap1000017.hg.1"], "HuEx-1_0": "3723687", "HuGene-1_1": "8007828", "HuGene-2_1": "16835016"}, "retired": [1651, 4138, 8152, 147077], "summary": "This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008].", "symbol": "MAPT", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1446659"}, "unigene": "Hs.101174", "uniprot": {"Swiss-Prot": "P10636", "TrEMBL": ["I3L2Z2", "B3KTM0", "A0A0G2JPD5", "A0A0G2JMX7", "A0A0G2JS76", "A0A0G2JQJ7", "A0A7P0T936", "A0A7I2PLE3", "I3L170", "A0A7I2PJZ2"]}, "wikipedia": {"url_stub": "Tau protein"}}